def14a
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Filed by the
Registrant þ
Filed by a Party other than the
Registrant o
Check the appropriate box:
o Preliminary
Proxy Statement
o Confidential,
for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
þ Definitive
Proxy Statement
o Definitive
Additional Materials
o Soliciting
Material Pursuant to
240.14a-12
THE SHERWIN-WILLIAMS COMPANY
(Name of Registrant as Specified
In Its Charter)
(Name of Person(s) Filing Proxy
Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
þ
|
No fee required.
|
|
o
|
Fee computed on table below per Exchange Act
Rules 14a-6(i)(4)
and 0-11.
|
|
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act
Rule 0-11
(set forth the amount on which the filing fee is calculated and
state how it was determined):
|
|
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
o
|
Fee paid previously with preliminary materials.
|
|
o
|
Check box if any part of the fee is offset as provided by
Exchange Act
Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
The
Sherwin-Williams Company
NOTICE OF
ANNUAL MEETING OF SHAREHOLDERS
To Be Held April 20, 2010
The Annual Meeting of Shareholders of
The Sherwin-Williams
Company will be held in the Landmark Conference Center,
927 Midland Building, 101 West Prospect Avenue, Cleveland, Ohio
on Tuesday, April 20, 2010 at 9:00 A.M., local time, for
the following purposes:
|
|
|
|
1.
|
To fix the number of directors of Sherwin-Williams at 11 and to
elect the 11 director nominees named in the attached Proxy
Statement to hold office until the next Annual Meeting of
Shareholders and until their successors are elected;
|
|
|
2.
|
To approve the amendment and restatement of The Sherwin-Williams
Company 2006 Equity and Performance Incentive Plan;
|
|
|
3.
|
To ratify the appointment of Ernst & Young LLP as
Sherwin-Williams independent registered public accounting
firm;
|
|
|
4.
|
To consider a shareholder proposal if presented at the Annual
Meeting; and
|
|
|
5.
|
To transact such other business as may properly come before the
Annual Meeting.
|
Shareholders of record at the close of business on
February 26, 2010, the record date for the Annual Meeting,
are the only shareholders entitled to notice of and to vote at
the Annual Meeting.
Your vote is important. Whether or not you plan to attend the
Annual Meeting, please promptly vote on the Internet, by
telephone or by completing and returning the enclosed proxy
card. Voting early will help avoid additional solicitation costs
and will not prevent you from voting in person at the Annual
Meeting if you wish to do so.
L. E. Stellato
Secretary
101 West Prospect Avenue
Cleveland, Ohio 44115-1075
March 9, 2010
ADMISSION
TO THE 2010 ANNUAL MEETING.
You are entitled to attend the Annual Meeting only if you were a
Sherwin-Williams shareholder at the close of business on
February 26, 2010. We may ask you to present evidence of
share ownership and valid photo identification to enter the
Annual Meeting. Please refer to the section entitled How
can I attend the Annual Meeting? on page 4 for
further information.
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY
MATERIALS FOR THE SHAREHOLDER MEETING TO BE HELD ON
APRIL 20, 2010.
Sherwin-Williams Proxy Statement and 2009 Annual Report to
Shareholders are available at http://proxymaterials.sherwin.com.
TABLE OF
CONTENTS
|
|
|
|
|
|
|
|
1
|
|
|
|
|
4
|
|
|
|
|
8
|
|
|
|
|
10
|
|
|
|
|
11
|
|
|
|
|
13
|
|
|
|
|
14
|
|
|
|
|
16
|
|
|
|
|
20
|
|
|
|
|
20
|
|
|
|
|
20
|
|
|
|
|
21
|
|
|
|
|
35
|
|
|
|
|
43
|
|
|
|
|
44
|
|
|
|
|
49
|
|
|
|
|
62
|
|
|
|
|
62
|
|
|
|
|
63
|
|
|
|
|
66
|
|
|
|
|
67
|
|
|
|
|
68
|
|
|
|
|
68
|
|
|
|
|
69
|
|
|
|
|
69
|
|
|
|
|
69
|
|
|
|
|
A-1
|
|
|
|
|
B-1
|
|
THE
SHERWIN-WILLIAMS COMPANY
101
West Prospect Avenue
Cleveland,
Ohio 44115-1075
PROXY
STATEMENT
March 9, 2010
PRELIMINARY
We are providing the enclosed proxy materials to you in
connection with the solicitation by the Board of Directors of
proxies to be voted at the Annual Meeting of Shareholders to be
held on April 20, 2010. We began mailing these proxy
materials to our shareholders on March 9, 2010. The use of
the terms we, us and our
throughout this Proxy Statement refers to
Sherwin-Williams
and/or its management.
ANNUAL
REPORT
We are enclosing our Annual Report to Shareholders for the year
ended December 31, 2009 with these proxy materials. We may
submit additional financial and other reports at the Annual
Meeting, but we do not intend to take any action relating to
those reports.
ABOUT THE
MEETING
What
is the purpose of the Annual Meeting?
At the Annual Meeting, shareholders will act upon the proposals
outlined in the Notice of Annual Meeting of Shareholders. These
proposals include:
the election of directors;
|
|
|
|
|
the approval of the amendment and restatement of The
Sherwin-Williams Company 2006 Equity and Performance Incentive
Plan;
|
|
|
|
the ratification of the appointment of Sherwin-Williams
independent registered public accounting firm; and
|
|
|
|
the consideration of a shareholder proposal if presented at the
Annual Meeting.
|
In addition, our management will report on
Sherwin-Williams performance and respond to questions from
shareholders. We are not aware of any other matters that will be
brought before the Annual Meeting for action.
Who is
entitled to vote at the Annual Meeting?
You are entitled to vote at the Annual Meeting only if you were
a record holder of our common stock or our ESOP serial preferred
stock at the close of business on February 26, 2010, the
record date for the Annual Meeting. At the close of business on
the record date, 109,886,195 shares of common stock and
216,753 shares of ESOP serial preferred stock were
outstanding. Each share owned on the record date is entitled to
one vote.
What
is the difference between a shareholder of record and a
beneficial owner of shares held in street name?
Shareholder of Record. If your shares are
registered directly in your name with our transfer agent, BNY
Mellon Shareowner Services, you are considered the shareholder
of record with respect to those shares.
Beneficial Owner of Shares Held in Street
Name. If your shares are held in an account at a
broker, bank or other similar organization, then you are the
beneficial owner of shares held in street name. The
organization holding your account is considered the shareholder
of record for purposes of voting at the Annual Meeting. As a
beneficial owner, you have the right to instruct that
organization on how to vote the shares held in your account.
1
How do
I vote?
Most shareholders have a choice of voting by mail, on the
Internet, by telephone or in person at the Annual Meeting.
Voting by mail. If you are a shareholder of
record, you may vote by signing, dating and returning your proxy
card in the enclosed prepaid envelope. The proxy holders will
vote your shares in accordance with your directions. If you sign
and return your proxy card, but do not properly direct how your
shares should be voted on a proposal, the proxy holders will
vote your shares FOR Proposals 1, 2 and 3 and
AGAINST Proposal 4. If you sign and return
your proxy card, the proxy holders will vote your shares
according to their discretion on any other proposals and other
matters that may be brought before the Annual Meeting.
If you hold shares in street name, you should complete, sign and
date the voting instruction card provided to you by your broker
or nominee.
Voting on the Internet or by Telephone. If you
are a shareholder of record, detailed instructions for Internet
and telephone voting are attached to your proxy card. Your
Internet or telephone vote authorizes the proxy holders to vote
your shares in the same manner as if you signed and returned
your proxy card by mail. If you are a shareholder of record and
you vote on the Internet or by telephone, your vote must be
received by 11:59 p.m. E.D.T. on April 19, 2010; you should
not return your proxy card.
If you hold shares in street name, you may be able to vote on
the Internet or by telephone as permitted by your broker or
nominee.
Voting in Person. All shareholders may vote in
person at the Annual Meeting. Shareholders of record may also be
represented by another person present at the Annual Meeting by
signing a proxy designating such person to act on your behalf.
If you hold shares in street name, you may vote in person at the
Annual Meeting only if you have obtained a signed proxy from
your broker or nominee giving you the right to vote your shares.
What
happens if I hold shares in street name and I do not give voting
instructions?
If you are the beneficial owner of shares held in street name
and do not provide the organization that holds your shares with
specific voting instructions, under the rules of the New York
Stock Exchange, that organization may generally vote on routine
matters but cannot vote on non-routine matters. Proposals 1, 2
and 4 are considered non-routine matters. Therefore, if you do
not instruct the organization that holds your shares how to vote
on Proposals 1, 2 and 4, that organization does not have the
authority to vote on those proposals. This is generally referred
to as a broker non-vote. Because Proposals 1, 2
and 4 are considered non-routine matters, broker non-votes are
expected to exist on those proposals. Proposal 3 is considered a
routine matter and, therefore, broker non-votes are not expected
to exist on that proposal.
Who
tabulates the vote?
Representatives of The Bank of New York Mellon will
tabulate the votes and act as inspectors of election at the
Annual Meeting.
How do
I vote if I am a participant in the Stock Ownership and
Automatic Dividend Reinvestment Plan or the Employee Stock
Purchase and Savings Plan?
If you are a participant in one of these plans, your proxy card
also serves as voting instructions for the number of shares that
you are entitled to direct the vote under each plan. You may
vote your shares in the same manner outlined above. If you are a
participant in our Employee Stock Purchase and Savings Plan,
your voting instructions must be received by the close of
business on April 15, 2010 in order to allow the trustee
sufficient time for voting.
If you are a participant in our Employee Stock Purchase and
Savings Plan and you do not timely provide your voting
instructions, the trustee will vote your shares in the same
proportion as the trustee votes those shares for which it
receives proper instructions. The trustee will vote any
unallocated shares held in our Employee Stock Purchase and
Savings Plan in the same proportion as the trustee votes
2
those shares for which it receives proper instructions.
What
are the voting recommendations of the Board of
Directors?
The Board of Directors recommends that you vote:
|
|
|
|
|
FOR fixing the number of directors at
11 and electing the 11 nominees for directors
(Proposal 1);
|
|
|
|
FOR approving the amendment and
restatement of The Sherwin-Williams Company 2006 Equity and
Performance Incentive Plan (Proposal 2);
|
|
|
|
FOR ratifying the appointment of Ernst
& Young LLP as Sherwin-Williams independent
registered public accounting firm (Proposal 3); and
|
|
|
|
AGAINST the shareholder proposal
(Proposal 4).
|
What
constitutes a quorum for the Annual Meeting?
A quorum of shareholders is necessary for us to hold
a valid Annual Meeting. For a quorum, there must be present, in
person or by proxy, or by use of communications equipment,
shareholders of record entitled to exercise not less than fifty
percent of the voting power of Sherwin-Williams. Both
abstentions and broker non-votes are counted for the purpose of
determining the presence of a quorum.
What
vote is required to approve each proposal?
Election of Directors
(Proposal 1). Proposal 1 to fix the
number of directors at 11 requires the affirmative vote of the
holders of a majority of the shares present, in person or by
proxy, and entitled to vote on this proposal. To be elected as a
director, a nominee must receive the affirmative vote of a
plurality of the votes cast. Under the plurality voting
standard, the nominees receiving the most for votes
will be elected. Any broker
non-votes
with respect to the election of one or more directors will not
be counted as a vote cast and, therefore, will have no effect on
the vote.
Under our Majority Voting Policy, in an uncontested election,
any nominee for director who receives a greater number of
withheld votes than for votes is
required to tender his or her resignation for consideration by
the Nominating and Corporate Governance Committee of the Board
of Directors. We have provided more information about our
Majority Voting Policy under the heading Corporate
Governance Majority Voting Policy.
Approval of the Amendment and Restatement of the 2006 Equity
and Performance Incentive Plan (Proposal
2). Proposal 2 to approve the amendment and
restatement of The Sherwin-Williams Company 2006 Equity and
Performance Incentive Plan requires the affirmative vote of a
majority of the votes cast. A proxy card marked as abstaining
with respect to this proposal and any broker non-votes with
respect to this proposal will not be counted as a vote cast and,
therefore, will have no effect on the vote.
Ratification of Independent Registered Public Accounting Firm
(Proposal 3). Proposal 3 to ratify the
appointment of Ernst & Young LLP as Sherwin-Williams
independent registered public accounting firm requires the
affirmative vote of a majority of the votes cast. A proxy card
marked as abstaining with respect to this proposal will not be
counted as a vote cast and, therefore, will have no effect on
the vote.
Shareholder Proposal (Proposal 4). Proposal 4
requires the affirmative vote of a majority of the votes cast. A
proxy card marked as abstaining with respect to this proposal
and any broker non-votes with respect to this proposal will not
be counted as a vote cast and, therefore, will have no effect on
the vote.
Other Items. All other proposals and other
business as may properly come before the Annual Meeting require
the affirmative vote of a majority of the votes cast, except as
otherwise required by statute or our Amended Articles of
Incorporation or Regulations.
3
Can I
revoke or change my vote after I submit my proxy?
Yes. You can revoke or change your vote before the proxy
holders vote your shares by timely:
|
|
|
|
|
giving a revocation to our Senior Vice President, General
Counsel and Secretary in writing, in a verifiable communication
or at the Annual Meeting;
|
|
|
|
returning a later signed and dated proxy card;
|
|
|
|
entering a new vote on the Internet or telephone; or
|
|
|
|
voting in person at the Annual Meeting.
|
How
can I attend the Annual Meeting?
You are entitled to attend the Annual Meeting only if you were a
shareholder at the close of business on February 26, 2010,
the record date. We may ask you to present evidence of share
ownership and valid photo identification to enter the Annual
Meeting.
|
|
|
|
|
If you are a shareholder of record, or own your shares through
our Stock Ownership and Automatic Dividend Reinvestment Plan or
our Employee Stock Purchase and Savings Plan, an admission
ticket is attached to your proxy card. Simply tear it off and
bring it to the Annual Meeting.
|
|
|
|
If you hold your shares in street name, we may ask you to
provide proof of beneficial ownership as of the record date,
such as a bank or brokerage account statement showing ownership
on February 26, 2010, a copy of the voting instruction card
provided by your broker or nominee, or similar evidence of
ownership.
|
Where
will I be able to find voting results of the Annual
Meeting?
We intend to announce preliminary voting results at the Annual
Meeting and publish final voting results in a Current Report on
Form 8-K to be filed with the SEC within four business days
of the Annual Meeting.
Who
pays the costs of this proxy solicitation?
The enclosed proxy is solicited by the Board of Directors, and
Sherwin-Williams will pay the entire cost of solicitation. We
have retained Georgeson Inc. to aid in the solicitation of
proxies for which it will receive a fee estimated at $15,000
plus reasonable expenses.
In addition, we may reimburse banks, brokers and other nominees
for costs reasonably incurred by them in forwarding proxy
materials to beneficial owners of our common stock. Our officers
and other employees may also solicit the return of proxies.
Proxies will be solicited by personal contact, mail, telephone
and electronic means.
Are
the Proxy Statement and the 2009 Annual Report to Shareholders
available on the Internet?
Yes. This Proxy Statement and our 2009 Annual Report
to Shareholders are available at
http://proxymaterials.sherwin.com.
You may help us save money in the future by accessing your proxy
materials online, instead of receiving paper copies in the mail.
If you would like to access proxy materials on the Internet
beginning next year, please follow the instructions located
under Access Proxy Materials Online in the
Corporate Governance section on the Investor
Relations page of our website at www.sherwin.com.
CORPORATE
GOVERNANCE
We have a long history of good corporate governance practices
that has greatly aided our long-term success. The Board of
Directors and management have recognized for many years the need
for sound corporate governance practices in fulfilling their
respective duties and responsibilities to shareholders. We
describe below our key corporate governance policies that enable
us to manage our business in accordance with high ethical
standards and in the best interests of our shareholders.
Corporate Governance Guidelines. The Board of
Directors has adopted Corporate Governance Guidelines, which
provide the framework for the governance of our company. The
4
Board of Directors reviews our Corporate Governance Guidelines
at least annually. From time to time, the Board of Directors may
revise our Corporate Governance Guidelines to reflect new
regulatory requirements and evolving corporate governance
practices.
Leadership Structure. Our Corporate
Governance Guidelines provide that the same person should hold
the positions of Chairman and Chief Executive Officer, except in
unusual circumstances such as during a period of transition in
the office of the chief executive officer. Currently, the Board
believes this leadership structure provides the most efficient
and effective leadership model for Sherwin-Williams by enhancing
the Chairman and Chief Executive Officers ability to
provide clear insight and direction of business strategies and
plans to both the Board and management. The Board believes
Sherwin-Williams can most effectively execute its business
strategies and plans if the Chairman is also a member of the
management team. A single person, acting in the capacities of
Chairman and Chief Executive Officer, provides unified
leadership and focus.
Another key component of our leadership structure is our strong
governance practices to ensure that the Board effectively
carries out its responsibility for the oversight of management.
All directors, with the exception of the Chairman, are
independent, and all committees are made up entirely of
independent directors. We do not have a lead independent
director. Non-management directors meet at least twice each year
in regularly scheduled executive sessions and may schedule
additional executive sessions as appropriate. Committee chairs
preside over these executive sessions on a rotating basis, and
members of management do not attend these executive sessions.
The Board has full access to the management team at all times.
In addition, the Board or any committee may retain, at such
times and on such terms as determined by the Board or committee
in its sole discretion, independent legal, financial and other
independent consultants and advisors to advise and assist the
Board or committee in discharging its oversight responsibilities.
Business Ethics Policy. We have
operated under a Business Ethics Policy for many years and are
committed to conducting business in an ethical and legal manner
throughout the world. Our Business Ethics Policy applies to all
of our directors, officers and employees and outlines the broad
principles of ethical and legal conduct embraced by our company
to guide our business related conduct. Under our Business Ethics
Policy, any director or employee who reasonably believes or
suspects that Sherwin-Williams or any director or employee has
engaged or is engaging in improper or illegal activities, fraud
or activities that appear to be inconsistent with or in
violation of our Business Ethics Policy is responsible for
reporting such activities. We do not permit retaliation of any
kind against any person who, in good faith, reports any known or
suspected improper activities pursuant to our Business Ethics
Policy.
Our Business Ethics Policy includes additional ethical
obligations for our senior financial management (which includes
our chief executive officer, our chief financial officer, and
the controller, treasurer and principal financial and accounting
personnel in our operating groups and corporate departments).
Our senior financial management is responsible for creating and
maintaining a culture of high ethical standards throughout our
company to ensure the fair and timely reporting of our financial
results and financial condition.
Risk Management. Management is
responsible for assessing and managing Sherwin-Williams
exposure to various risks. Management has an enterprise risk
management process to identify, assess and manage the most
significant risks facing Sherwin-Williams.
The Audit Committee has oversight responsibility to review
managements risk management process, including the
policies and guidelines used by management to identify, assess
and manage Sherwin-Williams exposure to risk. The Audit
Committee also has oversight responsibility for financial risks.
The Board of Directors has oversight responsibility for all
other risks. Management reviews financial risks with the Audit
Committee at least quarterly and reviews its risk management
process with the Audit Committee on an ongoing basis. Management
reviews various significant risks with the Board throughout the
year, as necessary and/or appropriate, and conducts a formal
review of its
5
assessment and management of the most significant risks with the
Board on an annual basis.
Communications with Directors. The
Board of Directors has adopted a process by which shareholders
and all other interested parties may communicate with the
non-management directors or the chairperson of any of the
committees of the Board of Directors. You may send
communications by regular mail to the attention of the
Chairperson, Audit Committee; Chairperson, Compensation and
Management Development Committee; or Chairperson, Nominating and
Corporate Governance Committee; or to the non-management
directors as a group to the Non-Management Directors, each
c/o Corporate Secretary, The Sherwin-Williams Company, 101
West Prospect Avenue, 12th Floor, Midland Building, Cleveland,
Ohio 44115.
Sherwin-Williams management will review all communications
received to determine whether the communication requires
immediate action. Management will pass on all communications
received, or a summary of such communications, to the
appropriate director or directors.
Complaint Procedures for Accounting, Auditing and
Financial Related Matters. The Audit
Committee has established procedures for receiving, retaining
and treating complaints from any source regarding accounting,
internal accounting controls and auditing matters. The Audit
Committee has also established procedures for the confidential,
anonymous submission by employees of concerns regarding
questionable accounting or auditing matters. Interested parties
may communicate such complaints by following the procedures
described under the heading Communications with
Directors, above. Employees may report such complaints by
following the procedures outlined in our Business Ethics Policy.
We do not permit any retaliation of any kind against any person
who, in good faith, submits a complaint or concern under these
procedures.
Independence of Directors. Under our
Director Independence Standards (a copy of which is attached as
Appendix A), 10 of our current 11 directors and
director nominees are independent. In addition, all members of
the Audit Committee, the Compensation and Management Development
Committee, and the Nominating and Corporate Governance Committee
are independent.
Majority Voting Policy. The
Board of Directors has adopted a Majority Voting Policy. Any
nominee for director in an uncontested election who receives a
greater number of withheld votes than
for votes shall promptly tender his or her
resignation. The Nominating and Corporate Governance Committee
will promptly consider the tendered resignation and will
recommend to the Board of Directors whether to accept the
tendered resignation or to take some other action, such as
rejecting the tendered resignation and addressing the apparent
underlying causes of the withheld votes.
In making this recommendation, the Committee will consider all
factors deemed relevant by its members. These factors may
include the underlying reasons why shareholders
withheld votes for election from such director (if
ascertainable), the length of service and qualifications of the
director whose resignation has been tendered, the
directors contributions to Sherwin-Williams, whether by
accepting such resignation Sherwin-Williams will no longer be in
compliance with any applicable law, rule, regulation or
governing document, and whether or not accepting the resignation
is in the best interests of Sherwin-Williams and our
shareholders.
In considering the Committees recommendation, the Board of
Directors will consider the factors considered by the Committee
and such additional information and factors that the Board of
Directors believes to be relevant. We will promptly publicly
disclose the Board of Directors decision and process in a
periodic or current report filed with the SEC.
Executive Sessions. The non-management
members of the Board of Directors meet at least twice each year
in regularly scheduled executive sessions. Additional executive
sessions may be scheduled by the non-management directors. The
chairpersons of the Audit Committee, the Compensation and
Management Development Committee, and the Nominating and
Corporate Governance Committee rotate presiding over these
sessions.
Annual Board Self-Assessments. The
Board of Directors has instituted annual self-assessments of the
Board of Directors, as well
6
as the Audit Committee, the Compensation and Management
Development Committee, and the Nominating and Corporate
Governance Committee, to assist in determining whether the Board
of Directors and its committees are functioning effectively. In
early 2010, the Board and each of its committees completed
self-evaluations and reviewed and discussed the results. The
Nominating and Corporate Governance Committee oversees this
evaluation process.
Board Committee Charters. The Board of
Directors has adopted written charters for the Audit Committee,
the Compensation and Management Development Committee, and the
Nominating and Corporate Governance Committee. Each committee
reviews and evaluates the adequacy of its charter at least
annually and recommends any proposed changes to the Board of
Directors for approval.
Stock Ownership Guidelines. The Board
of Directors has established a minimum share ownership
requirement for its directors, executive officers and operating
presidents. Each director who has served on the Board of
Directors for at least five years is expected to own a minimum
of 10,000 shares of common stock. Each executive officer
and operating president who has served in such capacity for at
least five years is expected to own shares of common stock equal
in value to a multiple of his base salary ranging from a low of
three times to a high of five times for the Chairman and Chief
Executive Officer. For purposes of meeting this minimum share
ownership requirement, each equivalent share of common stock and
each share of restricted stock held under our benefit plans is
considered as a share of common stock. Stock options are not
considered towards meeting this requirement.
All directors, executive officers and operating presidents have
either met our stock ownership guidelines or are pursuing plans
to meet our guidelines within the time frames prescribed.
Executive Compensation Adjustment and Recapture
Policy. The Board of Directors has adopted a
policy regarding the adjustment and recapture of compensation
paid or payable to certain key employees and executives. Under
the policy, employees who participate in our 2007 Executive
Performance Bonus Plan are required to reimburse
Sherwin-Williams for any award paid under this plan in the event:
|
|
|
|
|
The award was based upon the achievement of financial results
that were subsequently the subject of an accounting restatement
due to the material noncompliance with any financial reporting
requirement under the federal securities laws;
|
|
|
|
The Board of Directors determines that the employee engaged in
knowing or intentional fraudulent or illegal conduct that caused
or partially caused the need for the restatement; and
|
|
|
|
A lower amount would have been paid to the employee based upon
the restated financial results.
|
The reimbursement will be equal to the difference in the amount
of the award prior to the restatement and the amount of the
award determined using the restated financial results.
In addition, under our 2006 Equity and Performance Incentive
Plan, (a) all outstanding stock awards will be cancelled
and (b) the employee will be required to reimburse
Sherwin-Williams for any economic gains received by the employee
pursuant to a stock award during the one-year period preceding
the Board of Directors determination that the employee
engaged in the conduct described above.
Availability of Corporate Governance
Materials. You may access all committee
charters, our Corporate Governance Guidelines, our Director
Independence Standards, our Business Ethics Policy, our Majority
Voting Policy and other corporate governance materials in the
Corporate Governance section on the Investor
Relations page of our website at www.sherwin.com.
7
ELECTION
OF DIRECTORS (PROPOSAL 1)
At the Annual Meeting, the number of directors is to be fixed at
11, and 11 directors are to be elected to hold office until
the next Annual Meeting of Shareholders and until their
successors are elected.
Our Board of Directors currently has 11 members. All of
these directors are standing for re-election as nominees. All of
the nominees were elected by the shareholders at the 2009 Annual
Meeting, except for Messrs. Kadien and Stropki.
Messrs. Kadien and Stropki were appointed as directors by
unanimous action of the Board on October 16, 2009 and
July 15, 2009, respectively.
All of the nominees are independent, except for Mr. Connor.
Mr. Connor is not considered to be independent because of his
position as Chairman and Chief Executive Officer of
Sherwin-Williams.
There are no family relationships among any of the directors and
executive officers.
Each of the nominees has agreed to serve if elected. If any
nominee declines or is unable to accept such nomination or is
unable to serve, an event which we do not expect, the Board of
Directors reserves the right in its discretion to substitute
another person as a nominee or to reduce the number of nominees.
In this event, the proxy holders may vote in their discretion
for any substitute nominee proposed by the Board of Directors
unless you indicate otherwise.
The following is biographical information regarding each nominee:
Arthur F.
Anton
President and Chief Executive Officer,
Swagelok Company
Director of Sherwin-Williams since 2006
Arthur F. Anton, 52, has served as President and Chief Executive
Officer of Swagelok Company (manufacturer and provider of fluid
system products and services) since January 2004. Mr. Anton
served as President and Chief Operating Officer of Swagelok from
January 2001 to January 2004, Executive Vice President of
Swagelok from July 2000 to January 2001, and Chief Financial
Officer of Swagelok from August 1998 to July 2000.
Mr. Anton is also a Director of Olympic Steel, Inc. and
University Hospitals Health System and is Chairman of the
Manufacturing Advocacy & Growth Network.
James C.
Boland
Former President, Chief Executive Officer
and Vice Chairman,
Cavaliers Operating Company, LLC
Director of Sherwin-Williams since 1998
James C. Boland, 70, served as Vice Chairman of Cavaliers
Operating Company, LLC (formerly known as Cavaliers/Gund Arena
Company) from January 2003 to June 2007 and President and Chief
Executive Officer of CAVS/Gund Arena Company from
January 1998 to January 2003. Prior to his time with the
Cavaliers, Mr. Boland served for 22 years as a partner of
Ernst & Young LLP in various roles including Vice Chairman
and Regional Managing Partner as well as a member of the
firms Management Committee from 1988 to 1996 and as Vice
Chairman of National Accounts from 1997 to his retirement from
the firm in 1998. Mr. Boland is also a Director of
Developers Diversified Realty Corporation, The Goodyear
Tire & Rubber Company and Invacare Corporation and is
a Trustee of Bluecoats, Inc. and The Harvard Business School
Club of Cleveland. Mr. Boland is a former Director of
International Steel Group Inc.
Christopher M.
Connor
Chairman and Chief Executive Officer,
Sherwin-Williams
Director of Sherwin-Williams since 1999
Christopher M. Connor, 53, has served as Chairman of
Sherwin-Williams since April 2000 and Chief Executive Officer of
Sherwin-Williams since October 1999. Mr. Connor served
as President of Sherwin-Williams from July 2005 to October 2006.
Mr. Connor has been with Sherwin-Williams since 1983 in
roles of increasing responsibility. Mr. Connor is also a
Director of Eaton Corporation. Mr. Connor is a former
Director of Diebold, Incorporated and National City Corporation.
8
David F.
Hodnik
Retired, Former President and
Chief Executive Officer,
Ace Hardware Corporation
Director of Sherwin-Williams since 2005
David F. Hodnik, 62, prior to his retirement in April 2005,
served as Chief Executive Officer of Ace Hardware Corporation
(cooperative of independent hardware retail stores) since
January 1997. Mr. Hodnik also served as President of Ace
Hardware from January 1996 through December 2004.
Mr. Hodnik joined Ace Hardware in October 1972 and held
various financial, accounting and operating positions at Ace
Hardware.
Thomas G.
Kadien
Senior Vice President,
Consumer Packaging and IP Asia
International Paper Company
Director of Sherwin-Williams since 2009
Thomas G. Kadien, 53, has served as Senior Vice President,
Consumer Packaging and IP Asia of International Paper Company
(global paper and packaging company) since January 2010 and has
served as Senior Vice President of International Paper since May
2004. Mr. Kadien joined International Paper in 1978 and has
held various sales, marketing and management positions with
International Paper, including President of xpedx from October
2005 to January 2010, President IP Europe from April
2003 to October 2005, Vice President Commercial
Printing and Imaging Papers from August 2000 to April 2003, and
Vice President Fine Papers from June 2000 to August
2000. Mr. Kadien is also a Member of the Board of Visitors
of the University of Memphis.
Susan J.
Kropf
Retired, Former President and
Chief Operating Officer,
Avon Products, Inc.
Director of Sherwin-Williams since 2003
Susan J. Kropf, 61, prior to her retirement in January 2007,
served as President and Chief Operating Officer of Avon
Products, Inc. (global manufacturer and marketer of beauty and
related products) since January 2001. Mrs. Kropf served as
Executive Vice President and Chief Operating Officer, North
America and Global Business Operations, of Avon from December
1999 to January 2001 and Executive Vice President and President,
North America, of Avon from March 1997 to December 1999.
Mrs. Kropf joined Avon in 1970 and held various positions
in manufacturing, marketing and product development.
Mrs. Kropf is also a Director of Coach, Inc., MeadWestvaco
Corporation, The Kroger Co. and the Wallace Foundation.
Gary E.
McCullough
President and Chief Executive Officer,
Career Education Corporation
Director of Sherwin-Williams since 2002
Gary E. McCullough, 51, has served as President and Chief
Executive Officer of Career Education Corporation (provider of
post-secondary educational services) since March 2007.
Immediately prior to joining Career Education Corporation, Mr.
McCullough served as Senior Vice President of Abbott
Laboratories and President of its Ross Products Division from
December 2003 to March 2007. Immediately prior to joining
Abbott Laboratories, Mr. McCullough served as Senior Vice
President Americas of Wm. Wrigley Jr. Company from
March 2000 to December 2003. Mr. McCullough also spent
13 years at the Procter & Gamble Company where he
served in a variety of marketing and management positions. Mr.
McCullough is also a Director of Career Education Corporation.
A. Malachi Mixon,
III
Chairman and Chief Executive Officer,
Invacare Corporation
Director of Sherwin-Williams since 1993
A. Malachi Mixon, III, 69, has served as Chief Executive Officer
of Invacare Corporation (manufacturer and distributor of home
health care products) since January 1980 and Chairman of
Invacare since September 1983. Mr. Mixon served as President of
Invacare from January 1980 to November 1996. Mr. Mixon is
also a Director of Park-Ohio Holdings Corp., is Chairman of The
Cleveland Clinic Foundation and the Cleveland Institute of Music
and is on the Visiting Committee of the Harvard School of
Business Administration. Mr. Mixon is a former Director of
The Lamson and Sessions Co.
9
Curtis E.
Moll
Chairman and Chief Executive Officer,
MTD Holdings Inc
Director of Sherwin-Williams since 1997
Curtis E. Moll, 70, has served as Chairman and Chief Executive
Officer of MTD Holdings Inc (manufacturer of outdoor power
equipment and tools, dies and stampings for the automotive
industry) since October 1980. Mr. Moll is also
a Director of AGCO Corporation and is Chairman of the Board
of Directors of Shiloh Industries, Inc.
Richard K.
Smucker
Executive Chairman and
Co-Chief Executive Officer,
The J.M. Smucker Company
Director of Sherwin-Williams since 1991
Richard K. Smucker, 61, has served as Co-Chief Executive Officer
of The J.M. Smucker Company (makers of food products) since
February 2001 and Executive Chairman of J.M. Smucker since
June 2008. Mr. Smucker served as President of J.M. Smucker
from January 1987 to June 2008 and Chief Financial Officer of
J.M. Smucker from June 2003 to January 2005. Mr. Smucker is also
a Director of J.M. Smucker and is a Trustee of Miami University
of Ohio and the Musical Arts Association (The Cleveland
Orchestra). Mr. Smucker is a former Director of
Wm. Wrigley Jr. Company.
John M.
Stropki, Jr.
Chairman, President and
Chief Executive Officer,
Lincoln Electric Holdings, Inc.
Director of Sherwin-Williams since 2009
John M. Stropki, Jr., 59, has served as President and Chief
Executive Officer of Lincoln Electric Holdings, Inc.
(manufacturer and reseller of welding and cutting products)
since June 2004 and Chairman of Lincoln Electric Holdings since
October 2004. Mr. Stropki served as Executive Vice
President and Chief Operating Officer of Lincoln Electric
Holdings from May 2003 to June 2004 and Executive Vice President
of Lincoln Electric Holdings and President, North America
of The Lincoln Electric Company from May 1996 to May 2003.
Mr. Stropki is also a Director of Lincoln Electric Holdings.
The Board of Directors unanimously recommends that you
vote FOR Proposal 1 relating to the election of
directors.
EXPERIENCE,
QUALIFICATIONS, ATTRIBUTES AND SKILLS OF DIRECTORS AND
NOMINEES
In considering each director nominee and the composition of the
Board of Directors as a whole, the Nominating and Corporate
Governance Committee utilizes a diverse group of experiences,
characteristics, attributes and skills, including diversity in
gender, ethnicity and race, that the Committee believes enables
a director nominee to make a significant contribution to the
Board, Sherwin-Williams and our shareholders. These experiences,
characteristics, attributes and skills, which are more fully
described in the table on the next page, include management
experience, independence, financial expertise, experience in
manufacturing/distribution, technical/research and development,
international operations, marketing and sales, and retail
operations and minority status. The Committee may also consider
such other experiences, characteristics, attributes and skills,
as it deems appropriate, given the then-current needs of the
Board and Sherwin-Williams.
These experiences, characteristics, attributes and skills relate
directly to the management and operations of Sherwin-Williams.
Success in each of these categories is a key factor in
Sherwin-Williams overall operational success and creating
shareholder value. The Committee believes that directors who
possess these experiences, characteristics, attributes and
skills are better able to provide oversight of
Sherwin-Williams management and our long-term and
strategic objectives. The following table sets forth the
experience, characteristics, attributes and skills of each
director nominee that led the Board to conclude that such
persons should serve as directors. The Board also considered the
specific experience described in each nominees
biographical information, as disclosed above.
10
|
|
|
|
|
|
|
Directors with Attribute
|
|
Management Experience
|
|
A. F. Anton
|
|
G. E. McCullough
|
Experience as a CEO, COO, President or Senior
Vice President of a company or a significant subsidiary,
operating division or business unit.
|
|
J. C. Boland
C. M. Connor
D. F. Hodnik
T. G. Kadien
S. J. Kropf
|
|
A. M. Mixon, III
C. E. Moll
R. K. Smucker
J. M. Stropki, Jr.
|
Independence
|
|
A. F. Anton
|
|
G. E. McCullough
|
Satisfy the independence requirements of the New York Stock
Exchange.
|
|
J. C. Boland
D. F. Hodnik
T. G. Kadien
S. J. Kropf
|
|
A. M. Mixon, III
C. E. Moll
R. K. Smucker
J. M. Stropki, Jr.
|
Financial Expertise
|
|
A. F. Anton
|
|
G. E. McCullough
|
Possess the knowledge and experience to be qualified as an
audit committee financial expert as that term is
defined by SEC regulations.
|
|
J. C. Boland
D. F. Hodnik
|
|
R. K. Smucker
J. M. Stropki, Jr.
|
Manufacturing; Distribution
|
|
A. F. Anton
|
|
G. E. McCullough
|
Experience in, or experience in a senior management position
responsible for, managing significant manufacturing and
distribution operations.
|
|
J. C. Boland
C. M. Connor
D. F. Hodnik
T. G. Kadien
S. J. Kropf
|
|
A. M. Mixon, III
C. E. Moll
R. K. Smucker
J. M. Stropki, Jr.
|
Technical; Research and Development
|
|
A. F. Anton
|
|
A. M. Mixon, III
|
Experience in, or experience in a senior management position
responsible for, managing a significant technical or research
and development function.
|
|
C. M. Connor
T. G. Kadien
S. J. Kropf
G. E. McCullough
|
|
C. E. Moll
R. K. Smucker
J. M. Stropki, Jr.
|
International Operations
|
|
A. F. Anton
|
|
G. E. McCullough
|
Experience working in a major organization with global
operations with a thorough understanding of different cultural,
political and regulatory requirements.
|
|
J. C. Boland
C. M. Connor
D. F. Hodnik
T. G. Kadien
S. J. Kropf
|
|
A. M. Mixon, III
C. E. Moll
R. K. Smucker
J. M. Stropki, Jr.
|
Marketing; Sales
|
|
A. F. Anton
|
|
G. E. McCullough
|
Experience in, or experience in a senior management position
responsible for, managing the marketing and/or sales function.
|
|
C. M. Connor
D. F. Hodnik
T. G. Kadien
S. J. Kropf
|
|
A. M. Mixon, III
C. E. Moll
R. K. Smucker
J. M. Stropki, Jr.
|
Retail Operations
|
|
C. M. Connor
|
|
|
Experience in, or experience in a senior management position
responsible for, managing retail operations.
|
|
D. F. Hodnik
T. G. Kadien
|
|
|
Minority; Diversity
|
|
S. J. Kropf
|
|
|
Contribute to the board in a way that enhances perspectives
through diversity in gender, ethnic background, race, etc.
|
|
G. E. McCullough
A. M. Mixon, III
|
|
|
INDEPENDENCE
OF DIRECTORS
The Board of Directors has adopted categorical Director
Independence Standards to assist the Board of Directors in
determining the independence of each director. To be considered
independent, the Board of Directors must affirmatively determine
that the director has no material relationship with
Sherwin-Williams. In each case, the Board of Directors broadly
considers all relevant facts and circumstances, including the
directors commercial, industrial, banking, consulting,
legal, accounting, charitable and familial relationships, and
such other criteria as the Board of Directors may determine from
time to time.
During the Board of Directors annual review of director
independence, the Board of Directors considers transactions,
relationships and arrangements between each director or an
immediate family member of the director and Sherwin-Williams.
The Board of Directors also considers transactions,
relationships and arrangements between each director or an
11
immediate family member of the director and
Sherwin-Williams senior management.
Under our Director Independence Standards, the following
relationships are not considered to be material relationships
that would impair a directors independence:
|
|
|
|
|
if the director is a current employee, or an immediate family
member of the director is a current executive officer, of
another company that has made payments to, or received payments
from, Sherwin-Williams for property or services in an amount
which, in any of the last three fiscal years, is less than
$1 million or two percent, whichever is greater, of such
other companys annual gross revenues;
|
|
|
|
if the director, or an immediate family member of the director,
is an executive officer of another company which is indebted to
Sherwin-Williams, or to which Sherwin-Williams is indebted, in
an amount which is less than five percent of such other
companys total assets;
|
|
|
|
if the director, or an immediate family member of the director,
serves as an officer, director or trustee of a
not-for-profit
organization, and Sherwin-Williams discretionary
charitable contributions (excluding matching contributions) to
the organization are less than $500,000 or five percent,
whichever is greater, of that organizations annual gross
revenues;
|
|
|
|
if the director serves as a director or executive officer of
another company that also uses Sherwin-Williams
independent auditor;
|
|
|
|
if the director is a member of, or associated with, the same
professional association, or social, educational, civic,
charitable, fraternal or religious organization or club as
another Sherwin-Williams director or executive officer; or
|
|
|
|
if the director serves on the board of directors of another
company at which another Sherwin-Williams director or executive
officer also serves on the board of directors (except for
compensation committee interlocks.)
|
A complete copy of our Director Independence Standards is
attached as Appendix A.
Early this year, the Board of Directors performed its annual
director independence review for 2010. As part of this review,
the Board of Directors considered investments by
Sherwin-Williams and a director in a private equity fund that
invests in minority businesses. The Board of Directors does not
believe this relationship impairs the independence of the
director.
As a result of this review, the Board of Directors determined
that 10 of our 11 current directors and director nominees
are independent. In addition, all members of the Audit
Committee, the Compensation and Management Development
Committee, and the Nominating and Corporate Governance Committee
are independent. The Board of Directors determined that
Mrs. Kropf and Messrs. Anton, Boland, Hodnik, Kadien,
McCullough, Mixon, Moll, Smucker and Stropki meet these
standards and are independent and, in addition, satisfy the
independence requirements of the New York Stock Exchange.
Mr. Connor is not considered to be independent because of
his position as Chairman and Chief Executive Officer of
Sherwin-Williams.
12
2009
DIRECTOR COMPENSATION TABLE
The following table sets forth information regarding the
compensation of our nonemployee directors for 2009.
Mr. Connor, who is our Chairman and Chief Executive
Officer, does not receive any additional compensation for
services as a director.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned
|
|
|
|
|
|
Option
|
|
|
All Other
|
|
|
|
|
|
|
or Paid in
|
|
|
Stock Awards
|
|
|
Awards
|
|
|
Compensation
|
|
|
Total
|
|
Name
|
|
Cash
($)(8)
|
|
|
($)(9,10)
|
|
|
($)(11)
|
|
|
($)(12,13)
|
|
|
($)
|
|
|
A. F. Anton
|
|
|
85,000
|
|
|
|
68,240
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
153,240
|
|
J. C.
Boland(1)
|
|
|
100,000
|
|
|
|
68,240
|
|
|
|
-0-
|
|
|
|
5,000
|
|
|
|
173,240
|
|
D. E.
Evans(2)
|
|
|
28,333
|
|
|
|
68,240
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
96,573
|
|
D. F. Hodnik
|
|
|
85,000
|
|
|
|
68,240
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
153,240
|
|
T. G.
Kadien(3)
|
|
|
21,250
|
|
|
|
93,125
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
114,375
|
|
S. J. Kropf
|
|
|
85,000
|
|
|
|
68,240
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
153,240
|
|
R. W.
Mahoney(2,4)
|
|
|
32,166
|
|
|
|
68,240
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
100,406
|
|
G. E. McCullough
|
|
|
85,000
|
|
|
|
68,240
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
153,240
|
|
A. M.
Mixon, III(5)
|
|
|
92,667
|
|
|
|
68,240
|
|
|
|
-0-
|
|
|
|
5,000
|
|
|
|
165,907
|
|
C. E.
Moll(6)
|
|
|
93,500
|
|
|
|
68,240
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
161,740
|
|
R. K. Smucker
|
|
|
85,000
|
|
|
|
68,240
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
153,240
|
|
J. M. Stropki,
Jr.(7)
|
|
|
42,500
|
|
|
|
81,142
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
123,642
|
|
|
|
1
|
Mr. Boland served as Chair of the Audit Committee from
January December 2009.
|
|
2
|
Messrs. Evans and Mahoney retired as directors on April 15,
2009 at the 2009 Annual Meeting of Shareholders in accordance
with the Board of Directors retirement policy.
|
|
3
|
Mr. Kadien began his term as a director on October 16, 2009.
|
|
4
|
Mr. Mahoney served as Chair of the Compensation and
Management Development Committee from January
April 2009.
|
|
5
|
Mr. Mixon served as Chair of the Compensation and
Management Development Committee from May December
2009.
|
|
6
|
Mr. Moll served as Chair of the Nominating and Corporate
Governance Committee from January December 2009.
|
|
7
|
Mr. Stropki began his term as a director on July 15, 2009.
|
|
8
|
The amounts set forth in this column reflect the annual
retainer, the annual retainer for committee chairs, and any
meeting fees. Mrs. Kropf and Messrs. Boland, McCullough,
Mixon and Moll defer payments of all of their fees under our
Director Deferred Fee Plan. Cash amounts deferred during 2009
were as follows: Mr. Boland ($100,000), Mrs. Kropf
($85,000), Mr. McCullough ($85,000), Mr. Mixon
($92,667) and Mr. Moll ($93,500). These amounts were
credited to either a common stock account or a shadow stock
account under our Director Deferred Fee Plan. The number of
shares of common stock (which includes shares acquired through
the reinvestment of dividends) held by the nonemployee directors
under our Director Deferred Fee Plan at December 31, 2009
was as follows: Mr. McCullough (12,925), Mr. Moll (23,006)
and Mr. Smucker (12,290). The number of shares of shadow
stock (which includes shares acquired through the reinvestment
of dividend equivalents) held by the nonemployee directors under
our Director Deferred Fee Plan at December 31, 2009 was as
follows: Mr. Boland (22,303), Mrs. Kropf (9,802) and
Mr. Mixon (31,914).
|
13
|
|
9
|
The values set forth in this column reflect 1,483 shares of
restricted stock granted during 2009 to each of our nonemployee
directors under our 2006 Stock Plan for Nonemployee Directors.
The values of restricted stock are equal to the aggregate grant
date fair value computed in accordance with the Stock
Compensation Topic (718) of the Accounting Standards
Codification (ASC), excluding the effect of
estimated forfeitures. The grant date fair value of restricted
stock is based on the fair market value of our common stock (the
average of the highest and lowest reported sale prices) on the
date of grant.
|
|
10
|
The number of shares of restricted stock held by our nonemployee
directors at December 31, 2009 was 2,818 for each of Mrs.
Kropf and Messrs. Anton, Boland, Evans, Hodnik, Mahoney,
McCullough, Mixon, Moll and Smucker and 1,483 for each of
Messrs. Kadien and Stropki. Dividends are paid on shares of
restricted stock at the same rate as paid on our common stock.
|
|
11
|
The number of stock options held by our nonemployee directors at
December 31, 2009 was as follows: Mr. Evans (11,000),
Mrs. Kropf (7,000), Mr. Mahoney (9,000),
Mr. McCullough (9,000), Mr. Mixon (11,000),
Mr. Moll (1,167) and Mr. Smucker (3,500). No stock
options have been granted to our nonemployee directors since
2003, and our director compensation program no longer includes
the granting of stock options.
|
|
12
|
The amounts set forth in this column reflect charitable matching
gifts under our matching gifts to education program and our
matching gifts for volunteer leaders program. These programs are
available to all full-time employees and directors and are
described on the next page.
|
|
13
|
The amounts set forth in this column do not include the
incremental cost of our Business Travel Accident Insurance Plan.
Coverage under this plan is provided to all directors, executive
officers and full-time salaried employees. We pay an aggregate
premium for the insurance policy underlying this plan. The total
aggregate premium in 2009 for this plan for all directors,
executive officers and employees was $36,028.
|
DIRECTOR
COMPENSATION PROGRAM
The Compensation and Management Development Committee is
responsible for annually reviewing and approving the
compensation for our nonemployee directors. All of our
nonemployee directors are paid under the same compensation
program. Officers of Sherwin-Williams who also serve as
directors do not receive any additional compensation for
services as a director.
We use a combination of cash and equity-based compensation to
attract and retain our nonemployee directors. Compensation for
our nonemployee directors consists of an annual cash retainer;
an additional annual cash retainer for chairs of the Audit
Committee, the Compensation and Management Development
Committee, and the Nominating and Corporate Governance
Committee; meeting fees; an annual grant of restricted stock;
and other benefits.
Stock options are not currently a part of our nonemployee
director compensation program. In addition, we do not provide
retirement benefits to our nonemployee directors.
Director Fees. For 2009, the cash and
equity compensation program for our nonemployee directors
consisted of the following:
|
|
|
|
|
An annual cash retainer of $85,000;
|
|
|
|
An additional annual cash retainer of $15,000 for the chair of
the Audit Committee;
|
|
|
|
An additional annual cash retainer of $11,500 for the chair of
the Compensation and Management Development Committee;
|
|
|
|
An additional annual cash retainer of $8,500 for the chair of
the Nominating and Corporate Governance Committee;
|
|
|
|
A meeting fee of $1,750 for each Board or committee meeting
attended in excess of twelve meetings during the calendar year.
For purposes of calculating the number of meetings during the
calendar year, any Board and committee meetings held within 24
hours shall constitute one meeting; and
|
14
|
|
|
|
|
An annual grant of restricted stock valued at approximately
$85,000 at the time of the grant under our 2006 Stock Plan for
Nonemployee Directors.
|
|
|
|
Shares of restricted stock vest in annual increments of
one-third of the shares granted over a period of three years.
The shares will immediately vest in the event of the death or
disability of the director or in the event of a change in
control of Sherwin-Williams. In the event of the retirement of
the director, the shares will continue to vest in accordance
with the original three-year vesting schedule.
|
For 2010, the annual cash retainers for the chair of the
committees of the Board were increased to $21,000 for the Audit
Committee, $15,000 for the Compensation and Management
Development Committee and $11,000 for the Nominating and
Corporate Governance Committee. In addition, the value of the
annual grant of restricted stock was increased to approximately
$95,000.
We reimburse all directors for reasonable travel and other
out-of-pocket expenses incurred in connection with attendance at
meetings of the Board of Directors and its committees.
Other Benefits. We also pay the
premiums for liability insurance and business travel accident
insurance for all directors, including $225,000 accidental death
and dismemberment coverage and $225,000 permanent total
disability coverage, while the directors are traveling on
Sherwin-Williams business.
Directors may also receive the same discounts as our employees
on the purchase of products at Sherwin-Williams stores and
are eligible to participate in our matching gifts programs on
the same basis as employees. These programs provide for annual
matches for gifts of up to $5,000 under the matching gifts to
education program and $1,000 under the matching gifts for
volunteer leaders program, as well as annual grants of up to
$200 under the grants for volunteers program. Amounts of
matching gifts and grants under these programs are included in
the All Other Compensation column of the 2009
Director Compensation Table.
Deferral of Director Fees. Directors
may elect to defer all or a part of their retainer and meeting
fees under our Director Deferred Fee Plan. The amounts deferred
during 2009 are set forth in a footnote to the 2009 Director
Compensation Table.
Deferred fees may be credited to a common stock account, a
shadow stock account or an interest bearing cash account. The
value of the shadow stock account reflects changes in the market
price of our common stock and the payment of dividend
equivalents at the same rate as dividends are paid on our common
stock. The number of shares of common stock and shadow stock
held by participating directors under the plan is set forth in a
footnote to the 2009 Director Compensation Table.
Amounts deferred may be distributed either in annual
installments over a period up to ten years or in a lump sum
pursuant to a directors payment election. Amounts credited
to a shadow stock account are distributed in cash.
15
BOARD
MEETINGS AND COMMITTEE MEMBERSHIP
The Board of Directors held five meetings during 2009. Each
director attended at least 75% of the meetings of the Board of
Directors and committees on which he or she served. Each
director is expected to attend, absent unusual circumstances,
all annual and special meetings of shareholders. All directors
except two attended the 2009 Annual Meeting of Shareholders.
The Board of Directors has established an Audit Committee, a
Compensation and Management Development Committee, and a
Nominating and Corporate Governance Committee. The Board of
Directors has adopted a written charter for each committee. You
can find a complete copy of each charter in the Corporate
Governance section on the Investor Relations
page of our website at www.sherwin.com. The following table sets
forth the current membership of the committees.
|
|
|
|
|
|
|
|
|
|
|
Compensation and
|
|
Nominating and
|
|
|
|
|
Management
|
|
Corporate
|
Name
|
|
Audit
|
|
Development
|
|
Governance
|
|
A. F. Anton
|
|
x
|
|
|
|
|
J. C. Boland
|
|
Chair
|
|
|
|
x
|
D. F. Hodnik
|
|
x
|
|
|
|
|
T. G. Kadien
|
|
x
|
|
|
|
|
S. J. Kropf
|
|
|
|
x
|
|
|
G. E. McCullough
|
|
x
|
|
|
|
|
A. M. Mixon, III
|
|
|
|
Chair
|
|
x
|
C. E. Moll
|
|
|
|
x
|
|
Chair
|
R. K. Smucker
|
|
|
|
x
|
|
x
|
J. M. Stropki, Jr.
|
|
|
|
x
|
|
|
Audit Committee. The purpose of the Audit
Committee is to assist the Board of Directors in fulfilling the
Board of Directors oversight responsibilities on matters
relating to:
|
|
|
|
|
the integrity of our financial statements;
|
|
|
|
the independent registered public accounting firms
qualifications and independence;
|
|
|
|
the performance of our internal audit function and independent
registered public accounting firm;
|
|
|
|
our compliance with legal and regulatory requirements;
|
|
|
|
preparing the report required by the rules of the SEC to be
included in our annual proxy statement; and
|
|
|
|
engaging in such other matters as may from time to time be
specifically delegated to the Audit Committee by the Board of
Directors.
|
The Audit Committee met five times during 2009. Each member of
the Audit Committee is independent as defined in the corporate
governance listing standards of the New York Stock Exchange, SEC
regulations and our Director Independence Standards. The Board
of Directors has determined that Messrs. Anton, Boland, Hodnik
and McCullough are audit committee financial
experts, as that term is defined by SEC regulations.
Mr. Boland serves on the audit committees of three other public
companies. The Board of Directors, after full review and
consideration of such service, determined that Mr. Bolands
simultaneous service on these other audit committees does not
impair his ability to effectively serve on
Sherwin-Williams Audit Committee.
Compensation and Management Development
Committee. The purpose of the Compensation and
Management Development Committee is to assist the Board of
Directors in fulfilling the Board of Directors oversight
responsibilities on matters relating to:
|
|
|
|
|
compensating our management, which includes our executive
officers;
|
16
|
|
|
|
|
overseeing our management succession planning;
|
|
|
|
producing a compensation committee report required by the rules
of the SEC to be included in our annual proxy statement; and
|
|
|
|
engaging in such other matters as may from time to time be
specifically delegated to the Compensation Committee by the
Board of Directors.
|
The Compensation Committee met six times during 2009. Each
member of the Compensation Committee is independent as defined
in the corporate governance listing standards of the New York
Stock Exchange and our Director Independence Standards.
Process for Determining Director and Executive
Compensation. The Compensation Committee reports
to the Board of Directors on all compensation matters regarding
our directors, executives and other key salaried employees. The
Compensation Committee annually reviews and approves the
compensation for our directors, executives and other key
salaried employees. The Compensation Committee does not
generally delegate any of its authority to other persons,
although it has the power to delegate authority to
subcommittees. The Compensation Committee relies upon several
members of our management and their staff, as well as an outside
compensation consultant, in order to assist the Compensation
Committee in performing its duties.
We strive to pay our directors and executives compensation that
is competitive in the marketplace. In order to assist the
Compensation Committee in determining compensation that is
competitive, the Compensation Committee has engaged Towers
Watson, an outside compensation consulting firm, as its
compensation consultant. Towers Watson annually compiles
information regarding the compensation that similar companies
are paying to their directors and executives. Our Senior Vice
President HR and his staff usually work directly
with Towers Watson to compile the market compensation
information. We use that information as a starting point to set
compensation levels for our directors and executives.
Role of the Compensation Consultant. Towers
Watson serves as an advisor to the Compensation Committee on
compensation matters relating to our directors and executives.
Towers Watson generally provides the Compensation Committee with
market compensation data and makes recommendations with regard
to the form and amount of director and executive compensation
based on the market data. Towers Watson typically makes
recommendations with regard to the base salary, annual cash
incentive compensation and long-term equity incentive
compensation for our Chief Executive Officer.
Towers Watson also from time to time identifies peer companies
for benchmarking director and executive compensation, provides
other market compensation information and analysis, assists with
the development of, and changes to, compensation plans and
programs, and attends Compensation Committee meetings.
From time to time, Towers Watson provides services to
Sherwin-Williams in addition to services related to director and
executive compensation. The aggregate fees paid to Towers Watson
for providing these additional services during 2009 were less
than $120,000.
Role of Management. Several members of our
management participate in the Compensation Committees
executive compensation process. The Compensation Committee
relies upon our Senior Vice President HR and his
staff for input in determining director and executive
compensation levels. Towers Watson typically provides the
requested market compensation information to our Senior Vice
President HR, and our Senior Vice
President HR typically meets with Towers Watson to
discuss this information. Our Chief Executive Officer does not
meet with Towers Watson on an individual basis. With regard to
director compensation, Towers Watson also typically provides the
Compensation Committee with recommendations of any changes to
director compensation. Our Senior Vice President HR
may also make recommendations to the Compensation Committee of
changes to director compensation based upon the market
compensation information.
With regard to executive compensation, management generally
makes recommendations to the Compensation Committee and plays a
more active role in the compensation process. Management makes
recommendations relating to the development of compensation
plans and programs and changes to existing plans and programs.
17
Management also makes recommendations with respect to:
|
|
|
|
|
the evaluation of executive performance;
|
|
|
|
salary increases;
|
|
|
|
the performance goals (and weightings) for annual cash incentive
compensation;
|
|
|
|
the financial performance goals for grants of restricted stock;
|
|
|
|
the results attained with respect to performance goals; and
|
|
|
|
the number of stock options and shares of restricted stock
granted.
|
Prior to providing recommendations to the Compensation Committee
at its formal meetings, our Senior Vice President HR
generally will meet with our Chief Executive Officer to review
the recommendations, except for recommendations concerning our
Chief Executive Officers compensation. Our Chief Executive
Officer and our Senior Vice President HR also may
meet with the chair of the Compensation Committee prior to
meetings to review the agenda for the meetings and the
compensation recommendations. Our Chief Executive Officer and
our Senior Vice President HR generally attend all
Committee meetings. Our Chief Executive Officer does not have
the ability to call meetings. Our Senior Vice
President HR serves as secretary for the
Compensation Committee at its meetings. Our Chief Executive
Officer is excused from that part of the meeting during which
the Compensation Committee discusses his annual performance
evaluation and compensation.
Nominating and Corporate Governance
Committee. The purpose of the Nominating and
Corporate Governance Committee is to assist the Board of
Directors in fulfilling the Board of Directors oversight
responsibilities on matters relating to:
|
|
|
|
|
identifying individuals qualified to become members of the Board
of Directors;
|
|
|
|
recommending to the Board of Directors the director nominees for
election as directors;
|
|
|
|
recommending to the Board of Directors the director nominees for
each committee of the Board of Directors;
|
|
|
|
reviewing, developing and recommending to the Board of Directors
a set of corporate governance guidelines;
|
|
|
|
guiding the Board of Directors in its annual evaluation of the
Board of Directors performance; and
|
|
|
|
engaging in such other matters as may from time to time be
specifically delegated to the Nominating Committee by the Board
of Directors.
|
The Nominating Committee met three times in 2009. Each member of
the Nominating Committee is independent as defined in the
corporate governance listing standards of the New York Stock
Exchange and our Director Independence Standards.
Director Qualifications. The Nominating
Committee seeks a diverse group of candidates who possess the
appropriate characteristics, skills, experience and time to make
a significant contribution to the Board of Directors,
Sherwin-Williams and our shareholders. The Nominating Committee
seeks input from senior management and other members of the
Board of Directors to identify and evaluate potential director
candidates. Each candidate is evaluated in the context of the
Board of Directors as a whole, with the objective that the Board
of Directors can best perpetuate Sherwin-Williams success
and represent shareholders interests through the exercise
of sound business judgment using the directors diversity
of characteristics, skills and experiences, including diversity
in gender, ethnicity and race. Each candidate shall have the
highest personal and professional character and integrity, and
shall have demonstrated exceptional ability and judgment in
their respective endeavors. Candidates must possess sufficient
time to effectively carry out their duties and responsibilities.
The Nominating Committee may, but typically does not, employ
professional search firms (for which it would pay a fee) to
assist it in identifying potential members of the Board of
Directors with the desired skills and disciplines.
18
Diversity of Director Nominees. In considering
the composition of the Board of Directors as a whole, the
Nominating Committee utilizes a diverse group of experiences,
characteristics and skills, including diversity in gender,
ethnicity and race, as described under the heading
Experience, Qualifications, Attributes and Skills of
Directors and Nominees. The Nominating Committee utilizes
these factors when identifying, considering and recommending
director nominees. On an ongoing basis, the Committee reviews
the group of experiences, characteristics and skills of
potential director candidates as part of its process of
identifying individuals qualified to become Board members and
recommending director nominees. The Committee also reviews the
group of experiences, characteristics and skills of current
directors, and utilizes its committee self-assessment
questionnaires, to assess the Committees overall
effectiveness in recommending a diverse group of director
nominees as a whole.
Consideration of Candidates Recommended by
Shareholders. The Nominating Committees
policy with respect to the consideration of director candidates
recommended by shareholders is that the Nominating Committee
will consider such candidates on the same basis and in the same
manner as it considers all director candidates. Recommendations
are required to include the following information:
|
|
|
|
|
the name and address of the shareholder;
|
|
|
|
the number of shares of common stock that is owned by the
shareholder;
|
|
|
|
a description of all arrangements or understandings between or
among any of (a) the shareholder, (b) each candidate
and (c) any other person or persons pursuant to which the
recommendation is being made;
|
|
|
|
the candidates full name, address and telephone numbers;
|
|
|
|
a statement of the candidates qualifications and
experiences, and any other relevant qualities;
|
|
|
|
the information that would be required under the rules of the
SEC in a proxy statement soliciting proxies for the election of
the candidate as a director;
|
|
|
|
a statement, signed by both the shareholder and the candidate
(a) that the shareholder and the candidate currently do not
have, and in the prior three years have not had, directly or
indirectly, any business, professional or other relationship
with each other, and that the shareholder and the candidate do
not have any agreement, arrangement or understanding with each
other with respect to the candidates proposed service as a
director, or (b) if either of the foregoing statements is
incorrect in any manner, describing in detail the relationship,
agreement, arrangement or understanding;
|
|
|
|
the candidates resume, a list of other boards of
directors of public companies on which the candidate currently
serves or has served in the past five years, educational
information and at least three references; and
|
|
|
|
a written statement signed by the candidate agreeing that if he
or she is nominated by the Board of Directors, he or she will
(a) be a nominee for election to the Board of Directors,
(b) provide all information necessary to be include in
Sherwin-Williams proxy statement under applicable SEC or
NYSE rules, and (c) serve as a director if he or she is
elected by shareholders.
|
You may find a complete description of these requirements under
Procedures for Shareholders to Recommend Director
Candidates in the Corporate Governance section
on the Investor Relations page of our website at
www.sherwin.com. Shareholders may submit recommendations, along
with proof of shareholder status, in writing to Chairperson,
Nominating and Corporate Governance Committee,
c/o
Corporate Secretary, The
Sherwin-Williams
Company, 101 West Prospect Avenue, 12th Floor, Midland
Building, Cleveland, Ohio 44115.
19
AUDIT
COMMITTEE REPORT
Management has the primary responsibility for the integrity of
Sherwin-Williams financial information and the financial
reporting process, including the system of internal control over
financial reporting. Ernst & Young LLP,
Sherwin-Williams independent registered public accounting
firm, is responsible for conducting independent audits of
Sherwin-Williams financial statements and the
effectiveness of internal control over financial reporting in
accordance with the standards of the Public Company Accounting
Oversight Board (United States) and expressing an opinion on the
financial statements and the effectiveness of internal controls
over financial reporting based upon those audits. The Audit
Committee is responsible for overseeing the conduct of these
activities by management and Ernst & Young LLP.
As part of its oversight responsibility, the Audit Committee has
reviewed and discussed the audited financial statements, the
adequacy of financial controls and the effectiveness of
Sherwin-Williams internal control over financial reporting
with management and Ernst & Young LLP. The Audit
Committee also has discussed with Ernst & Young LLP
the matters required to be discussed by Statement on Auditing
Standards No. 114 (The Auditors Communication with
those Charged with Governance). The Audit Committee has received
the written disclosures and the letter from Ernst & Young
LLP required by applicable requirements of the Public Company
Accounting Oversight Board regarding the independent
accountants communications with the audit committee
concerning independence. The Audit Committee also has discussed
with Ernst & Young LLP that firms independence.
Based upon these reviews and discussions, the Audit Committee
recommended to the Board of Directors that the audited financial
statements be included in Sherwin-Williams Annual Report
on
Form 10-K
for the year ended December 31, 2009 for filing with the
Securities and Exchange Commission.
AUDIT
COMMITTEE
J. C. Boland, Chairman
A. F. Anton
D. F. Hodnik
T. G. Kadien
G. E. McCullough
COMPENSATION
COMMITTEE REPORT
The Compensation and Management Development Committee has
reviewed and discussed with management the Compensation
Discussion and Analysis contained in this Proxy Statement. Based
upon this review and discussions, the Compensation Committee
recommended to the Board of Directors that the Compensation
Discussion and Analysis be included in Sherwin-Williams
Annual Report on Form 10-K for the year ended
December 31, 2009 and this Proxy Statement.
COMPENSATION
AND MANAGEMENT
DEVELOPMENT COMMITTEE
A. M. Mixon, III, Chairman
S. J. Kropf
C. E. Moll
R. K. Smucker
J. M. Stropki, Jr.
COMPENSATION
RISK ASSESSMENT
We conducted a risk assessment of our compensation policies and
practices for our employees, including those related to our
executive compensation programs. Towers Watson, an outside
compensation consulting firm, assisted us in conducting the
assessment.
The risk assessment included a detailed analysis of the risks
associated with the mix between fixed and variable compensation,
the design of annual and long-term incentive compensation, the
number of shares of common stock subject to outstanding equity
awards and reserved for future equity awards, the equity
ownership and equity awards held by executives, severance and
change of control agreements, and other employee benefits. The
assessment included a qualitative analysis of various program
designs and corporate governance processes, as well as a
quantitative analysis of historical pay and performance
outcomes. The assessment also considered mitigating factors such
as our stock ownership guidelines and our Executive Compensation
Adjustment and Recapture Policy.
We discussed the findings of the risk assessment with the
Compensation and Management Development Committee. Based upon
the assessment, we believe that our compensation policies and
practices do not encourage excessive or unnecessary risk-taking
and are not reasonably likely to have a material adverse effect
on Sherwin-Williams.
20
COMPENSATION
DISCUSSION AND ANALYSIS
Executive Summary
This Compensation Discussion and Analysis describes our
compensation programs and how they apply to our executives,
including:
|
|
|
|
|
C.M. Connor, Chairman and Chief Executive Officer;
|
|
|
|
J.G. Morikis, President and Chief Operating Officer;
|
|
|
|
S. P. Hennessy, Senior Vice President Finance and
Chief Financial Officer;
|
|
|
|
S. J. Oberfeld, President, Paint Stores Group; and
|
|
|
|
T. W. Seitz, Senior Vice President Strategic
Excellence Initiatives.
|
We refer to these five executives as our named
executives, and they are included in the Summary
Compensation Table.
The major components of our executive compensation program are
base salary, annual cash incentive compensation, long-term
equity incentive compensation through stock options and
restricted stock, and other employee and executive benefits. We
benchmark our executive compensation against compensation paid
at similar chemical, building product manufacturing and retail
companies, as well as against compensation derived from an
average of five general broad-based surveys of industrial
companies of similar size to us. We use this market compensation
information to ensure that our executive compensation program is
competitive in comparison with our peers.
We also prepare and use tally sheets when approving changes in
compensation for our named executives to allow us to review how
a change in the amount of each compensation component affects
total compensation and to review each named executives
total compensation in the aggregate.
The unprecedented global economic conditions of the last few
years impacted our decisions relating to compensation earned by
our executives during 2009 and influenced the implementation of
our executive compensation programs for 2010. However, even
during these challenging economic times, the overall design of
our compensation programs has remained the same. We design and
manage our company-wide compensation programs to align with our
overall business strategy and to create value for our
shareholders. We believe it is important that our executive
compensation programs are competitive, maintain a performance
and achievement-oriented environment, and align the interests of
our executives with those of our shareholders.
|
|
|
|
|
Our named executives did not receive a merit salary increase in
2009 as a part of our efforts to manage employee-related costs
during the economic recession. Our named executives received an
average of 1.7% merit salary increases in the beginning of 2010.
Mr. Connor elected to decline his merit salary increase for
2010.
|
|
|
|
Our named executives earned annual cash incentive compensation
for 2009 based upon the achievement of company and individual
performance goals. No annual cash incentive compensation was
earned or paid to our named executives for 2008.
|
|
|
|
Beginning in 2009, we eliminated the threshold earnings goal of
our annual incentive compensation program. We made this change
to focus our executives on achieving their company and
individual financial and operating performance goals and
eliminate the risk of putting too much emphasis on achieving one
threshold goal.
|
|
|
|
We granted additional shares of restricted stock to our named
executives in 2009. We granted these additional shares to
provide our executives with an incentive to deliver long-term
value during the global economic slowdown.
|
|
|
|
We also changed some features of our restricted stock program
beginning in 2010. Our annual grant of restricted stock now
consists of two-thirds performance-based shares and one-third
time-based shares to reflect current market practices. In
addition, we changed the financial goals for performance-based
restricted stock to average return on average equity and
earnings per share.
|
21
|
|
|
|
|
We terminated our grantor trust program during
2009. Executives who had been eligible to participate
in our grantor trust program had not been eligible to
participate in our deferred compensation plan. Accordingly, we
amended our deferred compensation plan to permit those
executives to be eligible to participate in such plan effective
January 1, 2010.
|
|
|
|
During early 2010, we adopted a policy that we will not enter
into any future severance agreements (including material
amendments of existing agreements) with senior executives that
provide for cash severance payments exceeding 2.99 times base
salary and bonus or that provide for excise tax
gross-up
payments, without shareholder approval or ratification.
|
Overview
of Our Executive Compensation Program
The Compensation Committee. The
Compensation and Management Development Committee assists our
Board of Directors in fulfilling our Board of Directors
oversight responsibilities to administer our executive
compensation program. Each member of the Compensation Committee
is independent as defined in the corporate governance listing
standards of the New York Stock Exchange and our director
independence standards.
The Compensation Committee reports to the Board of Directors on
all compensation matters regarding our executives and other key
salaried employees. You may learn more about the Compensation
Committees responsibilities by reading the Compensation
Committees charter, which is available in the
Corporate Governance section on the Investor
Relations page of our website at www.sherwin.com. We have
also included additional information about the Compensation
Committee, including the role of compensation consultant and
management in the compensation setting process, under the
heading Board Meetings and Committee Membership
Compensation and Management Development
Committee.
Components of Compensation. The major
components of our executive compensation program, the primary
purpose of each component and the form of compensation for each
component are described in the following table.
|
|
|
|
|
Component
|
|
Primary Purpose
|
|
Form of Compensation
|
|
Base Salary
|
|
Provides base compensation for the day-to-day performance of job
responsibilities.
|
|
Cash.
|
Annual Cash Incentive Compensation
|
|
Rewards performance during the year based on the achievement of
annual performance goals.
|
|
Cash.
|
Long-Term Equity Incentive Compensation
|
|
Encourages improvement in the long-term performance of our
company, thereby aligning the interests of our executives with
the interests of our shareholders.
|
|
Stock options, which vest over a three-year period, and
performance-based (which vests based upon the achievement of
financial performance goals) and time-based restricted stock.
|
Other Employee And Executive Benefits
|
|
Provides a broad-based executive compensation program for
employee retention, retirement and health.
|
|
Retirement and savings programs, health and welfare programs,
and employee benefit plans, programs and arrangements generally
available to all employees; limited perquisites, executive life
insurance program and executive long-term disability program.
|
22
Compensation Objectives. We design and
manage our company-wide compensation programs to align with our
overall business strategy and to create value for our
shareholders. We believe it is important that our executive
compensation programs:
|
|
|
|
|
Are competitive. Our programs are designed to
attract, hire, retain and motivate talented and skilled
individuals at all levels of our company around the world. We
benchmark executive compensation against compensation paid at
companies that are similar to us.
|
|
|
|
Maintain a performance and achievement-oriented
environment. A significant portion of our
executives compensation is tied to annual and long-term
performance goals. We select performance goals that we believe
help drive our business and create value for our shareholders.
We reward executives for overall company results while also
recognizing individual performance.
|
|
|
|
Align the interests of our executives with those of our
shareholders. We believe it is important that a
portion of our executives incentive compensation is
impacted by the price of our common stock to align the interests
of our executives with the interests of our shareholders. We tie
our long-term equity incentive compensation to the value of our
common stock.
|
The policies we use to make compensation decisions and the
decisions we make are materially similar for all executives.
These policies and decisions result in higher compensation
levels for our Chairman and Chief Executive Officer primarily
based upon the higher market compensation that is available for
chief executive officers.
We compensate our executives principally by using a combination
of fixed and performance-based compensation, annual and
long-term compensation, and cash and stock-based compensation.
We determine this mix by reviewing the mix available at the peer
companies listed on the next page and the general survey data
described below. We do not have a specific policy for the
allocation of compensation between fixed and performance-based
compensation, annual and long-term compensation, and cash and
stock-based compensation.
The following table illustrates the allocation of the major
compensation components for our named executives for 2009 in
terms of this mix. The percentages reflect the amounts of 2009
salary and targeted annual cash incentive compensation and the
aggregate grant date fair values of stock options and shares of
restricted stock granted in 2009. Although the percentages
differ for our named executives, an average of 76% of these
major compensation components for our named executives is
variable and tied to company performance.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of 2009
|
|
|
|
|
|
|
|
|
Allocation of 2009 Total
|
|
|
|
Performance-Based
|
|
|
|
Allocation of 2009 Total
|
|
|
|
|
Compensation Between
|
|
|
|
Compensation Between
|
|
|
|
Compensation Between
|
|
|
|
|
|
|
|
|
Performance-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Named Executive
|
|
|
Fixed
|
|
|
|
Based
|
|
|
|
Annual
|
|
|
|
Long-Term
|
|
|
|
Cash
|
|
|
|
Stock-Based
|
|
C. M. Connor
|
|
|
|
18%
|
|
|
|
|
82%
|
|
|
|
|
29%
|
|
|
|
|
71%
|
|
|
|
|
42%
|
|
|
|
|
58%
|
|
J. G. Morikis
|
|
|
|
23%
|
|
|
|
|
77%
|
|
|
|
|
30%
|
|
|
|
|
70%
|
|
|
|
|
46%
|
|
|
|
|
54%
|
|
S. P. Hennessy
|
|
|
|
25%
|
|
|
|
|
75%
|
|
|
|
|
28%
|
|
|
|
|
72%
|
|
|
|
|
46%
|
|
|
|
|
54%
|
|
S. J. Oberfeld
|
|
|
|
22%
|
|
|
|
|
78%
|
|
|
|
|
32%
|
|
|
|
|
68%
|
|
|
|
|
47%
|
|
|
|
|
53%
|
|
T. W. Seitz
|
|
|
|
30%
|
|
|
|
|
70%
|
|
|
|
|
38%
|
|
|
|
|
62%
|
|
|
|
|
57%
|
|
|
|
|
43%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
For purposes of this table, (a) fixed compensation consists
of salary, (b) performance-based compensation consists of
annual cash incentive compensation, stock options and restricted
stock, (c) annual compensation consists of salary and
annual cash incentive compensation, (d) long-term
compensation consists of stock options and restricted stock,
(e) cash compensation consists of salary and annual cash
incentive compensation, and (f) stock-based compensation
consists of stock options and restricted stock.
|
23
Benchmarking
Our Starting Point
We offer our executives compensation that is intended to be
competitive in the market. The Compensation Committee has
retained Towers Watson, an outside compensation consulting firm,
to identify annually the compensation paid to executives holding
equivalent positions or having similar responsibilities at
chemical, building product manufacturing and retail peer
companies with comparable sales. Towers Watson also compiles
compensation data derived from five general broad-based surveys
of industrial companies of similar size to us. These surveys are
sponsored by nationally recognized compensation consulting
firms. Many of the peer companies, along with us, participate in
the broad-based surveys, improving our compensation comparisons.
We calculate an average of (a) the compensation available
at the peer companies and (b) the average compensation
derived from the five general broad-based surveys. We refer to
this average as market compensation. This market
compensation provides a framework for us to determine the mix of
compensation components and target compensation levels. We
generally benchmark the target compensation that we pay to our
executives to approximate the median market compensation. We
benchmark against median market compensation because it allows
us to attract and retain employees and helps us to manage the
overall cost of our compensation program. We use this
information only as a starting point, not as a determining
factor, in setting compensation.
We review compensation paid at these peer companies because
their size and business make them most comparable to us. We also
believe these companies likely compete with us for executive
talent. For compensation earned in 2009, these peer companies
included the companies listed in the following table. The peer
companies are regularly reviewed and changed from time to time
to account for acquisitions, mergers and other business related
changes, and the information is updated annually. The 2009 group
of peer companies reflects the elimination of Rohm and Haas
Company and American Standard Companies as a result of those
companies having been acquired.
|
|
|
|
|
Air Products & Chemicals, Inc.
|
|
Eastman Chemical Co.
|
|
Newell Rubbermaid Inc.
|
Akzo Nobel, N.V.
|
|
Fortune Brands Inc.
|
|
Owens Corning
|
Ashland Inc.
|
|
Leggett & Platt Inc.
|
|
PPG Industries, Inc.
|
Avery Dennison Corporation
|
|
The Lubrizol Corporation
|
|
The Stanley Works
|
The Black & Decker Corporation
|
|
Masco Corporation
|
|
USG Corporation
|
Celanese Corporation
|
|
Mohawk Industries, Inc.
|
|
Weyerhaeuser Company
|
The market compensation information provided by Towers Watson
includes base salary, annual cash incentive compensation,
long-term equity incentive compensation and total direct
compensation. We define total direct compensation as the sum of
base salary, annual cash incentive compensation and long-term
equity incentive compensation. We review total direct
compensation to help us determine whether the principal
compensation components that we pay to our executives are
competitive in the aggregate.
This market compensation information is presented annually to
the Compensation Committee. The Compensation Committee compares
each named executives base salary, annual cash incentive
compensation, long-term equity incentive compensation and total
direct compensation to the median market compensation. The
Committee may use its discretion to adjust a component of
compensation above or below the median market compensation for
reasons such as an executives performance,
responsibilities, experience and tenure in his particular
position, our company-wide performance, and the amount of an
executives compensation in relation to other employees.
We do not have a formal policy of setting target compensation
levels as a specific percentile of market compensation. In
addition, the Compensation Committee did not increase or
decrease the amount of any compensation component based upon the
amount of any other
24
compensation component or its review of projected targeted total
direct compensation.
The following table sets forth the projected total direct
compensation for each of our named executives as a percent of
the median market total direct compensation. For purposes of
this table, projected total direct compensation includes 2010
base salary, 2010 targeted annual cash incentive compensation,
the annual grant of stock options in October 2009 and the
targeted value of the annual grant of shares of restricted stock
in February 2010.
|
|
|
|
|
|
|
Projected Targeted
|
|
|
Total Direct Compensation
|
|
|
as a Percentage of
|
Named Executive
|
|
Market Compensation
|
|
C. M. Connor
|
|
|
105
|
%
|
J. G. Morikis
|
|
|
112
|
%
|
S. P. Hennessy
|
|
|
107
|
%
|
S. J. Oberfeld
|
|
|
113
|
%
|
T. W. Seitz
|
|
|
118
|
%
|
The median total direct compensation paid by the peer companies
reflects 2008 compensation because more current compensation
amounts were not available at the time the Compensation
Committee reviewed the information. The projected targeted total
direct compensation for Messrs. Morikis, Oberfeld and Seitz
materially exceeded median market compensation principally due
to the values of our grants of stock options and restricted
stock, as explained below. In addition, the projected targeted
total direct compensation for Mr. Seitz materially exceeded
market compensation due in part to his compensation being
aligned with the other senior executives.
The actual amounts we pay our executives may vary from the
targeted amounts based upon the achievement of company and
individual performance goals. Individual components may be
greater than or lesser than that targeted because we focus on
the overall competitiveness of the entire compensation program.
Major
Components of Our Executive Compensation Program
Base Salary. Each executive salaried
position at our company is assigned a salary grade that
corresponds to a salary range with a minimum and maximum. We
review the salary ranges against median market base salaries
based upon the position and level of responsibility. The
midpoint of the range generally approximates the median market
salary paid for an equivalent or similar position at the peer
companies and according to the general survey data. The
Compensation Committee reviews and approves the base salary of
each executive annually and at other times in connection with
any promotion or other change in responsibility. Base salary is
the only fixed component of our executives total direct
compensation. Annual base salary increases are effective in
March.
Annual salary increases are based, in part, on the overall
annual salary budget guidelines for our company. We adopt annual
salary guidelines for all of our employees as part of our annual
operating process, which includes a range of merit salary
increases. The maximum amount of the range is equal to the
amount necessary to increase the salary of an employee (whose
salary is below median market for his position, but who receives
the highest performance rating) to an amount that approximates
the median market salary for his position. For 2009, our salary
budget included no merit salary increases for employees in upper
level salary grades, which included our executives, due to our
efforts to manage employee-related costs during this challenging
global economic environment. For 2010, we adopted an overall
2.0% merit budget for annual salary increases with possible
merit increases ranging from 0% to 6.5%.
In addition, each executive undergoes an annual performance
review. The executives performance for the prior year is
reviewed by his direct supervisor. With regard to the evaluation
of our Chairman and Chief Executive Officer, each director
provides ratings and comments for performance results, business
strategy, developing a management team, and leadership. The
results are reviewed by the Compensation Committee and by the
non-management directors in executive session.
As part of this annual performance review, all salaried
employees, including our executives, are assigned a performance
rating that corresponds with a range of potential merit
25
increases. Increases are based upon the executives
performance, responsibilities, experience and tenure in his
particular position and our company-wide performance. These
factors are not quantified or weighted in any objective manner.
Instead, the Compensation Committee exercises its discretion and
subjective judgment in assessing those factors and in approving
a specific merit increase within the range.
In early 2010, the Compensation Committee performed its annual
review of the base salaries of each executive. The Compensation
Committee approved 2010 merit salary increases for our named
executives, except for Mr. Connor. Mr. Connor elected
to decline his merit salary increase for 2010 in light of the
increase in his annual cash incentive compensation opportunity,
as described below.
The following table sets forth the 2009 and 2010 base salaries
and the percentage merit increases for our named executives. The
table reflects a $37,000 increase to Mr. Morikis 2010
base salary to offset the elimination of the executive
automobile program.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Merit Increase
|
|
2009
|
|
% Merit Increase
|
|
2010
|
Named Executive
|
|
for 2009
|
|
Base Salary ($)
|
|
for 2010
|
|
Base Salary ($)
|
|
C. M. Connor
|
|
|
0
|
%
|
|
|
1,221,987
|
|
|
|
0
|
%
|
|
|
1,221,987
|
|
J. G. Morikis
|
|
|
0
|
%
|
|
|
705,566
|
|
|
|
2.5
|
%
|
|
|
760,205
|
|
S. P. Hennessy
|
|
|
0
|
%
|
|
|
562,127
|
|
|
|
2.0
|
%
|
|
|
573,370
|
|
S. J. Oberfeld
|
|
|
0
|
%
|
|
|
512,999
|
|
|
|
2.0
|
%
|
|
|
523,259
|
|
T. W. Seitz
|
|
|
0
|
%
|
|
|
473,907
|
|
|
|
2.0
|
%
|
|
|
483,385
|
|
Annual Cash Incentive Compensation. We
pay annual cash incentive compensation to our executives under
our shareholder-approved 2007 Executive Performance Bonus Plan.
All of our executives participate in our Performance Plan. Our
annual incentive compensation program is intended to motivate
and compensate our executives for achieving annual performance
goals. Our Performance Plan is designed so that our executives
may earn higher than average annual cash incentive compensation
for achieving above target business results and lower than
average annual cash incentive compensation when target
performance goals are not met.
The Compensation Committee annually reviews target and maximum
annual cash incentive compensation levels for our executives as
a percent of their salary. Target incentive awards are
determined by using the median market annual cash incentive
compensation, which generally equals the amount an executive
could receive under our Performance Plan if he achieves a 100%
average of his performance goals. The maximum incentive awards
are determined by using the maximum annual cash incentive
compensation available at the peer companies and according to
the general survey data, which generally equals the amount an
executive could receive if he achieves a 125% average of his
performance goals. The Compensation Committee expects our
executives to achieve, and provides appropriate incentives to
exceed, the target levels of performance. The maximum levels of
performance are intended to require significant effort to reach.
The following table sets forth the 2009 minimum, target and
maximum cash incentive amount levels, as a percent of salary,
for each named executive based upon the executive achieving an
average of 0%, 100% and 125%, respectively, of his performance
goals. We increased the target and maximum annual cash incentive
levels that may be earned in 2010 for Mr. Connor (to 105%
and 210%, respectively) to align those levels with the target
and maximum annual cash incentive compensation available at the
peer and survey companies.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Amount as a
|
|
|
Percentage of Salary
|
Named Executive
|
|
Minimum
|
|
Target
|
|
Maximum
|
|
C. M. Connor
|
|
|
0
|
%
|
|
|
95
|
%
|
|
|
190
|
%
|
J. G. Morikis
|
|
|
0
|
%
|
|
|
75
|
%
|
|
|
150
|
%
|
S. P. Hennessy
|
|
|
0
|
%
|
|
|
75
|
%
|
|
|
150
|
%
|
S. J. Oberfeld
|
|
|
0
|
%
|
|
|
60
|
%
|
|
|
120
|
%
|
T. W. Seitz
|
|
|
0
|
%
|
|
|
60
|
%
|
|
|
120
|
%
|
During 2009, the Compensation Committee approved the performance
goals of all of our named executives. Our Chairman and Chief
Executive Officer also approved the goals of our other named
executives. Performance goals varied by executive and usually
related to the
26
business unit or function for which such person has
responsibility. Performance goals were weighted between 10% and
30%. Financial performance goals were generally weighted more
heavily.
We set financial performance goals at levels that coincide with
those established in our annual operating budget. The
Compensation Committee reviews our annual operating budget, each
financial objective therein and approves financial performance
goals that are set at levels that are of the same magnitude as
is set forth in our annual operating budget. In recent years,
target levels for most of the financial performance goals have
been set at levels that showed improvement over the prior year.
Due to the global economic recession and the corresponding lower
expectations for financial and operating results for 2009, many
of the 2009 financial performance goals were not set at levels
that showed improvement over 2008. The Compensation Committee
believes that setting performance goals at these lower levels
for 2009 appropriately matched incentive opportunities with
performance expectations and the degree of difficulty of
achieving them.
The following table shows for each named executive the 2009
performance goals, weightings, targets and actual results.
|
|
|
|
|
|
|
|
|
2009 Annual Cash Incentive Performance Goals
|
|
|
|
|
|
|
Actual
|
Named Executive
|
|
Performance Goals and Weightings
|
|
Target
|
|
Results
|
|
C. M. Connor
|
|
Earnings per share (weighted 30%)
|
|
$3.25
|
|
$3.78
|
J. G. Morikis
|
|
Net sales (weighted 20%, 20% and 10%, respectively)
|
|
$7.50 billion
|
|
$7.09 billion
|
S. P. Hennessy
|
|
After tax return on equity (weighted 20%, 10% and 10%,
respectively)
|
|
23.98%
|
|
27.14%
|
|
|
Free cash flow (weighted 10%, 10% and 20%, respectively)
|
|
$326.80 million
|
|
$605.30 million
|
|
|
Consolidated working capital as a % of sales (weighted 10%)
|
|
12.32%
|
|
10.71%
|
|
|
Earnings before interest, taxes, depreciation and amortization
(weighted 10%, 20% and 20%, respectively)
|
|
$796.30 million
|
|
$833.75 million
|
S. J. Oberfeld
|
|
Paint Stores Group sales (weighted 20%)
|
|
$4.50 billion
|
|
$4.21 billion
|
|
|
Paint Stores Group profit before taxes (weighted 20%)
|
|
$390 million
|
|
$469 million
|
|
|
Paint Stores Group return on sales (weighted 20%)
|
|
8.70%
|
|
11.10%
|
|
|
Paint Stores Group return on net assets employed (weighted 20%)
|
|
32.20%
|
|
41.99%
|
|
|
Paint Stores Group working capital as a % to sales (weighted 20%)
|
|
15.13%
|
|
13.99%
|
T. W. Seitz
|
|
Earnings per share (weighted 20%)
|
|
$3.25
|
|
$3.78
|
|
|
Net sales (weighted 20%)
|
|
$7.50 billion
|
|
$7.09 billion
|
|
|
Operational excellence savings (weighted 15%)
|
|
$58 million
|
|
$68.25 million
|
|
|
Raw material costs to adjusted budget (weighted 15%)
|
|
1.66%
|
|
6.69%
|
|
|
Incremental annualized product cost savings (weighted 15%)
|
|
1.00
|
|
1.25
|
|
|
Return on net assets employed (weighted 10%)
|
|
11.90%
|
|
13.93%
|
|
|
Leadership and drive performance for excellence initiatives
(weighted 5%)
|
|
1.00
|
|
1.10
|
27
We intend annual cash incentive amounts to be fully deductible
for federal income tax purposes under Section 162(m) of the
Internal Revenue Code. In order to achieve this, we establish an
annual maximum payout amount against which payouts for
achievements may be made to 162(m) participants. The maximum
payout for 162(m) participants is based upon one or more of the
performance measurements defined in our 2007 Executive
Performance Bonus Plan. For 2009, the Compensation Committee
approved 0.7% of earnings before interest, taxes, depreciation
and amortization (EBITDA) as the amount of the maximum payout
for 162(m) participants. We selected EBITDA as the method for
determining the amount of the maximum payout because we consider
EBITDA a useful measure of our operating profitability. We
explain how we calculate EBITDA on page 33 of our 2009
Annual Report to Shareholders. For 2009, Sherwin-Williams
EBITDA was $833.75 million. This amount resulted in a
maximum payout of $5.84 million for the 162(m)
participants. After the Compensation Committee determines the
amount of the maximum payout, the Compensation Committee may
exercise discretion to reduce, but not to increase, the amount
of the actual award payable under the 2007 Executive Performance
Bonus Plan based on company and individual performance goals as
described below.
The Compensation Committee reviews and approves each named
executives achievement of performance goals for the prior
year and approves new performance goals for the current year. In
determining the level of achievement of performance goals, the
Compensation Committee may exercise its discretion whether to
reflect or exclude the impact of changes in accounting standards
or non-recurring items. In determining the level of achievement
for certain 2009 financial performance goals, the Committee
excluded the impact of asset impairment charges and a loss on
the dissolution of a foreign subsidiary.
In recent years, the Compensation Committee had established a
threshold goal to increase company earnings, and 75% of this
earnings increase must have been achieved to have paid annual
incentive compensation under our Performance Plan. Beginning in
2009, the Compensation Committee eliminated the threshold
earnings goal so that participants focus their efforts on
achieving their company and individual financial and operating
performance goals, rather than putting too much emphasis on
achieving just one threshold earnings goal.
The following table shows the actual annual incentive
compensation amounts earned by our named executives during 2009.
|
|
|
|
|
|
|
|
|
|
|
Annual Incentive Compensation
|
Named
|
|
Earned in 2009
|
Executive
|
|
Amount ($)
|
|
% of Salary
|
|
C. M. Connor
|
|
|
1,684,000
|
|
|
|
133%
|
|
J. G. Morikis
|
|
|
732,000
|
|
|
|
100%
|
|
S. P. Hennessy
|
|
|
636,000
|
|
|
|
113%
|
|
S. J. Oberfeld
|
|
|
444,000
|
|
|
|
83%
|
|
T. W. Seitz
|
|
|
437,000
|
|
|
|
90%
|
|
Long-term Equity Incentive
Compensation. We grant long-term equity
incentive compensation in the form of stock options and
restricted stock annually under our shareholder-approved 2006
Equity and Performance Incentive Plan. Our long-term equity
compensation program is designed to focus the efforts of our
employees on performance objectives that contribute to company
success on a long-term basis, while serving important employee
retention, recognition and management succession planning
purposes. Our stock option program is the primary means in which
we grant long-term stock compensation to a broad group of key
employees based strictly upon increases in our stock price. Our
restricted stock program is designed for a more select group of
key employees and rewards participants based upon the
achievement of financial performance goals and for the
appreciation in our stock price.
When making equity grants, we begin by determining the median
market value of long-term equity incentive compensation. For the
2009 grant of stock options and the 2010 grant of restricted
stock, we generally kept grant values consistent with the prior
years grant values. This resulted in these equity grant
values exceeding the values indicated by the general survey
data. The general survey data reflected grants made by companies
during the current economic downturn, resulting in lower values
compared to the previous year.
28
We allocate that value between stock options and restricted
stock by targeting comparable values for stock options and
restricted stock. We allocate the mix of stock options and
restricted stock in this way because we want to equally reward
the growth in the value of our common stock and the achievement
of financial performance goals.
Long-term incentive opportunities are intended to be competitive
with market long-term incentive opportunities. Therefore, we do
not consider the amount of outstanding stock options and shares
of restricted stock currently held by an executive when making
awards of stock options and restricted stock.
We have used a consistent approach in granting stock options and
restricted stock over the years. We grant stock options and
restricted stock on an annual basis at regularly scheduled
Compensation Committee meetings. We schedule the dates of these
meetings approximately three years in advance. We typically
grant restricted stock in February and stock options in October.
We grant restricted stock and stock options in February and
October so that our annual grants are made at different times of
the year. Information relating to the stock options and shares
of restricted stock granted to our named executives is set forth
in the Summary Compensation Table and the 2009 Grants of
Plan-Based Awards Table.
At each October Compensation Committee meeting, we grant stock
options to all eligible employees. These grants are made
typically on the same day that the Audit Committee approves our
earnings release for the third quarter and a day or so before we
release our third quarter earnings results. At each February
Compensation Committee meeting, we grant restricted stock. This
meeting typically occurs in the third week of February,
approximately three or four weeks after we release our annual
earnings results. We may also grant restricted stock and stock
options at other regularly scheduled Compensation Committee
meetings in connection with an employees initial hire,
promotion and other events. The dates of these grants may occur
shortly before we release our quarterly earnings results. We do
not take into account our earnings results when determining the
number of stock options or shares of restricted stock to be
granted.
Stock Options. The number of stock options
granted to an executive is based upon the executives
position and level of responsibility using comparable positions
at the peer companies and according to the general survey data.
We determine the specific number of stock options to be granted
by calculating the Black-Scholes value of the stock options over
a prior
90-day
period. Black-Scholes is a generally accepted model used in
estimating the value of stock options. We identify the minimum,
median and maximum values of stock options granted by the peer
companies and according to the general survey data. The
Compensation Committee generally grants stock options to
approximate median market value.
In accordance with the terms of our stock plan, the option
exercise price for all stock options is equal to the average of
the high and low market price of our common stock on the date
options are granted. Accordingly, the exercise price may be
higher or lower than the closing price of our common stock on
that day. The Committee believes that the average of the high
and low prices is a better representation of the fair market
value of our stock and is less volatile than the closing price.
We do not reprice stock options, and our stock plans do not
contain reload features. Stock options typically vest at the
rate of one-third per year for three years (beginning one year
from the date of grant) and expire ten years from the date of
grant. In October 2009, we granted stock options to all
executives.
Restricted Stock. We determine the granting of
restricted stock in a manner similar to how we determine the
granting of stock options. We identify the median value of
restricted stock granted by the peer companies and according to
the general survey data. The Compensation Committee generally
grants restricted stock with a value higher than the median to
allow our executives the opportunity to earn above target
compensation for above target performance. Shares of restricted
stock are subject to a substantial risk of
forfeiture and vest in accordance with performance and
time restrictions.
29
The number of shares of restricted stock that will vest at the
end of the restriction period is based upon the achievement of
performance goals. Performance goals are established so that
less than 100% of the shares of restricted stock will vest if
the target level of performance goals are not achieved and 100%
of the shares will vest if the maximum level of performance
goals are achieved or exceeded. The maximum level of performance
is intended to require significant effort to reach. Up to 100%
of the shares of restricted stock may be forfeited if the
performance goals are not achieved.
In February 2009, the Compensation Committee approved the annual
grant of restricted stock to our executives. The number of
shares granted was equal to approximately 1.5 times the target
value, and we correspondingly set above target goals higher
making achievement of the goals more difficult to attain and
providing a greater incentive for above target performance. In
addition, the Compensation Committee granted additional shares
of restricted stock to provide our named executives with an
incentive to focus on delivering long-term value during the
global economic slowdown. The Compensation Committee believes
that the value of this grant of additional shares of restricted
stock balances the recognition of no annual cash incentive
compensation having been paid to our named executives for 2008
with the challenge of improving our financial performance.
The following table shows the number of shares of restricted
stock granted to our named executives during 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares of Restricted
|
|
|
Stock Granted in 2009
|
Named Executive
|
|
Annual
|
|
Additional
|
|
Total
|
|
C. M. Connor
|
|
|
53,000
|
|
|
|
17,000
|
|
|
|
70,000
|
|
J. G. Morikis
|
|
|
21,000
|
|
|
|
9,000
|
|
|
|
30,000
|
|
S. P. Hennessy
|
|
|
15,500
|
|
|
|
8,500
|
|
|
|
24,000
|
|
S. J. Oberfeld
|
|
|
14,000
|
|
|
|
6,000
|
|
|
|
20,000
|
|
T. W. Seitz
|
|
|
7,500
|
|
|
|
5,000
|
|
|
|
12,500
|
|
The shares of restricted stock granted in 2008 and prior years
vest at the end of four years. The shares of restricted stock
granted in 2009 vest at the end of three years. The Compensation
Committee reduced the vesting period from four years to three
years to reflect current market practices. During the vesting
period, executives beneficially own the shares of restricted
stock.
The number of shares of restricted stock that will actually vest
will range from 0% to 100% based upon our companys
achievement of specified financial performance goals. These
goals measure average return on average equity and EBITDA over
the vesting period.
|
|
|
|
|
We calculate average return on average equity for the vesting
period as follows. Return on average equity for each year of the
vesting period is calculated by dividing our reported net income
(excluding any items relating to nonrecurring events or which
result in a distortion of comparative results) by our average of
beginning and ending shareholders equity for that year. We
then calculate the average of those amounts over the vesting
period to arrive at average return on average equity. The
vesting of shares of restricted stock in February 2010 excluded
the impact of asset impairment charges and a loss on the
dissolution of a foreign subsidiary that occurred during the
vesting period.
|
|
|
|
We explain how we calculate EBITDA on page 33 of our 2009
Annual Report to Shareholders.
|
The Compensation Committee selected these two performance
measures because they reward our executives in achieving two
important business objectives earnings growth and
improved return on resources provided by our shareholders. The
Compensation Committee believes these objectives help us improve
our long-term financial results and, therefore, are expected to
increase shareholder value.
At the end of the vesting period, the Compensation Committee
will review performance against the goals and determine the
number of shares of restricted stock that will vest.
For the 2009 grant of restricted stock:
|
|
|
|
|
100% of the shares of restricted stock will vest in the event we
achieve at least a 18% average return on average equity and
|
30
|
|
|
|
|
at least $2.51 billion of EBITDA over the three-year period;
|
|
|
|
|
|
No shares will vest in the event we achieve below 12% average
return on average equity or below $2.41 billion of EBITDA
over the three-year period; and
|
|
|
|
Between 26% and 100% (on a sliding scale) of the restricted
stock will vest in the event we achieve between 12% and 18%
average return on average equity and between $2.41 billion
and $2.51 billion of EBITDA over the three-year period. We
use this sliding scale to reward improvements in our results at
various achievement levels.
|
2009 and 2010 Vesting of Restricted Stock. In
February 2009, the Compensation Committee approved the vesting
of 100% of the shares of restricted stock granted in February
2005. During that four-year period, Sherwin-Williams achieved at
least a 17% average return on average equity and at least an 8%
cumulative growth in EBITDA.
In February 2010, the Compensation Committee approved the
vesting of 84.8% of the shares of restricted stock granted in
February 2006. During that four-year period, Sherwin-Williams
achieved a 30.8% average return on average equity and a 6.5%
cumulative growth in EBITDA. The lower achievement resulted from
decreased EBITDA during 2008 and 2009 due to the global
recession.
2010 Restricted Stock Changes. We changed some
features of our restricted stock program beginning in 2010. Our
annual grant of restricted stock now consists of two-thirds
performance-based shares and one-third time-based shares. We
made this change to reflect current market practices. With
respect to the performance-based shares, the number of shares
granted is equal to approximately 2 times the target value, and
we correspondingly set above target goals higher making
achievement of the goals more difficult to attain. We made this
change to provide a greater incentive for above target
performance. In addition, we changed the financial goals for
performance-based restricted stock to average return on average
equity and earnings per share over the three-year period. We
added earnings per share as a performance goal because it is
widely communicated and easily understood, and is a key measure
used in evaluating the success of our companys performance
and in determining the market value of our common stock.
Other
Arrangements, Policies and Practices
Perquisites. We offer limited
perquisites to our executives: personal use of the corporate
aircraft, an executive automobile program (which is being phased
out as automobile lease terms end) and relocation expenses. By
the end of the first quarter of 2010, no named executive will
participate in the executive automobile program. These
perquisites represent a small portion of the total compensation
paid to our executives. The incremental costs of these
perquisites for 2009 are set forth in a footnote to the
All Other Compensation column of the Summary
Compensation Table.
Other Benefits. We provide our named
executives with various retirement and savings programs, health
and welfare programs, and employee benefit plans, programs and
arrangements generally available to all employees and other
executive benefits. We annually review these items in connection
with our preparation and review of the overall compensation
packages of our named executives and in connection with our
review of tally sheets. We also offer deferred compensation
plans under which participating employees may elect to defer
compensation on a pre-tax basis. None of our named executives
participated in these deferred plans during 2009.
Other executive benefit programs include an executive life
insurance program and an executive long-term disability program.
The 2009 amounts for these programs are set forth in a separate
table that is included in a footnote to the All Other
Compensation column of the Summary Compensation Table.
The life insurance and long-term disability programs are
designed to provide our named executives with life and
disability benefits greater than the life and disability
benefits available under the broad-based life insurance and
31
long-term disability programs that we offer to other employees
due to benefit limitations within the broad-based programs.
Termination of Grantor Trust. We
terminated our grantor trust program effective December 31,
2009. During 2009, all of our named executives participated in
our grantor trust program. We had initiated our grantor trust
program in 2003 to provide those employees who had accumulated a
significant retirement benefit in our deferred compensation plan
with financial security equal to that provided under our
qualified retirement plans. Since 2003, employees who had been
eligible to participate in the grantor trust program had not
been eligible to participate in our deferred compensation plan.
Accordingly, the Compensation Committee also approved amendments
to The Sherwin-Williams Company 2005 Deferred Compensation
Savings and Pension Equalization Plan, including amendments that
permit those executives to be eligible to participate in the
Deferred Compensation Plan effective January 1, 2010. The
Deferred Compensation Plan is a nonqualified plan that provides
participating employees with the employer contributions the
employees would have received under our qualified retirement
plans, but for federal tax limitations. Amounts deferred are
credited with market earnings based on the same investment
choices available to all employees under our qualified
retirement plans.
Under our grantor trust program, each participating employee
established a brokerage account as part of an irrevocable
individual trust. We made supplemental retirement compensation
payments to these individual trusts through our regular
bi-weekly payroll. The amount of the supplemental retirement
compensation payment was equal to the employee contribution and
the company contribution that the participating employee would
otherwise have been permitted under our Deferred Compensation
Plan if the employee had participated in such plan. The
supplemental retirement compensation payment was immediately
taxed as ordinary income to the employee in the current year
upon the employees receipt of such payments.
A participant in our grantor trust program was entitled to
invest funds held in his individual trust in various
investments, such as stocks, bonds, mutual funds, money market
funds and certificates of deposit. These investments included
the same investments as were available under our Deferred
Compensation Plan. To the extent a participant invested funds
held in his trust in the same investments as were available
under our Deferred Compensation Plan, the participant was
entitled to receive an annual tax
gross-up
payment. The tax
gross-up
payment reimbursed the participant for the immediate tax
recognized on the taxable interest and earnings of the trust
earned in the previous calendar year. We did not
gross-up the
supplemental retirement compensation payments, nor did we
gross-up the
unrealized appreciation in the value of investments held in a
trust.
Our grantor trust program was designed so that the supplemental
retirement compensation payments and
tax-gross-up
payments would provide the participants with the same after-tax
amount at retirement age as would have been provided under our
Deferred Compensation Plan. We have set forth the amounts of the
company contribution portion of the supplemental retirement
compensation payments and the tax
gross-up
payments for 2009 for the named executives in a footnote to the
All Other Compensation column of the Summary
Compensation Table.
Internal Pay Equity. The Compensation
Committee broadly considers internal pay equity when setting
compensation levels for executives with similar
responsibilities, experience and tenure. However, the
Compensation Committee has no specific policy and follows no
established guidelines or formulas when comparing compensation
levels among executives. In connection with grants of stock
options and restricted stock, the Compensation Committee
generally grants the same number of stock options and shares of
restricted stock to employees who are in similar pay grades.
Use of Tally Sheets. When approving
changes in compensation for our named executives, we prepare a
tally sheet for each named executive. Tally sheets set forth the
dollar amounts of all components of each named executives
current compensation, including salary, annual cash incentive
compensation, long-term incentive compensation, retirement and
savings programs, health and welfare programs
32
and other executive benefits, including perquisites.
The Compensation Committee uses tally sheets as a reference to
ensure that its members understand the total compensation of our
named executives. Tally sheets also allow the Compensation
Committee and management to review, in one place, how a change
in the amount of each compensation component affects each named
executives total compensation and to review each named
executives total compensation in the aggregate. Based upon
its most recent review, the Compensation Committee determined
that total compensation, in the aggregate, for each of our named
executives to be consistent with the Compensation
Committees expectations. The Compensation Committee did
not increase or decrease the amount of compensation of our named
executives solely based upon the review of tally sheets.
The Compensation Committee and management also reviewed
potential payments to our named executives under termination and
change in control scenarios including: normal and early
retirement; death and disability; voluntary termination;
involuntary (not for cause) termination; termination for
cause; and termination following a change in control.
This review included potential severance payment obligations,
potential values of accelerated shares of restricted stock and
stock options, and projected payment obligations in connection
with our retirement and savings programs, health and welfare
plans, and other executive benefits. The Compensation Committee
determined that the total potential payments, in the aggregate,
for each of our named executives under each scenario to be
reasonable and not excessive.
Tax and Accounting Considerations. From
time to time, we review the accounting and tax laws, rules and
regulations that may affect our compensation programs. However,
tax and accounting considerations have not significantly
impacted the compensation programs we offer to our executives.
Section 162(m) of the Internal Revenue Code generally
provides that certain compensation in excess of $1 million
per year paid to a companys chief executive officer and
any of its four other highest paid executive officers is not
deductible by a company unless the compensation qualifies for an
exception. Section 162(m) provides an exception to the
deductibility limit for performance-based compensation if
certain procedural requirements, including shareholder approval
of the material terms of the performance goal, are satisfied.
Under our 2007 Executive Performance Bonus Plan, we have the
ability to pay non-discretionary annual cash incentive
compensation to our named executives that will qualify for
deductibility. Independent of our Performance Plan, the
Compensation Committee retains the discretion to reward
individual performance by paying executive compensation amounts
that may not be deductible under Section 162(m). The
Compensation Committee believes that its ability to exercise
such discretion is in the best interests of Sherwin-Williams and
our shareholders. The Compensation Committee did not approve the
payment of any such discretionary bonus amounts for 2009 that
are not deductible under Section 162(m).
Executive Compensation Adjustment and Recapture
Policy. We have a policy regarding the
adjustment and recapture of compensation paid or payable to key
employees and executives. Under the policy, employees who
receive an award under our 2007 Executive Performance Bonus Plan
are required to reimburse Sherwin-Williams in the event:
|
|
|
|
|
The amount was based upon the achievement of financial results
that were subsequently the subject of an accounting restatement
due to the material noncompliance with any financial reporting
requirement under the federal securities laws;
|
|
|
|
The employee engaged in knowing or intentional fraudulent or
illegal conduct that caused or partially caused the need for the
restatement; and
|
|
|
|
A lower amount would have been made to the employee based upon
the restated financial results.
|
The reimbursement will be equal to the difference in the amount
of the award prior to the restatement and the amount of the
award determined using the restated financial results.
33
In addition, under our 2006 Equity and Performance Incentive
Plan, (a) all stock awards will be cancelled and
(b) the employee will be required to reimburse
Sherwin-Williams for any economic gains received by the employee
pursuant to a stock award during the one-year period preceding
the Board of Directors determination that the employee
engaged in such conduct.
Severance Pay Agreements. To ensure
continuity and the continued dedication of our executives during
any period of uncertainty caused by the possible threat of a
takeover, we have entered into severance pay agreements with our
executives, including each of our named executives. These
severance pay agreements have not been a significant factor in
setting compensation levels and have not affected the
Compensation Committees decisions with respect to the
compensation components.
In 2006, the Compensation Committee engaged Towers Watson to
evaluate our then existing severance pay agreements to determine
how these agreements compared to market practices. Towers
Watsons evaluation included a review of material terms of
the agreements, including the change in control trigger
threshold, severance pay single versus double triggers,
severance pay multiples, continuation of retirement, health and
welfare benefits, excise tax
gross-ups,
and the impact of Section 409A of the Internal Revenue Code.
Based upon this evaluation, the Compensation Committee approved
a new form of severance agreement in February 2007, and we
entered into new severance agreements with each of our
executives. The Compensation Committee believes that the
material terms of the severance agreements are consistent with
market practices.
Potential cash severance payments are based upon a multiplier of
base salary and annual cash incentive pay. Because
Mr. Connors base salary and annual cash incentive pay
are higher than that of our other named executives,
Mr. Connors potential cash severance payment is
correspondingly higher than that of our other named executives.
Additional information regarding the severance agreements,
including the estimated amounts payable to each named executive,
is set forth under the heading Potential Payments upon
Termination or Change in Control.
Policy Concerning Future Severance
Agreements. We adopted a policy in early
2010, which provides that we will not enter into any future
severance agreements (including material amendments of existing
agreements) with a senior executive providing for cash severance
payments exceeding 2.99 times base salary and bonus without
shareholder approval or ratification. For purposes of this
policy, severance payments shall not include the acceleration of
equity based awards, vacation pay, retirement benefits, health
continuation coverage and outplacement services. In addition,
future severance agreements will not provide for any tax
gross-up
payments.
Stock Ownership Guidelines. We have
established a minimum share ownership requirement for our
directors, executive officers and operating presidents. We
require each director who has served on the Board of Directors
for at least five years to own a minimum of 10,000 shares
of common stock. We require each executive and operating
president who has served in such capacity for at least five
years to own shares of common stock equal in value to a multiple
of his base salary ranging from a low of three times to a high
of five times. The requirements for our executives and operating
presidents are as follows.
|
|
|
|
|
Minimum Share
|
|
|
Ownership as
|
|
|
Multiple of
|
Title
|
|
Base Salary
|
|
Chief Executive Officer
|
|
5 times
|
Chief Operating Officer
|
|
4 times
|
Other Executives and Operating Presidents
|
|
3 times
|
For purposes of meeting this requirement, each equivalent share
of common stock held under our benefit plans and each share of
restricted stock is considered as a share of common stock. Stock
options are not considered towards meeting the requirement. The
Compensation Committee reviews compliance with these guidelines
annually. All directors, executive officers and operating
presidents have either met the guidelines or are pursuing plans
to meet the guidelines.
34
SUMMARY
COMPENSATION TABLE
The following table sets forth information regarding the
compensation of our Chairman and Chief Executive Officer, our
Senior Vice President Finance and Chief Financial
Officer and our other three highest paid executive officers (our
named executives).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
Name
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Deferred
|
|
|
All
|
|
|
|
|
and
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Option
|
|
|
Plan
|
|
|
Compensation
|
|
|
Other
|
|
|
|
|
Principal
|
|
|
|
|
Salary
|
|
|
Bonus
|
|
|
Awards
|
|
|
Awards
|
|
|
Compensation
|
|
|
Earnings
|
|
|
Compensation
|
|
|
Total
|
|
Position
|
|
Year
|
|
|
($)
|
|
|
($)
|
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)
|
|
|
($)(3)
|
|
|
($)(4)
|
|
|
($)
|
|
|
C. M. Connor
|
|
|
2009
|
|
|
|
1,268,986
|
|
|
|
-0-
|
|
|
|
2,147,367
|
|
|
|
1,918,725
|
|
|
|
1,684,000
|
|
|
|
-0-
|
|
|
|
476,732
|
|
|
|
7,495,810
|
|
Chairman and
|
|
|
2008
|
|
|
|
1,214,590
|
|
|
|
-0-
|
|
|
|
1,542,697
|
|
|
|
1,782,113
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
524,807
|
|
|
|
5,064,207
|
|
Chief Executive Officer
|
|
|
2007
|
|
|
|
1,161,047
|
|
|
|
-0-
|
|
|
|
2,438,543
|
|
|
|
1,621,870
|
|
|
|
1,544,000
|
|
|
|
-0-
|
|
|
|
540,064
|
|
|
|
7,305,524
|
|
J. G. Morikis
|
|
|
2009
|
|
|
|
732,703
|
|
|
|
-0-
|
|
|
|
920,300
|
|
|
|
767,490
|
|
|
|
732,000
|
|
|
|
-0-
|
|
|
|
241,374
|
|
|
|
3,393,867
|
|
President and
|
|
|
2008
|
|
|
|
701,295
|
|
|
|
-0-
|
|
|
|
609,903
|
|
|
|
712,845
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
223,132
|
|
|
|
2,247,175
|
|
Chief Operating Officer
|
|
|
2007
|
|
|
|
663,481
|
|
|
|
-0-
|
|
|
|
801,135
|
|
|
|
648,748
|
|
|
|
697,000
|
|
|
|
-0-
|
|
|
|
254,948
|
|
|
|
3,065,312
|
|
S. P. Hennessy
|
|
|
2009
|
|
|
|
561,632
|
|
|
|
-0-
|
|
|
|
736,240
|
|
|
|
613,992
|
|
|
|
636,000
|
|
|
|
-0-
|
|
|
|
193,585
|
|
|
|
2,741,449
|
|
Senior Vice President
|
|
|
2008
|
|
|
|
535,863
|
|
|
|
-0-
|
|
|
|
448,458
|
|
|
|
513,248
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
197,075
|
|
|
|
1,694,644
|
|
Finance and
|
|
|
2007
|
|
|
|
503,617
|
|
|
|
-0-
|
|
|
|
562,200
|
|
|
|
486,561
|
|
|
|
604,000
|
|
|
|
-0-
|
|
|
|
193,997
|
|
|
|
2,350,375
|
|
Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S. J. Oberfeld
|
|
|
2009
|
|
|
|
532,729
|
|
|
|
-0-
|
|
|
|
613,533
|
|
|
|
552,593
|
|
|
|
444,000
|
|
|
|
-0-
|
|
|
|
153,728
|
|
|
|
2,296,583
|
|
President,
|
|
|
2008
|
|
|
|
493,225
|
|
|
|
-0-
|
|
|
|
448,458
|
|
|
|
513,248
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
187,869
|
|
|
|
1,642,800
|
|
Paint Stores Group
|
|
|
2007
|
|
|
|
459,272
|
|
|
|
-0-
|
|
|
|
562,200
|
|
|
|
486,561
|
|
|
|
276,000
|
|
|
|
-0-
|
|
|
|
249,720
|
|
|
|
2,033,753
|
|
T. W. Seitz
|
|
|
2009
|
|
|
|
487,711
|
|
|
|
-0-
|
|
|
|
383,458
|
|
|
|
322,346
|
|
|
|
437,000
|
|
|
|
163,213
|
|
|
|
497,321
|
|
|
|
2,291,049
|
|
Senior Vice President
|
|
|
2008
|
|
|
|
448,177
|
|
|
|
-0-
|
|
|
|
243,961
|
|
|
|
299,395
|
|
|
|
-0-
|
|
|
|
62,165
|
|
|
|
295,676
|
|
|
|
1,349,374
|
|
Strategic Excellence
|
|
|
2007
|
|
|
|
422,093
|
|
|
|
-0-
|
|
|
|
421,650
|
|
|
|
291,937
|
|
|
|
339,000
|
|
|
|
85,979
|
|
|
|
258,036
|
|
|
|
1,818,695
|
|
Initiatives
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
The values set forth in this column reflect shares of restricted
stock granted to our named executives. The values of restricted
stock are equal to the aggregate grant date fair value computed
in accordance with the Stock Compensation Topic (718) of the
ASC, excluding the effect of estimated forfeitures. This
valuation method values restricted stock based on the fair
market value of our common stock (the average of the highest and
lowest reported sale prices) on the date of grant. The values
are based upon the probable outcome of performance conditions.
|
The following table sets forth the aggregate grant date fair
value for the shares of restricted stock reflected in this
column assuming the highest level of performance conditions will
be achieved.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
C. M. Connor
|
|
$
|
3,221,050
|
|
|
$
|
2,314,045
|
|
|
$
|
3,048,178
|
|
J. G. Morikis
|
|
|
1,380,450
|
|
|
|
914,855
|
|
|
|
1,001,419
|
|
S. P. Hennessy
|
|
|
1,104,360
|
|
|
|
672,688
|
|
|
|
702,750
|
|
S. J. Oberfeld
|
|
|
920,300
|
|
|
|
672,688
|
|
|
|
702,750
|
|
T. W. Seitz
|
|
$
|
575,188
|
|
|
$
|
365,942
|
|
|
$
|
527,063
|
|
|
|
2 |
The values set forth in this column reflect stock options
granted to our named executives. The values of stock options are
equal to the aggregate grant date fair value computed in
accordance with the Stock Compensation Topic (718) of the ASC,
excluding the effect of estimated forfeitures. The values were
calculated using a Black-Scholes option pricing model with the
following weighted-average assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
Risk-free interest rate
|
|
|
2.39
|
%
|
|
|
3.01
|
%
|
|
|
4.03
|
%
|
Expected life of options
|
|
|
5.27
|
years
|
|
|
5.24
|
years
|
|
|
4.67
|
years
|
Expected dividend yield of stock
|
|
|
2.69
|
%
|
|
|
2.41
|
%
|
|
|
1.80
|
%
|
Expected volatility of stock
|
|
|
0.319
|
|
|
|
0.321
|
|
|
|
0.279
|
|
35
|
|
3
|
The amounts set forth in this column for Mr. Seitz reflect the
aggregate increase in the present value of his accumulated
benefit in our Salaried Employees Pension Investment Plan.
|
|
4
|
The amounts set forth in this column for 2009 include
compensation under the following plans and programs:
|
|
|
|
|
|
Pension Plans company contributions under our
Salaried Employees Revised Pension Investment Plan, a
defined contribution plan, or our Salaried Employees
Pension Investment Plan, a defined benefit plan;
|
|
|
|
Employee Stock Purchase and Savings Plan
company matching contributions under our Employee Stock
Purchase and Savings Plan, a defined contribution plan;
|
|
|
|
Grantor Trust Program company supplemental
compensation payments and tax gross-up payments relating to our
grantor trust program. We terminated our grantor trust program
during 2009 as described under the heading Termination of
Grantor Trust of Compensation Discussion and
Analysis;
|
|
|
|
Executive Life Insurance Plan the dollar
value of non-compensatory split-dollar life insurance benefits
under our Executive Life Insurance Plan;
|
|
|
|
Executive Disability Income Plan company
payments for premiums under our Executive Disability Income Plan;
|
|
|
|
Charitable Matching Gifts company charitable
matching contributions under our matching gifts programs; and
|
|
|
|
Perquisites perquisites and other personal
benefits. The incremental costs of all perquisites provided to
our named executives during 2009 were as follows: $24,275,
$25,066 and $13,392 for Messrs. Morikis, Hennessy and
Seitz, respectively, under our executive automobile program
(which is being phased out as individual automobile lease terms
end); and $5,010, $7,979 and $4,013 for Messrs. Connor,
Morikis and Hennessy, respectively, for personal use of
corporate aircraft.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C. M. Connor
|
|
J. G. Morikis
|
|
S. P. Hennessy
|
|
S. J. Oberfeld
|
|
T. W. Seitz
|
|
Pension Plans ($)
|
|
|
13,800
|
|
|
|
13,800
|
|
|
|
13,800
|
|
|
|
13,800
|
|
|
|
2,450
|
|
Employee Stock Plan ($)
|
|
|
14,700
|
|
|
|
14,700
|
|
|
|
14,700
|
|
|
|
14,700
|
|
|
|
14,700
|
|
Grantor Trust Supplemental Payments ($)
|
|
|
295,949
|
|
|
|
118,378
|
|
|
|
87,326
|
|
|
|
71,600
|
|
|
|
390,839
|
|
Grantor Trust Tax Gross-ups ($)
|
|
|
59,101
|
|
|
|
10,529
|
|
|
|
4,160
|
|
|
|
23,482
|
|
|
|
15,562
|
|
Executive Life Insurance Plan ($)
|
|
|
85,800
|
|
|
|
49,430
|
|
|
|
41,900
|
|
|
|
27,485
|
|
|
|
52,000
|
|
Executive Disability Income Plan ($)
|
|
|
2,372
|
|
|
|
2,283
|
|
|
|
2,620
|
|
|
|
2,661
|
|
|
|
3,378
|
|
Charitable Matching Gifts ($)
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
5,000
|
|
Perquisites ($)
|
|
|
5,010
|
|
|
|
32,254
|
|
|
|
29,079
|
|
|
|
-0-
|
|
|
|
13,392
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL ($)
|
|
|
476,732
|
|
|
|
241,374
|
|
|
|
193,585
|
|
|
|
153,728
|
|
|
|
497,321
|
|
Amounts do not include the incremental cost of our Business
Travel Accident Insurance Plan, which provides coverage for all
of our directors, executive officers and full-time salaried
employees. The total aggregate premium in 2009 for this plan for
all directors, executives and employees was $36,028.
36
Narrative Information Regarding the Summary Compensation
Table.
Employment Agreements. None of our named
executives have entered into employment agreements with
Sherwin-Williams.
Salary. The salary amounts disclosed in the
table are the amounts of base salary earned by our named
executives during the indicated year. The salary amounts paid to
our named executives during 2009 exceeded their base salaries
because calendar year 2009 contained
27 bi-weekly
pay periods instead of the usual 26. For 2009, salaries earned
by our named executives accounted for the following percentages
of their total compensation set forth in the table:
Mr. Connor (17%), Mr. Morikis (22%), Mr. Hennessy
(20%), Mr. Oberfeld (23%) and Mr. Seitz (21%). The
percentages for 2009 are lower than the percentages for 2008
because no annual cash incentive compensation was earned or paid
for 2008.
Stock and Option Awards. Consistent with
recently amended SEC rules, stock and option awards are required
to be valued using the aggregate grant date fair value computed
in accordance with Stock Compensation Topic (718) of the ASC.
Accordingly, the values of stock and option awards for 2007 and
2008 disclosed in our 2007 and 2008 proxy statements have been
recomputed to conform with the amended rules.
Salaried Employees Pension Investment
Plan. Mr. Seitz is the only named executive who
participates in our Salaried Employees Pension Investment
Plan. Information about this plan is set forth in the 2009
Pension Benefits Table and the accompanying narrative discussion.
2005 Deferred Compensation Savings and Pension Equalization
Plan. Our Deferred Compensation Plan is a
nonqualified plan that provides participating employees with the
employer contributions the employees would have received under
our qualified retirement plans, but for federal tax limitations.
Amounts deferred are credited with market earnings based on the
same investment choices available to all employees under our
qualified retirement plans. Our executives became eligible to
participate in our Deferred Compensation Plan effective
January 1, 2010.
2005 Key Management Deferred Compensation
Plan. Our Key Management Plan is a nonqualified
deferred compensation plan pursuant to which employees who
participate in our 2007 Executive Performance Bonus Plan or
other identified employee groups may elect to defer on a pre-tax
basis up to 100% of their base salary and bonus. None of our
named executives participate in our Key Management Plan.
Perquisites. The value of perquisites
disclosed in the table is based upon the incremental cost of
providing the benefit to the executive. During 2007, the
Compensation and Management Development Committee eliminated
most of the perquisites that we had provided to our executives.
Accordingly, perquisites for 2009 for our named executives
related only to our executive automobile program and personal
use of corporate aircraft.
|
|
|
|
|
The incremental cost of the executive automobile program is
determined by adding all of the costs of the program, including
lease costs and costs of maintenance, fuel, license and taxes.
The program is being phased out at the end of each individual
lease term.
|
|
|
|
The incremental cost of personal use of corporate aircraft is
determined based upon the variable operating costs of the
aircraft, which includes fuel costs, maintenance and repair
costs, landing fees, engine reserve fees, catering costs and
travel costs for the pilots. The incremental cost includes the
cost of dead head flights, which are return or
pick-up flights without passengers flown. An average hourly rate
is calculated by dividing the total variable operating costs for
the year by the number of hours the aircraft is flown. The
average hourly rate is then multiplied by the number of hours of
the executives personal use to derive the total
incremental cost. Fixed operating costs, such as pilot salaries,
depreciation and insurance, that do not change based upon usage
are not included.
|
In addition, we purchase tickets to sporting and cultural events
for business purposes. If not used for business purposes, the
tickets are made available to our executives and other employees
for personal use.
37
2009
GRANTS OF PLAN-BASED AWARDS TABLE
The following table sets forth information regarding the grants
of annual cash incentive compensation, stock options and
restricted stock during 2009 to our named executives.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
Grant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
Exercise
|
|
Date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards;
|
|
of
|
|
Fair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number
|
|
Base
|
|
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of
|
|
Price
|
|
of
|
|
|
|
|
Estimated Possible Payouts Under
|
|
Estimated Future Payouts Under
|
|
Securities
|
|
of
|
|
Stock
|
|
|
|
|
Non-Equity Incentive Plan
Awards(1)
|
|
Equity Incentive Plan
Awards(2)
|
|
Underlying
|
|
Option
|
|
and
|
|
|
Grant
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Options
|
|
Awards
|
|
Option
|
Name
|
|
Date
|
|
($)
|
|
($)
|
|
($)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
(#)(3)
|
|
($/Sh)(4)
|
|
Awards($)(5)
|
|
C. M. Connor
|
|
02/17/2009
|
|
|
-0-
|
|
|
|
1,205,537
|
|
|
|
2,411,074
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02/17/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,200
|
|
|
|
46,667
|
|
|
|
70,000
|
|
|
|
|
|
|
|
|
|
|
|
2,147,367
|
|
|
|
10/15/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
125,000
|
|
|
|
63.25
|
|
|
|
1,918,725
|
|
J. G. Morikis
|
|
02/17/2009
|
|
|
-0-
|
|
|
|
549,527
|
|
|
|
1,099,054
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02/17/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,800
|
|
|
|
20,000
|
|
|
|
30,000
|
|
|
|
|
|
|
|
|
|
|
|
920,300
|
|
|
|
10/15/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
63.25
|
|
|
|
767,490
|
|
S. P. Hennessy
|
|
02/17/2009
|
|
|
-0-
|
|
|
|
421,224
|
|
|
|
842,448
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02/17/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,240
|
|
|
|
16,000
|
|
|
|
24,000
|
|
|
|
|
|
|
|
|
|
|
|
736,240
|
|
|
|
10/15/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
|
|
63.25
|
|
|
|
613,992
|
|
S. J. Oberfeld
|
|
02/17/2009
|
|
|
-0-
|
|
|
|
319,638
|
|
|
|
639,275
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02/17/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,200
|
|
|
|
13,333
|
|
|
|
20,000
|
|
|
|
|
|
|
|
|
|
|
|
613,533
|
|
|
|
10/15/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36,000
|
|
|
|
63.25
|
|
|
|
552,593
|
|
T. W. Seitz
|
|
02/17/2009
|
|
|
-0-
|
|
|
|
292,626
|
|
|
|
585,253
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02/17/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,250
|
|
|
|
8,333
|
|
|
|
12,500
|
|
|
|
|
|
|
|
|
|
|
|
383,458
|
|
|
|
10/15/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,000
|
|
|
|
63.25
|
|
|
|
322,346
|
|
|
|
1
|
The amounts set forth in these columns reflect the annual cash
incentive compensation amounts that could have been earned
during 2009 based upon the achievement of performance goals
under our 2007 Executive Performance Bonus Plan. The grant date
of February 17, 2009 is the date that the performance goals were
approved by the Compensation and Management Development
Committee. The amounts of annual cash incentive compensation
earned in 2009 by our named executives under our 2007 Executive
Performance Bonus Plan have been determined and were paid in
February 2010. The amounts paid are included in the
Non-Equity Incentive Plan Compensation column of the
Summary Compensation Table.
|
|
2
|
The amounts set forth in these columns reflect the number of
shares of restricted stock granted on February 17, 2009
under our 2006 Equity and Performance Incentive Plan. These
shares vest in February 2012 based upon the achievement of
financial performance goals.
|
|
3
|
The amounts set forth in this column reflect the number of stock
options granted on October 15, 2009 under our 2006 Equity
and Performance Incentive Plan. These stock options vest at the
rate of one-third per year and expire on October 14, 2019.
|
|
4
|
The exercise price ($63.25) equals the average of the highest
and lowest sale prices of our common stock on the date of grant,
October 15, 2009. The closing price of our common stock on
the date of grant was $63.10.
|
|
5
|
The values of restricted stock set forth in this column are
equal to the aggregate grant date fair value computed in
accordance with the Stock Compensation Topic (718) of the ASC,
excluding the effect of estimated forfeitures. The grant date
fair value of restricted stock is based on the fair market value
of our common stock (the average of the highest and lowest
reported sale prices) on the date of grant. The values are based
upon the probable outcome of performance conditions.
|
The values of stock options set forth in this column are equal
to the aggregate grant date fair value computed in accordance
with Stock Compensation Topic (718) of the ASC, excluding the
effect of estimated forfeitures. The values were calculated
using a Black-Scholes option pricing model. The assumptions used
in this model are set forth in the table to footnote 2 of
the Summary Compensation Table.
38
Narrative Information Regarding the 2009 Grants of
Plan-Based Awards Table.
Non-equity Incentive Plan Awards. The
non-equity incentive plan awards set forth in the table reflect
annual cash incentive compensation that could have been earned
by our named executives during 2009 under our 2007 Executive
Performance Bonus Plan based upon the accomplishment of company
and individual financial and operating performance goals.
Annual cash incentive compensation is payable as a percentage of
salary. These percentages vary by named executive. The
threshold, target and maximum amounts set forth in the table
correspond to the named executive achieving an average of 0%,
100% and 125% of his performance goals, respectively. More
information is set forth under the heading Annual Cash
Incentive Compensation of Compensation Discussion
and Analysis.
Restricted Stock. We grant restricted stock
pursuant to our 2006 Equity and Performance Incentive Plan. The
shares of restricted stock granted in 2009 vest at the end of a
three-year period based upon the achievement of financial
performance goals. The number of shares of restricted stock that
will actually vest at the end of the vesting period will range
from 0% to 100% based upon achievement of the financial
performance goals.
The threshold amounts set forth in the table correspond to our
named executives receiving 26% of the shares of restricted stock
granted, which is the number of shares that will vest for the
minimum level of performance. No shares of restricted stock will
vest if the threshold level of performance is not achieved.
The maximum amounts set forth in the table correspond to the
Compensation Committees decision to grant a number of
shares of restricted stock equal to 1.5 times the target value
(and correspondingly setting above target goals higher making
achievement of the goals more difficult to attain) in order to
provide an incentive for above target performance. We have
included more information about these performance goals under
the heading Long-term Equity Incentive Compensation
of Compensation Discussion and Analysis.
Shares of restricted stock will vest immediately upon the death
or disability of the named executive or upon a change in control
of Sherwin-Williams.
During the vesting period, the executives are the beneficial
owners of the shares of restricted stock and possess all voting
and dividend rights. Dividends are payable at the same rate as
is paid on Sherwin-Williams common stock generally. During 2009,
the quarterly dividend rate was $0.355 per share. In
February 2010, the Board of Directors announced an increase
in the quarterly dividend rate to $0.36 per share payable on
March 12, 2010.
Stock Options. We grant stock options pursuant
to our 2006 Equity and Performance Incentive Plan. The option
exercise price is equal to the market value of our common stock
on the date options are granted. In accordance with the terms of
the plan, the market value is equal to the average of the
highest and lowest reported sale prices of our common stock on
the date of grant.
Stock options vest in three equal installments on the first,
second and third anniversary dates of the date of grant and have
a term of ten years. Stock options become immediately
exercisable in the event of the death or disability of the
executive or in the event of a change in control of
Sherwin-Williams. Stock options are not transferable other than
by will or the laws of descent and distribution.
39
OUTSTANDING
EQUITY AWARDS AT DECEMBER 31, 2009 TABLE
The following table sets forth information regarding the number
of unexercised stock options and the number and value of
unvested shares of restricted stock outstanding on
December 31, 2009 for our named executives.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Incentive
|
|
|
|
|
Option Awards
|
|
Plan Awards:
|
|
Equity Incentive
|
|
|
|
|
Number of
|
|
Number of
|
|
|
|
|
|
Number of
|
|
Plan Awards:
|
|
|
|
|
Securities
|
|
Securities
|
|
|
|
|
|
Unearned
|
|
Market or Payout
|
|
|
|
|
Underlying
|
|
Underlying
|
|
|
|
|
|
Shares,
|
|
Value of Unearned
|
|
|
|
|
Unexercised
|
|
Unexercised
|
|
Option
|
|
|
|
Units or Other
|
|
Shares, Units or
|
|
|
|
|
Options
|
|
Options
|
|
Exercise
|
|
Option
|
|
Rights That Have
|
|
Other Rights That
|
|
|
Option
|
|
(#)
|
|
(#)
|
|
Price
|
|
Expiration
|
|
Not Vested
|
|
Have Not Vested
|
Name
|
|
Grant
Date(1)
|
|
Exercisable
|
|
Unexercisable
|
|
($)
|
|
Date
|
|
(#)
|
|
($)(2)
|
|
C. M. Connor
|
|
|
10/18/2002
|
|
|
|
246,067
|
|
|
|
-0-
|
|
|
|
25.425
|
|
|
|
10/17/2012
|
|
|
|
59,000
|
(3)
|
|
|
3,637,350
|
|
|
|
|
10/24/2003
|
|
|
|
200,000
|
|
|
|
-0-
|
|
|
|
31.20
|
|
|
|
10/23/2013
|
|
|
|
43,375
|
(4)
|
|
|
2,674,069
|
|
|
|
|
10/20/2004
|
|
|
|
135,000
|
|
|
|
-0-
|
|
|
|
41.725
|
|
|
|
10/19/2014
|
|
|
|
43,000
|
(5)
|
|
|
2,650,950
|
|
|
|
|
10/21/2005
|
|
|
|
175,000
|
|
|
|
-0-
|
|
|
|
43.595
|
|
|
|
10/20/2015
|
|
|
|
70,000
|
(5)
|
|
|
4,315,500
|
|
|
|
|
10/18/2006
|
|
|
|
140,000
|
|
|
|
-0-
|
|
|
|
59.435
|
|
|
|
10/17/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
10/19/2007
|
|
|
|
66,667
|
|
|
|
33,333
|
|
|
|
63.44
|
|
|
|
10/18/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
10/14/2008
|
|
|
|
41,667
|
|
|
|
83,333
|
|
|
|
54.09
|
|
|
|
10/13/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
10/15/2009
|
|
|
|
-0-
|
|
|
|
125,000
|
|
|
|
63.25
|
|
|
|
10/14/2019
|
|
|
|
|
|
|
|
|
|
J. G. Morikis
|
|
|
10/21/2005
|
|
|
|
40,000
|
|
|
|
-0-
|
|
|
|
43.595
|
|
|
|
10/20/2015
|
|
|
|
28,700
|
(3)
|
|
|
1,769,355
|
|
|
|
|
10/18/2006
|
|
|
|
50,000
|
|
|
|
-0-
|
|
|
|
59.435
|
|
|
|
10/17/2016
|
|
|
|
14,250
|
(4)
|
|
|
878,513
|
|
|
|
|
10/19/2007
|
|
|
|
26,667
|
|
|
|
13,333
|
|
|
|
63.44
|
|
|
|
10/18/2017
|
|
|
|
17,000
|
(5)
|
|
|
1,048,050
|
|
|
|
|
10/14/2008
|
|
|
|
16,667
|
|
|
|
33,333
|
|
|
|
54.09
|
|
|
|
10/13/2018
|
|
|
|
30,000
|
(5)
|
|
|
1,849,500
|
|
|
|
|
10/15/2009
|
|
|
|
-0-
|
|
|
|
50,000
|
|
|
|
63.25
|
|
|
|
10/14/2019
|
|
|
|
|
|
|
|
|
|
S. P. Hennessy
|
|
|
10/20/2004
|
|
|
|
30,000
|
|
|
|
-0-
|
|
|
|
41.725
|
|
|
|
10/19/2014
|
|
|
|
15,000
|
(3)
|
|
|
924,750
|
|
|
|
|
10/21/2005
|
|
|
|
40,000
|
|
|
|
-0-
|
|
|
|
43.595
|
|
|
|
10/20/2015
|
|
|
|
10,000
|
(4)
|
|
|
616,500
|
|
|
|
|
10/18/2006
|
|
|
|
33,000
|
|
|
|
-0-
|
|
|
|
59.435
|
|
|
|
10/17/2016
|
|
|
|
12,500
|
(5)
|
|
|
770,625
|
|
|
|
|
10/19/2007
|
|
|
|
20,000
|
|
|
|
10,000
|
|
|
|
63.44
|
|
|
|
10/18/2017
|
|
|
|
24,000
|
(5)
|
|
|
1,479,600
|
|
|
|
|
10/14/2008
|
|
|
|
12,000
|
|
|
|
24,000
|
|
|
|
54.09
|
|
|
|
10/13/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
10/15/2009
|
|
|
|
-0-
|
|
|
|
40,000
|
|
|
|
63.25
|
|
|
|
10/14/2019
|
|
|
|
|
|
|
|
|
|
S. J. Oberfeld
|
|
|
10/19/2000
|
|
|
|
5,095
|
|
|
|
-0-
|
|
|
|
19.625
|
|
|
|
10/18/2010
|
|
|
|
13,500
|
(3)
|
|
|
832,275
|
|
|
|
|
10/17/2001
|
|
|
|
4,114
|
|
|
|
-0-
|
|
|
|
24.305
|
|
|
|
10/16/2011
|
|
|
|
10,000
|
(4)
|
|
|
616,500
|
|
|
|
|
10/18/2002
|
|
|
|
3,933
|
|
|
|
-0-
|
|
|
|
25.425
|
|
|
|
10/17/2012
|
|
|
|
12,500
|
(5)
|
|
|
770,625
|
|
|
|
|
10/24/2003
|
|
|
|
3,205
|
|
|
|
-0-
|
|
|
|
31.20
|
|
|
|
10/23/2013
|
|
|
|
20,000
|
(5)
|
|
|
1,233,000
|
|
|
|
|
10/20/2004
|
|
|
|
13,500
|
|
|
|
-0-
|
|
|
|
41.725
|
|
|
|
10/19/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
10/21/2005
|
|
|
|
16,000
|
|
|
|
-0-
|
|
|
|
43.595
|
|
|
|
10/20/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
10/18/2006
|
|
|
|
33,000
|
|
|
|
-0-
|
|
|
|
59.435
|
|
|
|
10/17/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
10/19/2007
|
|
|
|
20,000
|
|
|
|
10,000
|
|
|
|
63.44
|
|
|
|
10/18/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
10/14/2008
|
|
|
|
12,000
|
|
|
|
24,000
|
|
|
|
54.09
|
|
|
|
10/13/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
10/15/2009
|
|
|
|
-0-
|
|
|
|
36,000
|
|
|
|
63.25
|
|
|
|
10/14/2019
|
|
|
|
|
|
|
|
|
|
T. W. Seitz
|
|
|
10/20/2004
|
|
|
|
10,000
|
|
|
|
-0-
|
|
|
|
41.725
|
|
|
|
10/19/2014
|
|
|
|
17,500
|
(3)
|
|
|
1,078,875
|
|
|
|
|
10/21/2005
|
|
|
|
27,707
|
|
|
|
-0-
|
|
|
|
43.595
|
|
|
|
10/20/2015
|
|
|
|
7,500
|
(4)
|
|
|
462,375
|
|
|
|
|
10/18/2006
|
|
|
|
28,000
|
|
|
|
-0-
|
|
|
|
59.435
|
|
|
|
10/17/2016
|
|
|
|
6,800
|
(5)
|
|
|
419,220
|
|
|
|
|
10/19/2007
|
|
|
|
12,000
|
|
|
|
6,000
|
|
|
|
63.44
|
|
|
|
10/18/2017
|
|
|
|
12,500
|
(5)
|
|
|
770,625
|
|
|
|
|
10/14/2008
|
|
|
|
7,000
|
|
|
|
14,000
|
|
|
|
54.09
|
|
|
|
10/13/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
10/15/2009
|
|
|
|
-0-
|
|
|
|
21,000
|
|
|
|
63.25
|
|
|
|
10/14/2019
|
|
|
|
|
|
|
|
|
|
|
|
1
|
Options vest over three years in equal annual installments on
the first, second and third anniversary dates of the date of
grant.
|
|
2
|
The amounts set forth in this column equal the number of shares
of restricted stock granted multiplied by the closing price of
our common stock ($61.65) on December 31, 2009. The amounts
assume that 100% of the shares of restricted stock will vest
based upon the achievement of the specified financial
performance goals.
|
|
3
|
84.8% of these shares of restricted stock vested in February
2010 based upon the achievement of the performance goals.
|
|
4
|
Shares of restricted stock vest in February 2011 on the date
that the Board of Directors determines the level of achievement
of the performance goals.
|
|
5
|
Shares of restricted stock vest in February 2012 on the date
that the Board of Directors determines the level of achievement
of the performance goals.
|
40
2009
OPTION EXERCISES AND STOCK VESTED TABLE
The following table sets forth information regarding the number
and value of stock options exercised and restricted stock vested
during 2009 for our named executives.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
Stock Awards
|
|
|
Number of
|
|
|
|
Number of
|
|
|
|
|
Shares Acquired
|
|
Value Realized
|
|
Shares Acquired
|
|
Value Realized
|
|
|
on Exercise
|
|
on Exercise
|
|
on Vesting
|
|
on Vesting
|
Name
|
|
(#)
|
|
($)(1)
|
|
(#)
|
|
($)(2)
|
|
C. M. Connor
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
53,750
|
|
|
|
2,473,306
|
|
J. G. Morikis
|
|
|
10,000
|
|
|
|
195,994
|
|
|
|
11,500
|
|
|
|
529,173
|
|
S. P. Hennessy
|
|
|
41,795
|
|
|
|
1,259,492
|
|
|
|
13,750
|
|
|
|
632,706
|
|
S. J. Oberfeld
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
5,000
|
|
|
|
230,075
|
|
T. W. Seitz
|
|
|
9,692
|
|
|
|
229,591
|
|
|
|
6,250
|
|
|
|
287,594
|
|
|
|
1
|
The value realized on the exercise of stock options is equal to
the number of shares acquired multiplied by the difference
between the exercise price and the market price of our common
stock. The market price is equal to the average of the highest
and lowest reported sale prices of our common stock on the date
of exercise.
|
|
2
|
The value realized on the vesting of restricted stock is equal
to the number of shares of restricted stock vested multiplied by
the market price of our common stock ($46.015). The market price
is equal to the average of the highest and lowest reported sale
prices of our common stock on the vesting date.
|
2009
PENSION BENEFITS TABLE
The following table sets forth information relating to The
Sherwin-Williams Company Salaried Employees Pension
Investment Plan for 2009. Mr. Seitz is the only named
executive who participates in our Salaried Employees
Pension Investment Plan.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
Present Value
|
|
Payments During
|
|
|
|
|
Years Credited
|
|
of Accumulated
|
|
Last Fiscal
|
Name
|
|
Plan Name
|
|
Service (#)
|
|
Benefit ($)
|
|
Year ($)
|
|
C. M. Connor
|
|
N/A
|
|
|
-0-
|
|
|
-0-
|
|
-0-
|
J. G. Morikis
|
|
N/A
|
|
|
-0-
|
|
|
-0-
|
|
-0-
|
S. P. Hennessy
|
|
N/A
|
|
|
-0-
|
|
|
-0-
|
|
-0-
|
S. J. Oberfeld
|
|
N/A
|
|
|
-0-
|
|
|
-0-
|
|
-0-
|
T. W. Seitz
|
|
Salaried Employees Pension
Investment Plan
|
|
|
34
|
|
|
890,081
|
|
-0-
|
41
Material Features of our Salaried Employees Pension
Investment Plan. Our Salaried Employees
Pension Investment Plan is a qualified noncontributory defined
benefit pension plan. The benefit formula with respect to active
participants hired prior to January 1, 1984, including
Mr. Seitz, consists of the sum of two components:
(a) a traditional pension-type retirement benefit that is
determined based upon the greater of two formulas; and
(b) a contribution credit equal to 1% of the
participants earnings for periods after January 1,
1984. The plan was amended to eliminate the 1% contribution
credit effective July 1, 2009.
The pension-type retirement benefit is determined based upon the
greater of:
|
|
|
|
|
Average annual earnings are divided by 12 then multiplied by the
accrued benefit service (determined according to plan
provisions, up to a maximum of 40 years). The result is
then multiplied by 1%. For purposes of this formula, average
annual earnings are the average of earnings during the five
consecutive calendar years in which the participant earned the
most money during the 10 years prior to retirement.
Earnings include annual salary, overtime, bonuses and
commissions, but not moving expenses, tuition aid or any pay
designated as not creditable as earnings at the time it is
received, all subject to the applicable IRS limitations on
earnings. For purposes of this calculation, the plan disregards
the one year out of the 10 in which earnings were the lowest and
closes the gap so that the remaining nine years are
considered consecutive; or
|
|
|
|
Years and months of accrued benefit service are multiplied by
$14 to determine a monthly benefit amount; an additional medical
allowance of $15 is added.
|
Pension benefits may be collected upon attainment of normal
retirement age (age 65) or upon satisfying the criteria for
early retirement (age 55-59 with at least 20 years of
vesting service or age 60 or older if the participants
combination of age and years of vesting service equal at least
75). If otherwise eligible for early retirement, a participant
can elect to retire from
Sherwin-Williams
at age 62 with unreduced benefits. All other early retirement
benefit payments are actuarially reduced to reflect the longer
expected payout period. Pension benefits commence on the first
day of the calendar month following the month in which the
Pension Administration Committee approves the retirement
election.
The normal form of benefit for a married participant is a 60%
joint and survivor annuity, which provides reduced monthly
payments during the participants lifetime and lifetime
payments to the spouse following the participants death in
the amount of 60% of the reduced payments. With the
spouses consent, a married participant may alternatively
elect to receive benefits in the form of a single life annuity,
a joint and survivor annuity, a five-year certain annuity, a
10-year certain annuity or in a lump sum. The plan provides
guarantees that at least the first 12 monthly payments will
be paid to either the participant or his beneficiary if the
participant dies during the 12-month period following
retirement. We do not normally grant additional years of service
credit.
The 1% contribution credit is converted into units to account
for the participants benefit attributable to this portion
of the retirement benefit. The participants benefit is
determined based upon hypothetical returns achieved on the
allocation of units among investments in various mutual fund
alternatives as directed by the participant.
For purposes of determining the present value of
Mr. Seitzs accumulated benefit, the following
assumptions were used:
|
|
|
|
|
Mortality Table: RP2000;
|
|
|
|
Interest Rate: 5.5%;
|
|
|
|
Age at 1/1/2010: 61 years and 1 month;
|
|
|
|
2009 pay: $488,161;
|
|
|
|
Benefit Commencement at age 62 (earliest unreduced);
|
|
|
|
25% elect lump sum option/75% elect annuity;
|
|
|
|
Lump Sum Mortality Table: 417e Mortality Table; and
|
|
|
|
Lump Sum Interest Rate: 3.13%
(years 0-4),
5.07%
(years 5-20)
and 5.50% (years 20+).
|
Both the RP2000 and the 417e Mortality Table are commonly
accepted actuarial tables published by the IRS for purposes of
determining mortality in connection with the determination of
retirement benefits, among other things.
42
EQUITY
COMPENSATION PLAN INFORMATION
The following table provides information about our common stock
that may be issued under our equity compensation plans at
December 31, 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Number of
|
|
|
|
Securities Remaining
|
|
|
Securities to
|
|
|
|
Available for
|
|
|
Be Issued
|
|
|
|
Future Issuance under
|
|
|
upon Exercise
|
|
Weighted-Average Exercise
|
|
Equity Compensation
|
|
|
of Outstanding
|
|
Price of
|
|
Plans (Excluding Securities
|
|
|
Options, Warrants
|
|
Outstanding Options, Warrants
|
|
Reflected in
|
|
|
and
Rights (1)
|
|
and Rights
|
|
Column (a))(2)
|
Plan Category
|
|
(a)
|
|
(b)
|
|
(c)
|
|
Equity compensation plans approved by security
holders (1,
2)
|
|
|
10,897,652(3
|
)
|
|
$
|
50.30
|
|
|
|
2,483,797
|
|
Equity compensation plans not approved by security holders
|
|
|
-0-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
10,897,652(3
|
)
|
|
$
|
50.30
|
|
|
|
2,483,797
|
|
|
|
1
|
The amounts set forth in this column represent the number
of shares of common stock that may be issued in connection with
the exercise of outstanding stock options granted under The
Sherwin-Williams Company 1994 Stock Plan, The Sherwin-Williams
Company 1997 Stock Plan for Nonemployee Directors, The
Sherwin-Williams Company 2003 Stock Plan and The
Sherwin-Williams Company 2006 Equity and Performance Incentive
Plan. Our 1994 Stock Plan, 1997 Stock Plan and 2003 Stock Plan
have expired or have been terminated, although outstanding stock
options and restricted stock continue in force in accordance
with their terms.
|
|
2
|
The amounts set forth in this column include
2,328,293 shares of common stock remaining available for
future awards under our 2006 Equity and Performance Incentive
Plan and 155,504 shares of common stock remaining available
for future awards under our 2006 Stock Plan for Nonemployee
Directors.
|
|
3
|
At December 31, 2009, the 10,897,652 outstanding option
rights had a weighted average expected term of 6.73 years.
|
43
POTENTIAL
PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL
The following information and table set forth the amount of
payments to each of our named executives in the event of a
termination of employment as a result of normal and early
retirement, involuntary termination, death, disability,
voluntary termination (not for cause), termination for cause,
and termination following a change in control. The table also
sets forth the amount of payments to each of our named
executives in the event of a change in control without a
termination of employment.
We do not have employment agreements with any of our named
executives and do not have a formal severance policy or
arrangement that provides for payments to a named executive in
the event of a termination of employment (other than with
respect to a termination of employment following a change in
control as described below). The Compensation and Management
Development Committee has sole discretion to determine the
amount, if any, of severance payments and benefits that will be
offered to a named executive in the event of a termination. The
Compensation Committee believes that it is in the best interests
of Sherwin-Williams and our shareholders that executives are
treated fairly and equitably on a termination.
Assumptions and General
Principles. The following assumptions
and general principles apply with respect to the following table
and any termination of employment of a named executive.
|
|
|
|
|
The amounts shown in the table assume that each named executive
was terminated on December 31, 2009. Accordingly, the table
reflects amounts earned as of December 31, 2009 and
includes estimates of amounts that would be paid to the named
executive upon the occurrence of a termination or change in
control. The actual amounts to be paid to a named executive can
only be determined at the time of the termination or change in
control.
|
|
|
|
A named executive is entitled to receive amounts earned during
his term of employment regardless of the manner in which the
named executives employment is terminated. These amounts
include base salary, unused vacation pay and annual cash
incentive compensation. These amounts are not shown in the
table, except for potential prorated annual cash incentive
compensation as described below.
|
|
|
|
A named executive must be employed on December 31 to be entitled
to receive annual cash incentive compensation pursuant to our
2007 Executive Performance Bonus Plan. In the event a
termination occurs on a date other than December 31, the
Compensation Committee has discretion to award the named
executive an annual cash incentive compensation payment.
Typically, this payment would approximate a prorated amount of
the payment the named executive would have received under the
plan and takes into consideration the named executives
performance and contributions to achieving the performance
criteria under the plan to the date of termination. These annual
cash incentive payments have not typically been awarded in the
event of a voluntary termination or a termination for cause.
|
|
|
|
Because we have assumed a December 31, 2009 termination date,
each of our named executives is entitled to receive the annual
cash incentive compensation payment earned under the plan for
2009. Therefore, the amount set forth in the table for prorated
annual cash incentive compensation is the actual annual
incentive compensation earned by each named executive during
2009. This amount is also the amount set forth in the
Non-Equity Incentive Plan Compensation Column of the
Summary Compensation Table.
|
|
|
|
A named executive may exercise any stock options that are
exercisable prior to the date of termination and is entitled to
receive unrestricted shares of common stock with respect to any
restricted stock awards for which the vesting period has expired
prior to the date of termination. The number of unrestricted
shares to be received by a named executive will be determined by
the Compensation Committee pursuant to the applicable plan. Any
payments related to these stock options and restricted stock
awards are
|
44
|
|
|
|
|
not included in the table because they are not severance
payments.
|
|
|
|
|
|
A named executive will be entitled to receive all amounts
accrued and vested under our retirement and savings programs,
including our Employee Stock Purchase and Savings Plan and any
pension plans and deferred compensation plans in which the named
executive participates. These amounts will be determined and
paid in accordance with the applicable plan and are not included
in the table because they are not severance payments.
|
Normal Retirement. A named executive is
eligible to elect normal retirement at age 65. All of our
full-time salaried employees hired prior to January 1, 1993
are eligible for health care and life insurance benefits upon
normal retirement subject to the terms of the plans. In
addition, all outstanding stock options will continue to vest in
accordance with their terms, and all outstanding restricted
stock awards will continue to vest as if the named executive had
continued employment throughout the restriction period. The
number of unrestricted shares that the named executive will be
entitled to receive will be determined in accordance with the
plan as if the named executive had remained employed throughout
the restriction period.
At December 31, 2009, none of our named executives were
eligible for normal retirement.
Early Retirement. A named executive is
eligible to elect early retirement upon satisfying the criteria
for early retirement (age 55-59 with at least 20 years of
vesting service or age 60 or older if the combination of age and
years of vesting service equal at least 75). In the event of
early retirement, all outstanding stock options will continue to
vest in accordance with their terms. The Compensation Committee
has the discretion to cancel all of the named executives
rights to outstanding restricted stock, continue all rights in
full, or prorate the number of shares of restricted stock for
the portions of the restricted periods completed as of the date
of retirement. The number of unrestricted shares that the named
executive will be entitled to receive if the named
executives rights continue in full or prorata will be
determined in accordance with the plan as if the named executive
had remained employed throughout the restriction period.
At December 31, 2009, Messrs. Oberfeld and Seitz were
eligible for early retirement.
Involuntary Termination. In the event
of an involuntary termination not for cause, the Compensation
Committee has the sole discretion to determine the amount, if
any, of severance payments and benefits that will be offered to
a named executive. In making this determination, the
Compensation Committee may consider a number of factors,
including the reasons for the termination, the named
executives tenure and performance, the named
executives personal circumstances and the amount of
severance payments, if any, generally offered to executives at
other companies in similar positions. Because we do not have
sufficient experience with involuntary terminations of
executives at the positions of the named executives, we cannot
reasonably estimate the amount or range of amounts of severance
payments and benefits that would be offered to our named
executives. Therefore, although it is reasonably likely that we
will offer a severance payment and benefits to a named executive
in the event of an involuntary termination not for cause, these
amounts are not included in the table.
Death and Disability. In the
event of the death or disability of a named executive, all
outstanding stock options will immediately vest and become
exercisable, and all shares of restricted stock will immediately
vest and become unrestricted. The amounts set forth in the table
for stock options reflect the difference between the average of
the high and low market price of our common stock ($61.995) on
December 31, 2009 and the exercise prices for each option
for which vesting accelerated. The amounts set forth in the
table for restricted stock reflect the number of shares of
restricted stock for which the vesting accelerated multiplied by
the average of the high and low market price of our common stock
($61.995) on December 31, 2009.
In addition, each named executive participates in our executive
life insurance program. Under our executive life insurance
program, the beneficiary of a named executive is entitled to
receive a death benefit based upon the following formulas:
(a) if the event occurs prior to age 62, then the death
benefit will equal 4.0 times (for Messrs. Connor, Morikis
and Hennessy) or 3.5
45
times (for Messrs. Oberfeld and Seitz) the named
executives base salary; (b) if the event occurs on or
after age 62 and before age 65, then the death benefit will
equal 4.0 times (for Messrs. Connor, Morikis and Hennessy) or
3.5 times (for Messrs. Oberfeld and Seitz) the named
executives base salary at age 62; and (c) if the
event occurs at age 65 or older, then the death benefit will
equal 2.5 times (for Messrs. Connor, Morikis and Hennessy)
or 2.0 times (for Messrs. Oberfeld and Seitz) the named
executives base salary at age 62. All of our named
executives were less than 62 years of age on
December 31, 2009.
Each named executive also participates in our executive
long-term disability program. Upon the occurrence of a
disability under the program, a named executive will receive an
annual benefit equal to 60% of base salary until the earlier of:
(a) age 65; (b) recovery from the disability;
(c) the date the named executive begins receiving
retirement plan benefits; or (d) death. The amounts set
forth in the table reflect the amount of the first annual
payment (60% multiplied by the named executives current
base salary) under the program. The program is frozen to new
participants effective January 1, 2008.
Voluntary Termination and Termination for
Cause. A named executive is not entitled to
receive any additional forms of severance payments or benefits
upon his voluntary decision to terminate employment with
Sherwin-Williams prior to being eligible for retirement or upon
termination for cause.
Change in Control. Upon the occurrence
of a change in control, as generally defined below, all
outstanding stock options will immediately vest and become
exercisable and all shares of restricted stock will immediately
vest and become unrestricted for all participants under the
applicable stock plans, including the named executives. The
amounts set forth in the table for stock options reflect the
difference between the average of the high and low market price
of our common stock ($61.995) on December 31, 2009 and the
exercise prices for each option for which vesting accelerated.
The amounts set forth in the table for restricted stock reflect
the number of shares of restricted stock for which vesting
accelerated multiplied by the average of the high and low market
price of our common stock ($61.995) on December 31, 2009.
In addition, each named executive who participates in our
executive automobile program will receive the automobile
provided to him under such program paid in full. By the end of
the first quarter of 2010, no named executive will participate
in the executive automobile program.
We have also entered into change in control severance agreements
with each of our named executives. Forms of these agreements
have been filed as Exhibit 10(d) to our Annual Report on
Form 10-K for the fiscal year ended December 31, 2009.
Generally, pursuant to these agreements, a change in control
occurs:
(a) if any person becomes the beneficial owner of 30% or
more of Sherwin-Williams then-outstanding voting
securities (other than acquisitions of voting securities
(i) directly from Sherwin-Williams and approved by the
Board of Directors, (ii) by Sherwin-Williams or any
subsidiary, (iii) by the trustee or other fiduciary holding
securities under any employee benefit plan (or related trust)
sponsored or maintained by Sherwin-Williams or any subsidiary,
and (iv) in connection with a business transaction as
proscribed in the agreement);
(b) if a majority of members of Sherwin-Williams
incumbent Board of Directors during any two year period are
replaced other than in specific circumstances;
(c) upon the consummation of any reorganization, merger or
consolidation of Sherwin-Williams, or the sale or other
disposition of all or substantially all of the assets of
Sherwin-Williams, other than any transaction in which,
immediately following the transaction, (i) the voting
securities of Sherwin-Williams immediately prior to the
transaction represent more than 50% of the combined voting power
of the then-outstanding voting securities of the entity
resulting from the transaction, (ii) no person beneficially
owns, directly or indirectly, 30% or more of the combined voting
power of the then-outstanding voting securities of the entity
resulting from the transaction, and (iii) at least a
majority of the members of the board of directors of the entity
resulting from the transaction were members of
Sherwin-Williams incumbent Board of Directors at the time
of initiating the transaction; or
46
(d) upon the liquidation or dissolution of Sherwin-Williams
(other than pursuant to a transaction that complies with clauses
(c)(i), (c)(ii) and (c)(iii) above).
The severance agreements provide that upon a termination of
employment following a change in control (other than termination
for cause or by reason of death or disability) or if the named
executive terminates his employment in certain circumstances
defined in the agreement which constitutes good reason, in
addition to the accelerated vesting of stock options and
restricted stock described above, each will receive:
|
|
|
|
|
a lump sum severance payment in an amount equal to 3 times (with
respect to Messrs. Connor, Morikis and Hennessy) or 2.5 times
(with respect to Messrs. Oberfeld and Seitz) the sum of
(a) the named executives highest rate of base salary
during the three-year period prior to termination and
(b) an amount equal to the greater of (i) the average
of the annual cash incentive pay received by the named executive
for each of the three years prior to the date of termination or
(ii) the named executives target incentive pay for
the year in which the termination occurs;
|
|
|
|
a lump sum amount equal to the prorata portion of any annual
cash incentive compensation earned by the named executive
through the date of termination, assuming achievement of the
target level of the performance goals;
|
|
|
|
eighteen months of continued health care benefits;
|
|
|
|
outplacement services in an amount not to exceed 10% of the
named executives then-current base salary; and
|
|
|
|
an amount equal to the excise tax and taxes thereon charged, if
any, to the named executive as a result of any change in control
payments (provided, however, in the event the aggregate change
in control payments do not exceed 115% of the amount which would
cause the excise tax to be assessed, the severance payments
shall be reduced to a level which would cause no excise tax to
apply).
|
47
ESTIMATED
PAYMENTS ON TERMINATION OR CHANGE IN CONTROL
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Event
|
|
C.M. Connor
|
|
J.G. Morikis
|
|
S.P. Hennessy
|
|
S.J. Oberfeld
|
|
T.W. Seitz
|
|
Normal and Early Retirement
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prorated annual cash incentive
compensation
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
$
|
444,000
|
|
|
$
|
437,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
444,000
|
|
|
$
|
437,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prorated annual cash incentive
compensation
|
|
$
|
1,684,000
|
|
|
$
|
732,000
|
|
|
$
|
636,000
|
|
|
$
|
444,000
|
|
|
$
|
437,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,684,000
|
|
|
$
|
732,000
|
|
|
$
|
636,000
|
|
|
$
|
444,000
|
|
|
$
|
437,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Death
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prorated annual cash incentive
compensation
|
|
$
|
1,684,000
|
|
|
$
|
732,000
|
|
|
$
|
636,000
|
|
|
$
|
444,000
|
|
|
$
|
437,000
|
|
Accelerated stock options
|
|
|
658,747
|
|
|
|
263,497
|
|
|
|
189,720
|
|
|
|
189,720
|
|
|
|
110,670
|
|
Accelerated restricted stock
|
|
|
13,352,173
|
|
|
|
5,576,450
|
|
|
|
3,812,693
|
|
|
|
3,471,720
|
|
|
|
2,746,379
|
|
Life insurance proceeds
|
|
|
4,887,947
|
|
|
|
2,822,263
|
|
|
|
2,248,508
|
|
|
|
1,795,496
|
|
|
|
1,658,675
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
20,582,867
|
|
|
$
|
9,394,210
|
|
|
$
|
6,886,921
|
|
|
$
|
5,900,936
|
|
|
$
|
4,952,724
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prorated annual cash incentive
compensation
|
|
$
|
1,684,000
|
|
|
$
|
732,000
|
|
|
$
|
636,000
|
|
|
$
|
444,000
|
|
|
$
|
437,000
|
|
Accelerated stock options
|
|
|
658,747
|
|
|
|
263,497
|
|
|
|
189,720
|
|
|
|
189,720
|
|
|
|
110,670
|
|
Accelerated restricted stock
|
|
|
13,352,173
|
|
|
|
5,576,450
|
|
|
|
3,812,693
|
|
|
|
3,471,720
|
|
|
|
2,746,379
|
|
Disability benefits
|
|
|
733,192
|
|
|
|
423,339
|
|
|
|
337,276
|
|
|
|
307,799
|
|
|
|
284,344
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
16,428,112
|
|
|
$
|
6,995,286
|
|
|
$
|
4,975,689
|
|
|
$
|
4,413,239
|
|
|
$
|
3,578,393
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Voluntary Termination and
Termination for Cause
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No payments
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in Control
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accelerated stock options
|
|
$
|
658,747
|
|
|
$
|
263,497
|
|
|
$
|
189,720
|
|
|
$
|
189,720
|
|
|
$
|
110,670
|
|
Accelerated restricted stock
|
|
|
13,352,173
|
|
|
|
5,576,450
|
|
|
|
3,812,693
|
|
|
|
3,471,720
|
|
|
|
2,746,379
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
14,010,920
|
|
|
$
|
5,839,947
|
|
|
$
|
4,002,413
|
|
|
$
|
3,661,440
|
|
|
$
|
2,857,049
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in Control with
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prorated annual cash incentive
compensation
|
|
$
|
1,684,000
|
|
|
$
|
732,000
|
|
|
$
|
636,000
|
|
|
$
|
444,000
|
|
|
$
|
437,000
|
|
Accelerated stock options
|
|
|
658,747
|
|
|
|
263,497
|
|
|
|
189,720
|
|
|
|
189,720
|
|
|
|
110,670
|
|
Accelerated restricted stock
|
|
|
13,352,173
|
|
|
|
5,576,450
|
|
|
|
3,812,693
|
|
|
|
3,471,720
|
|
|
|
2,746,379
|
|
Cash severance payment
|
|
|
7,282,571
|
|
|
|
3,765,278
|
|
|
|
2,950,052
|
|
|
|
2,081,591
|
|
|
|
1,916,333
|
|
Continued health care benefits
|
|
|
19,907
|
|
|
|
20,300
|
|
|
|
19,794
|
|
|
|
18,219
|
|
|
|
17,376
|
|
Outplacement services
|
|
|
122,199
|
|
|
|
70,557
|
|
|
|
56,213
|
|
|
|
51,300
|
|
|
|
47,391
|
|
Automobile transfer
|
|
|
0
|
|
|
|
23,425
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
Excise tax
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
23,119,597
|
|
|
$
|
10,451,507
|
|
|
$
|
7,664,472
|
|
|
$
|
6,256,550
|
|
|
$
|
5,275,149
|
|
48
APPROVAL
OF THE AMENDMENT
AND RESTATEMENT OF
THE SHERWIN-WILLIAMS COMPANY
2006 EQUITY AND PERFORMANCE
INCENTIVE PLAN
(PROPOSAL 2)
On February 17, 2010, the Board of Directors of
Sherwin-Williams unanimously approved and adopted, subject to
the approval of Sherwin-Williams shareholders at the 2010
Annual Meeting, The Sherwin-Williams Company 2006 Equity and
Performance Incentive Plan (Amended and Restated as of
April 21, 2010) (the Amended Plan). The Amended
Plan affords the Board of Directors the flexibility to design
equity-based compensatory awards that are responsive to
Sherwin-Williams business needs and authorizes a variety
of awards designed to advance the interests and long-term
success of Sherwin-Williams.
The Amended Plan amends and restates in its entirety The
Sherwin-Williams Company 2006 Equity and Performance Incentive
Plan (the Current Plan), which was approved by
shareholders at the 2006 Annual Meeting. If the Amended Plan is
approved by shareholders, it will become effective on the day
following the 2010 Annual Meeting. Outstanding awards under the
Current Plan will continue in effect in accordance with their
terms.
As discussed below, shareholder approval of the Amended Plan is
intended to constitute approval for purposes of the approval
requirements of Section 162(m) of the Internal Revenue Code
of 1986, as amended (the Code), so that awards under
the Amended Plan can continue to satisfy the requirements for
performance-based compensation, thereby avoiding the
potential loss by Sherwin-Williams of tax deductions under
Section 162(m) of the Code.
Our principal reason for amending and restating the Current Plan
is to increase the number of shares of common stock available
for issuance. The Amended Plan will increase the maximum number
of shares available for awards from 10,000,000 shares of
common stock to 19,200,000 shares of common stock. The
Amended Plan includes various other changes. The most important
ones are described in the summary of proposed changes below,
which is followed by a summary description of the entire Amended
Plan. The full text of the Amended Plan is attached to this
proxy statement as Appendix B. The following description of
the Amended Plan is only a summary of its material terms and
provisions and is qualified by reference to the full text of the
Amended Plan attached as Appendix B.
Summary
of Material Changes
Increase in the Number of Available
Shares. The Current Plan authorizes the issuance
or transfer of an aggregate of 10,000,000 shares of common
stock, par value $1.00 per share. As of February 28, 2010,
220,519 of these shares had been issued (exclusive of
outstanding awards), 7,791,703 shares were subject to
outstanding awards and 1,987,778 shares were available for
future awards under the Current Plan. The Amended Plan increases
the total aggregate number of shares available for issuance or
transfer under the Amended Plan by 9,200,000 shares to
19,200,000 shares of common stock. The number and kind of
shares available under the Amended Plan are subject to
adjustment for stock dividends and stock splits and in certain
other situations as further described in the Amended Plan.
New Method for Counting Full-Value Awards. The
Current Plan limits the aggregate number of shares that may be
used with respect to awards of restricted stock, restricted
stock units, performance shares and performance units to
3,000,000 shares of common stock. The Amended Plan removes
this limit, but replaces it with a new method of accounting for
the number of shares of common stock that underlie future grants
of full value awards. Under the new counting method, for awards
of option rights and stock appreciation rights, one share will
be subtracted from the total number of shares of common stock
available under the Amended Plan for every share issued or
transferred in respect of those awards. For any award that is
not an option right or a stock appreciation right, however, two
shares of common stock will be subtracted from the total number
of shares of common stock available under the Amended Plan for
every share issued or transferred in respect of those awards.
Other Awards. The Amended Plan adds a new
category of awards, referred to as other
49
awards or other stock-based awards. Other
stock-based awards may be denominated or payable in, valued in
whole or in part by reference to, or otherwise based on, or
related to, shares of common stock or factors that may influence
the value of such shares of common stock. In addition, the
Amended Plan provides for the ability to grant cash awards as an
element of or as a supplement to any other award granted under
the Amended Plan.
Change of Control Definition. The Amended Plan
includes a definition of Change of Control. In
general, a change of control will be deemed to have occurred if:
(1) a person or group buys 30% or more of
Sherwin-Williams common stock (excluding certain purchases
by Sherwin-Williams or its benefit plans or purchases approved
by Sherwin-Williams or in connection with certain
friendly business transactions, and excluding
certain inadvertent purchases); (2) Sherwin-Williams
experiences a turn-over (not approved by Sherwin-Williams) of
more than half of its directors during a two-year period;
(3) Sherwin-Williams closes a reorganization, merger,
consolidation or significant sale of assets resulting in a
substantial change in its ownership or leadership; or
(4) Sherwin-Williams shareholders approve its
liquidation or dissolution.
Double-Trigger Accelerated Vesting Upon Change of
Control. The Amended Plan adds a
double-trigger acceleration provision with respect
to the vesting of awards in connection with a change of control.
Under award agreements governing awards under the Current Plan,
upon a change of control, the awards become immediately
exercisable and vested in full, without regard to the
participants post-change of control employment status.
Under the Amended Plan, upon a change of control, awards that
are assumed by the surviving entity will continue to vest and
become exercisable in accordance with their original terms
unless, within three years after the change of control, the
participants employment is terminated other than for
cause (as defined in the Amended Plan) or the
participant terminates his or her employment for good
reason (as defined in the Amended Plan). If a
participants employment is terminated under either of
those circumstances, his or her outstanding awards granted under
the Amended Plan will immediately vest and become exercisable in
full. Awards that are not assumed by the surviving entity will
also immediately vest and become exercisable in full.
Ratable Vesting. The Current Plan required
awards of restricted stock and restricted stock units to vest
over a period no shorter than three years. The Amended Plan
provides that awards of restricted stock and restricted stock
units may vest in installments during such three-year period.
Deferred Dividends or Other Distributions on
Performance-Based Awards. The Current Plan
provides that current dividends may be paid on awards of
restricted stock, restricted stock units and performance shares.
The Amended Plan requires that dividends and other distributions
on restricted stock, restricted stock units and performance
shares with restrictions or restriction periods that lapse upon
the achievement of management objectives be deferred until and
paid contingent on the achievement of the applicable management
objectives.
No Repricing of Option Rights or Stock Appreciation
Rights. The Current Plan prohibits amending an
option right to reduce its exercise price or replacing it with
another option right with a lower exercise price without
shareholder approval. The Amended Plan strengthens the
prohibition against repricing option rights and
extends this prohibition to stock appreciation rights. Under the
Amended Plan, except in connection with certain adjustment
events, we may not, without shareholder approval:
|
|
|
|
|
reduce the exercise price of outstanding option rights or reduce
the base price of outstanding stock appreciation rights; or
|
|
|
|
replace outstanding option rights or stock appreciation rights
with cash, other awards, or the same award with a lower exercise
price or base price, as applicable.
|
Cancellation of Underwater
Awards. The Amended Plan provides that option
rights and stock appreciation rights that have an exercise or
base price that is less than the consideration offered for
Sherwin-Williams common stock in a business transaction or
change of control may be cancelled without payment.
50
Clawback. The Amended Plan adds a recoupment,
or clawback provision, under which any award
agreement may provide for the cancellation or forfeiture of an
award or the forfeiture and repayment to Sherwin-Williams of any
gain related to an award, or other provisions intended to have a
similar effect, upon such terms and conditions as may be
determined by the Board of Directors in accordance with
Sherwin-Williams Executive Adjustment and Recapture Policy.
Summary
of the Amended Plan
Shares Subject to the Amended
Plan. Subject to adjustment as provided in the
Amended Plan, the number of shares of Sherwin-Williams common
stock that may be issued or transferred
|
|
|
|
|
upon the exercise of option rights or stock appreciation rights
(SARs);
|
|
|
|
as restricted stock and released from substantial risks of
forfeiture;
|
|
|
|
in payment of restricted stock units;
|
|
|
|
in payment of performance shares or performance units that have
been earned;
|
|
|
|
in payment of dividend equivalents paid with respect to
awards; or
|
|
|
|
as other stock-based awards or in payment of other stock-based
awards
|
will not exceed in the aggregate 19,200,000 plus any shares
relating to awards that expire, are forfeited or are cancelled
under the Amended Plan. These shares may be shares of original
issuance or treasury shares or a combination of the foregoing.
Each share of common stock issued or transferred pursuant to an
award of option rights or SARs will reduce the aggregate number
of shares available under the Amended Plan by one share of
common stock. Each share of common stock issued or transferred
(and in the case of shares of restricted stock, released from
all substantial risk of forfeiture) pursuant to an award other
than of option rights or SARs will reduce the aggregate number
of shares available under the Amended Plan by one share of
common stock if issued or transferred pursuant to an award
granted prior to the approval of the Amended Plan by
Sherwin-Williams shareholders and two shares of common
stock if issued or transferred pursuant to an award granted
after the approval of the Amended Plan by Sherwin-Williams
shareholders. Any shares of common stock that again become
available for issuance under the Amended Plan will be added back
to the aggregate plan limit in this same manner.
Shares covered by an award will not be counted as used unless
and until they are actually issued and delivered to a
participant and the total number of shares available under the
Amended Plan as of a given date will not be reduced by any
shares relating to prior awards that have expired or have been
forfeited or cancelled. Upon payment in cash of the benefit
provided by any award, any shares that were covered by that
award will be available for issue or transfer under the Amended
Plan. If shares are tendered or otherwise used in payment of the
exercise price of an option right, the total number of shares
covered by the option right being exercised will count against
the total number of shares available under the Amended Plan.
Shares withheld by Sherwin-Williams to satisfy any tax
withholding obligation will count against the total number of
shares available under the Amended Plan. The number of shares
that are repurchased by Sherwin-Williams with option right
proceeds will not increase the total number of shares available
under the Amended Plan. The number of shares covered by a SAR,
to the extent that it is exercised and settled in shares,
whether or not all shares covered by the award are actually
issued to the participant upon exercise of the SAR, will be
considered issued or transferred pursuant to the Amended Plan.
If, under the Amended Plan, a participant has elected to give up
the right to receive compensation in exchange for shares of
common stock based on fair market value, such shares of common
stock will not count against the aggregate plan limit.
The aggregate number of shares of common stock actually issued
or transferred by Sherwin-Williams upon the exercise of
incentive stock options will not exceed 19,200,000 shares.
No participant will be granted option rights or SARs, in the
aggregate, for more than 500,000 shares of common stock
during any calendar year, and no participant will be granted
restricted stock, restricted stock units,
51
performance shares or other share-based awards that are intended
to satisfy the requirements for qualified
performance-based compensation under Section 162(m)
of the Code, in the aggregate, for more than 200,000 shares
of common stock during any calendar year. No participant will
receive in any calendar year an award of performance units that
is intended to qualify as qualified performance-based
compensation under Section 162(m) of the Code with an
aggregate maximum value in excess of $5,000,000. No participant
will receive in any calendar year other awards payable in cash
that are intended to qualify as qualified
performance-based compensation under Section 162(m)
of the Code with an aggregate maximum value in excess of
$5,000,000. The foregoing limits are subject to certain
adjustments as provided in the Amended Plan.
Up to 5% of the maximum number of shares of common stock
available under the Amended Plan may be used for awards that do
not comply with the three-year and one-year requirements
applicable to such awards as described below.
Eligibility. Officers and employees of
Sherwin-Williams and its subsidiaries or any person who has
agreed to commence serving in any of those capacities within
90 days of the date of grant may be selected by the Board
of Directors to receive benefits under the Amended Plan. Any
person who provides services to Sherwin-Williams or a subsidiary
that are substantially equivalent to those typically provided by
an employee of Sherwin-Williams or a subsidiary may also be a
participant under the Amended Plan. The selection of those
officers and employees who will receive awards, and the number
of shares subject to awards, is entirely within the discretion
of the Board of Directors. The current number of
Sherwin-Williams officers and employees is approximately 29,220.
Option Rights. Option rights may be granted
that entitle the optionee to purchase shares of common stock at
a price not less than the fair market value per share on the
date of grant. The option price is payable:
|
|
|
|
|
in cash or by check or wire transfer;
|
|
|
|
by transfer to Sherwin-Williams of shares of common stock owned
by the optionee having a value equal to the option price;
|
|
|
|
by a combination of such payment methods; or
|
|
|
|
by such other methods as may be approved by the Board of
Directors.
|
To the extent permitted by law, any grant of an option right may
provide for deferred payment of the option price from the
proceeds of sale through a bank or broker of some or all of the
shares to which the exercise relates. The market price of
Sherwin-Williams shares of common stock, as reported on the New
York Stock Exchange on February 26, 2010, was $63.89 per
share.
Option rights that are awarded may consist of any of the
following:
|
|
|
|
|
options intended to qualify under particular provisions of the
Code;
|
|
|
|
options not intended to so qualify; or
|
|
|
|
a combination of the foregoing.
|
Incentive stock options may only be granted to participants who
satisfy the definition of employee under
Section 3401(c) of the Code.
No option right may be exercisable more than 10 years from
the date of grant. Each grant will specify the period of
continuous service with Sherwin-Williams that is necessary
before the option rights will become exercisable. A grant of
option rights may provide for the earlier vesting of such option
rights in the event of the retirement, death or disability of
the participant or a change of control of Sherwin-Williams.
Successive grants may be made to the same optionee whether or
not option rights previously granted remain unexercised. Any
grant of option rights may specify management objectives that
must be achieved as a condition to exercising such rights.
Before the exercise of such rights, the Board of Directors must
determine that the management objectives have been satisfied.
Option rights will be subject to an evidence of award containing
such terms and provisions, consistent with the Amended Plan, as
the Board of Directors may approve. The exercise of an option
right will result in the cancellation on a
share-for-share
basis of any related tandem SAR.
SARs. A SAR is a right, exercisable by
surrender of the related option right (if granted in tandem with
option rights) or by itself (if granted as a free-standing SAR),
to receive from Sherwin-Williams an amount not exceeding 100% of
the
52
spread between the base price established for the SAR (or option
price if a tandem SAR) and the value of a share of common stock
on the date of exercise. Any grant may specify that the amount
payable on exercise of a SAR may be paid in cash, in shares of
common stock, or in any combination of cash and shares, and may
either grant to the participant or retain in the Board of
Directors the right to elect among those alternatives. Any SAR
grant may specify that the amount payable on exercise may not
exceed a maximum specified by the Board of Directors at the time
of grant. Any grant may specify waiting periods before exercise
and permissible exercise dates and periods. Any grant of a SAR
may specify that such SAR be exercised only in the event of, or
earlier in the event of, the retirement, death or disability of
the participant or a change of control of Sherwin-Williams. Any
grant of SARs may specify management objectives that must be
achieved as a condition to exercise such rights. Before the
exercise of such SARs, the Board of Directors must determine
that the management objectives have been satisfied. SARs will be
subject to an evidence of award containing such terms and
provisions, consistent with the Amended Plan, as the Board of
Directors may approve.
Tandem SARs may be exercised only when the related option right
is exercisable and the spread is positive, and requires that the
related option right be surrendered for cancellation. Successive
grants of tandem SARs may be made to the same participant
regardless of whether any tandem SAR previously granted to the
participant remains unexercised.
Free-Standing SARs must have a base price that is not less than
the fair market value of a share of common stock on the date of
grant. Successive grants of free-standing SARs may be made to
the same participant regardless of whether any free-standing
SARs remain unexercised. No free-standing SAR may be exercised
more than 10 years from the date of grant.
Restricted Stock. A grant of restricted stock
constitutes the immediate transfer by Sherwin-Williams to a
participant of ownership of a specific number of shares of
common stock in consideration of the performance of services.
The participant is entitled to voting, dividend and other
ownership rights in such shares, but subject to a substantial
risk of forfeiture and restrictions on transfer as described
below. Such grant or sale may be made without additional
consideration or in consideration of a payment by the
participant that is less than current fair market value of
common stock.
Restricted stock that vests upon the passage of time must be
subject to a substantial risk of forfeiture within
the meaning of Section 83 of the Code for no less than
three years (but may vest ratably on an annual basis during the
three-year period as determined by the Board of Directors at the
date of grant). To enforce these forfeiture provisions, the
transferability of restricted stock will be prohibited or
restricted in a manner and to the extent prescribed by the Board
of Directors for the applicable period.
Any grant of restricted stock may specify management objectives
that, if achieved, will result in termination or early
termination of the restrictions applicable to such shares. If
the grant of restricted stock provides for management
objectives, the restrictions cannot lapse sooner than one year
from the date of grant, but may provide for earlier lapse in the
event of the retirement, death or disability of the participant
or the change of control of Sherwin-Williams. The Board of
Directors may grant some awards, including shares of restricted
stock, that are not subject to these minimum vesting
requirements, so long as the aggregate number of such awards
does not exceed 5% of the maximum numbers of shares of common
stock available under the Amended Plan.
Any grant of restricted stock may also specify in respect of
management objectives a minimum acceptable level of achievement
and may set forth a formula for determining the number of shares
of restricted stock on which restrictions will terminate if
performance is at or above the minimum level, but below full
achievement of the management objectives. Before termination or
early termination of the restrictions, the Board of Directors
must determine that the management objectives have been
satisfied. Any grant or sale of restricted stock may require
that any dividends or other distributions paid thereon during
the period of the restrictions be automatically deferred and
reinvested in additional shares of restricted stock, which may
be subject to the same restrictions as the underlying award.
However, dividends or other distributions on restricted stock
with restrictions that lapse as a result of the achievement of
management objectives will be deferred until and paid contingent
upon the
53
achievement of the applicable management objectives. Restricted
stock will be subject to an evidence of award containing such
terms and provisions, consistent with the Amended Plan, as the
Board of Directors may approve.
Restricted Stock Units. A grant of restricted
stock units constitutes an agreement by Sherwin-Williams to
deliver shares of common stock or cash to the participant in the
future in consideration of the performance of services, but
subject to the fulfillment of such conditions (including
management objectives) during the restriction period as the
Board of Directors may specify. Awards of restricted stock units
may be made without additional consideration or in consideration
of a payment by such participant that is less than the fair
market value per share at the date of grant.
During the restriction period, the participant will have no
rights of ownership in the shares of common stock deliverable
upon payment of the restricted stock units and will have no
right to vote them, but the Board of Directors may, at the date
of grant, authorize the payment of dividend equivalents on such
restricted stock units on either a current or deferred or
contingent basis, either in cash or in additional shares of
common stock. However, dividend equivalents on restricted stock
units subject to a restriction period that lapses as a result of
the achievement of management objectives shall be deferred until
and paid contingent upon the achievement of the applicable
management objectives. Each grant or sale will specify the time
and manner of payment of restricted stock units that have been
earned. Any grant or sale may specify that the amount payable
may be paid in cash, in shares of common stock or in any
combination thereof and may either grant to the participant or
retain in the Board of Directors the right to elect among those
alternatives.
If a restricted stock units restriction period lapses only
by the passage of time rather than the achievement of management
objectives, each such grant or sale will be subject to a
restriction period of not less than three years, except that a
grant or sale may provide that the restriction period will
expire not sooner than ratably on an annual basis during the
three-year period as determined by the Board of Directors at the
date of grant. The Board of Directors may provide for a shorter
restriction period in the event of the retirement, death or
disability of the participant or a change of control of
Sherwin-Williams.
Any grant of restricted stock units may specify management
objectives that, if achieved, will result in termination or
early termination of the restriction period. If the grant of
restricted stock units provides for management objectives, the
restriction period cannot lapse sooner than one year from the
date of grant, but may be subject to earlier lapse in the event
of the retirement, death or disability of the participant or a
change of control of Sherwin-Williams. The Board of Directors
may grant some awards, including restricted stock units, that
are not subject to these minimum vesting requirements, so long
as the aggregate number of such awards does not exceed 5% of the
total number of shares of common stock available under the
Amended Plan.
Any grant of restricted stock units may also specify in respect
of such management objectives a minimum acceptable level of
achievement and may set forth a formula for determining the
number of shares of restricted stock units on which the
restriction period will terminate if performance is at or above
the minimum level, but below full achievement of the management
objectives. Before the termination or early termination of the
restrictions applicable to such restricted stock units, the
Board of Directors must determine that the management objectives
have been satisfied. Restricted stock units will be subject to
an evidence of award containing such terms and provisions,
consistent with the Amended Plan, as the Board of Directors may
approve.
Performance Shares and Performance Units. A
performance share is the equivalent of one share of common stock
and a performance unit is the equivalent of $1.00 or such other
value as determined by the Board of Directors. The participant
will be given one or more management objectives to meet within a
specified performance period. Each grant may also specify, with
respect to such management objectives, a minimum acceptable
level or levels of achievement and will set forth a formula for
determining the number of performance shares or performance
units that will be earned if performance is at or above such
level(s), but falls short of full achievement of the specified
management objectives. The specified
54
performance period will be a period of time not less than one
year, except in the case of the retirement, death or disability
of the participant or a change of control of
Sherwin-Williams,
if the Board of Directors shall so determine. The Board of
Directors may grant some awards, including performance shares
and performance units, that are not subject to these minimum
vesting requirements, so long as the aggregate number of such
awards does not exceed 5% of the total number of shares of
common stock available under the Amended Plan.
If by the end of the performance period, the participant has
achieved the management objectives, the participant will be
deemed to have fully earned the performance shares or
performance units. If the participant has not fully achieved the
management objectives, but has attained or exceeded the
predetermined level or levels of acceptable achievement, the
participant will be deemed to have partly earned the performance
shares or performance units in accordance with a predetermined
formula. Before such awards will be earned and paid, the Board
of Directors must determine that the management objectives have
been satisfied.
To the extent earned, the performance shares or performance
units will be paid to the participant at the time and in the
manner determined by the Board of Directors. Any grant may
specify that the amount payable may be paid in cash, shares of
common stock or any combination thereof and may either grant to
the participant or retain in the Board of Directors the right to
elect among those alternatives. The grant may provide for the
payment of dividend equivalents in cash or in shares of common
stock on a deferred basis contingent upon the achievement of the
applicable management objectives. Performance shares and
performance units will be subject to an evidence of award
containing such terms and provisions, consistent with the
Amended Plan, as the Board of Directors may approve.
Other Awards. The Board of Directors may grant
to any participant such other awards that may be denominated or
payable in, valued in whole or in part by reference to, or
otherwise based on, or related to, shares of common stock or
factors that may influence the value of such shares, including,
without limitation:
|
|
|
|
|
convertible or exchangeable debt securities;
|
|
|
|
other rights convertible or exchangeable into shares of common
stock;
|
|
|
|
purchase rights for shares of common stock;
|
|
|
|
awards with value and payment contingent upon performance of
Sherwin-Williams or specified subsidiaries, affiliates or other
business units or any other factors designated by the Board of
Directors; and
|
|
|
|
awards valued by reference to the book value of shares of common
stock or the value of securities of, or the performance of
specified subsidiaries or affiliates or other business units of
Sherwin-Williams.
|
The Board of Directors will determine the terms and conditions
of such other awards. Shares of common stock delivered pursuant
to an award in the nature of a purchase right will be purchased
for such consideration, paid for at such time, by such methods,
and in such forms, including, without limitation, cash, shares
of common stock, other awards, notes or other property, as the
Board of Directors determines.
Cash awards, as an element of or supplement to any other award
granted under the Amended Plan, may also be granted under the
Amended Plan. The Board of Directors may grant shares of common
stock as a bonus, or may grant other awards in lieu of
obligations of Sherwin-Williams or any of its subsidiaries to
pay cash or deliver other property under the Amended Plan or
under other plans or compensatory arrangements, subject to such
terms as determined by the Board of Directors in a manner that
complies with Section 409A of the Code.
If the earning or vesting of, or elimination of restrictions
applicable to, other awards is based only on the passage of time
rather than the achievement of management objectives, the period
of time will be no shorter than three years, except that the
restrictions may be removed no sooner than ratably on an annual
basis during the three-year period as determined by the Board of
Directors at the date of grant. If the earning or vesting of, or
elimination of restrictions applicable to, other awards is based
55
on the achievement of management objectives, the earning,
vesting or restriction period may not terminate sooner than one
year from the date of grant. The Board of Directors may grant
some awards, including other awards, that are not subject to
these minimum vesting requirements, so long as the aggregate
number of such awards does not exceed 5% of the total number of
shares of common stock available under the Amended Plan.
Management Objectives. The Amended Plan
requires that the Board of Directors establish management
objectives for purposes of performance shares and
performance units. When so determined by the Board of Directors,
option rights, SARs, restricted stock, restricted stock units,
other awards or dividend credits may also specify management
objectives. Management objectives may be described in terms of
company-wide objectives or objectives that are related to the
performance of the individual participant or of the subsidiary,
division, department, region or function within Sherwin-Williams
or the subsidiary in which the participant is employed. The
management objectives may be made relative to the performance of
one or more other companies or subsidiaries, divisions,
departments, regions or functions within such other companies,
and may be made relative to an index or one or more of the
performance criteria themselves. The Board of Directors may
grant awards subject to management objectives that are or are
not intended to satisfy the requirements for qualified
performance-based compensation under Section 162(m)
of the Code. The management objectives applicable to any award
intended to satisfy the requirements for qualified
performance-based compensation under Section 162(m)
of the Code to a participant who is, or likely to become, a
covered employee, within the meaning of
Section 162(m) of the Code, will be based on one or more,
or a combination, of the following criteria:
|
|
|
|
|
Appreciation in value of shares;
|
|
|
|
Total shareholder return;
|
|
|
|
Earnings per share;
|
|
|
|
Operating income;
|
|
|
|
Net income;
|
|
|
|
Pretax earnings;
|
|
|
|
Earnings before interest, taxes, depreciation and amortization;
|
|
|
|
Pro forma net income;
|
|
|
|
Return on equity;
|
|
|
|
Return on designated assets;
|
|
|
|
Return on capital;
|
|
|
|
Economic value added;
|
|
|
|
Revenues;
|
|
|
|
Expenses;
|
|
|
|
Operating profit margin;
|
|
|
|
Operating cash flow;
|
|
|
|
Free cash flow;
|
|
|
|
Cash flow return on investment;
|
|
|
|
Operating margin or net profit margin; or
|
|
|
|
Any of the above criteria as compared to the performance of a
published or a special index deemed applicable by the Board of
Directors, including, but not limited to, the
Standard & Poors 500 Stock Index.
|
If the Board of Directors determines that a change in the
business, operations, corporate structure or capital structure
of Sherwin-Williams, or the manner in which it conducts its
business, or other events or circumstances render the management
objectives unsuitable, the Board of Directors may, in its
discretion, modify such management objectives or the related
level or levels of achievement, in whole or in part, as the
Board of Directors deems appropriate and equitable, except in
the case of an award intended to satisfy the requirements for
qualified performance-based compensation under
Section 162(m) of the Code (other than in connection with a
change of control) where such action would result in the loss of
the otherwise available exemption of the award under
Section 162(m) of the Code. In such case, the Board of
Directors will not make any modification of the management
objectives or the level or levels of achievement with respect to
such award.
Administration. The Amended Plan is to be
administered by the Board of Directors, except that the Board of
Directors has the authority to delegate any or all of its powers
to the Compensation and Management Development
56
Committee of the Board of Directors or another committee of the
Board of Directors (or a subcommittee). The Board of Directors
is authorized to interpret the Amended Plan and related
agreements and other documents. To the extent permitted by Ohio
law, the Board of Directors may delegate to one or more officers
of Sherwin-Williams the authority to grant and determine the
terms and conditions of awards granted under the Amended Plan.
However, such delegation will not be permitted with respect to
awards to any executive officer or any person subject to
Section 162(m) of the Code or who is an officer, director
or more than 10% beneficial owner of any class of the
Companys equity securities that is registered pursuant to
Section 12 of the Securities Exchange Act of 1934
(Exchange Act), as determined by the Board of
Directors in accordance with Section 16 of the Exchange Act.
Adjustments. The number or kind of shares
covered by outstanding awards under the Amended Plan and, if
applicable, the prices per share applicable thereto, shall be
adjusted in the event of stock dividends, stock splits,
combinations of shares, recapitalizations, mergers,
consolidations, spin-offs, reorganizations, liquidations,
issuances of rights or warrants, and similar events. In the
event of any such transaction or event, the Board of Directors,
in its discretion, may provide in substitution for any or all
outstanding awards under the Amended Plan such alternative
consideration (including cash), if any, as it may determine to
be equitable in the circumstances and may require the surrender
of all awards so replaced in a manner that complies with
Section 409A of the Code. In addition, for each option
right or SAR with an option price or base price greater than the
consideration offered in connection with any such transaction or
event or change of control, the Board of Directors may in its
sole discretion elect to cancel such option right or SAR without
any payment. The Board of Directors will also make or provide
for such adjustments in the number of shares available under the
Amended Plan and the other limitations contained in the Amended
Plan as the Board of Directors may determine appropriate to
reflect any transaction or event described above. However, any
such adjustment to the number of shares of common stock
available for the grant of incentive stock options will be made
only if and to the extent that such adjustment would not cause
any option intended to qualify as an incentive stock option to
fail to so qualify.
Change of Control. The treatment of
outstanding awards upon a change of control depends on whether
or not the awards are assumed by the entity effecting the change
of control. In general, a change of control will be deemed to
have occurred under the Amended Plan if: (1) a person or
group buys 30% or more of Sherwin-Williams common stock
(excluding certain purchases by Sherwin-Williams or its benefit
plans or purchases approved by
Sherwin-Williams
or in connection with certain friendly business
transactions, and excluding certain inadvertent purchases); (2)
Sherwin-Williams
experiences a turn-over (not approved by
Sherwin-Williams)
of more than half of its directors during a two-year period;
(3) Sherwin-Williams closes a reorganization, merger,
consolidation or significant sale of assets resulting in a
substantial change in its ownership or leadership; or
(4) Sherwin-Williams shareholders approve its
liquidation or dissolution.
Upon the occurrence of a change of control, any awards made to a
participant under the Amended Plan that are assumed by the
surviving entity will continue to vest and become exercisable in
accordance with the terms of the original grant unless, during
the three-year period commencing on the date of the change of
control, the participants employment is involuntarily
terminated by Sherwin-Williams for reasons other than for
cause (as defined in the Amended Plan) or the
participant terminates his or her employment for good
reason (as defined in the Amended Plan). If a
participants employment is terminated under such
circumstances, any outstanding option rights and SARs will
become fully vested and exercisable, any restrictions that apply
to awards made pursuant to the Amended Plan will lapse, and
awards made pursuant to the Amended Plan that are subject to
management objectives will immediately be earned or vest and
will become immediately payable in accordance with their terms
as if 100% of the management objectives have been achieved, on
the date of termination.
Upon the occurrence of a change of control, any awards made
under the Amended Plan that are not assumed by the entity
effecting the change of control will become fully vested and
exercisable on the date of the change of control
57
or will immediately vest and become immediately payable in
accordance with their terms as if 100% of the applicable
management objectives have been achieved, and any restrictions
that apply to such awards will lapse.
For each option right and SAR, the participant will receive a
payment equal to the difference between the consideration
(consisting of cash or other property (including securities of a
successor or parent corporation)) received by holders of common
stock in the change of control transaction and the exercise
price of the applicable option right or SAR, if such difference
is positive. Such payment will be made in the same form as the
consideration received by holders of common stock. Any option
rights or SARs with an option price or base price that is higher
than the per share consideration received by holders of common
stock in connection with the change of control will be cancelled
for no additional consideration.
The participant will receive the consideration (consisting of
cash or other property, including securities of a successor or
parent corporation) that such participant would have received in
the change of control transaction had he or she been,
immediately prior to such transaction, a holder of the number of
shares of common stock equal to the number of restricted stock
units and/or
shares of restricted stock covered by the award and the number
of shares of common stock payable for awards subject to
management objectives. These payments that are made as a result
of a change of control will be made at the same time as
consideration is paid to the holders of the common stock in
connection with the change of control.
If the change of control does not constitute a change of control
for purposes of Section 409A of the Code and the payment or
benefit constitutes a deferral of compensation under
Section 409A of the Code, then, to the extent necessary to
comply with Section 409A of the Code, payment or delivery
will be made on the date of payment or delivery originally
provided for such payment or benefit.
Clawback. Any award agreement may provide for
the cancellation or forfeiture of an award or the forfeiture and
repayment to Sherwin-Williams of any gain related to an award,
or other provisions intended to have a similar effect, upon such
terms and conditions as may be determined by the Board of
Directors in accordance with Sherwin-Williams Executive
Adjustment and Recapture Policy.
Transferability. No option right or SAR
granted under the Amended Plan is transferable by a participant,
except upon death, by will or by the laws of descent and
distribution. Except as otherwise determined by the Board of
Directors, option rights and SARs are exercisable during the
optionees lifetime only by him or her or by his or her
guardian or legal representative. In no event may any award
granted under the Amended Plan be transferred for value.
The Board of Directors may specify at the date of grant that
part or all of the shares of common stock will be subject to
further restrictions on transfer if such shares are:
|
|
|
|
|
to be issued or transferred by
Sherwin-Williams
upon exercise of option rights or SARs, upon termination of the
restriction period applicable to restricted stock units or upon
payment under any grant of performance shares, performance units
or other awards; or
|
|
|
|
no longer subject to the substantial risk of forfeiture and
restrictions on transfer with respect to restricted stock.
|
Withholding Taxes. To the extent that
Sherwin-Williams is required to withhold federal, state, local
or foreign taxes in connection with any payment made or benefit
realized by a participant or other person under the Amended
Plan, and the amounts available to Sherwin-Williams for such
withholding are insufficient, it will be a condition to the
receipt of such payment or the realization of such benefit that
the participant or such other person make arrangements
satisfactory to Sherwin-Williams for payment of the balance of
such taxes required to be withheld, which arrangements (in the
discretion of the Board of Directors) may include relinquishment
of a portion of such benefit.
If a participants benefit is to be received in the form of
common stock, and such participant fails to make arrangements
for the payment of tax, Sherwin-Williams shall withhold such
number of shares of common stock having a value equal to the
amount required to be withheld. Notwithstanding the foregoing,
unless otherwise
58
provided by the Board of Directors, when a participant is
required to pay Sherwin-Williams an amount required to be
withheld under applicable income and employment tax laws, the
participant may elect to satisfy the obligation, in whole or in
part, by electing to have withheld, from the shares required to
be delivered to the participant, such number of shares of common
stock having a value equal to the amount required to be withheld
(except in the case of restricted stock where an election under
Section 83(b) of the Code has been made), or by delivering
to Sherwin-Williams other shares of common stock held by such
participant. The shares used for tax withholding will be valued
at an amount equal to the fair market value of such common stock
on the date the benefit is to be included in the
participants income. In no event shall the fair market
value of the shares of common stock to be withheld
and/or
delivered to satisfy applicable withholding taxes in connection
with the benefit exceed the minimum amount of taxes required to
be withheld. Participants shall also make such arrangements as
Sherwin-Williams may require for the payment of any withholding
tax obligation that may arise in connection with the disposition
of shares of common stock acquired upon the exercise of option
rights.
Compliance with Section 409A of the
Code. To the extent applicable, it is intended
that the Amended Plan and any grants made under the Amended Plan
comply with the provisions of Section 409A of the Code so
that the income inclusion provisions of Section 409A(a)(1)
of the Code do not apply to the participants. The Amended Plan
and any grants made under the Amended Plan will be administered
in a manner consistent with this intent.
Neither a participant nor any of a participants creditors
or beneficiaries will have the right to subject any deferred
compensation (within the meaning of Section 409A of the
Code) payable under the Amended Plan and grants of deferred
compensation under the Amended Plan to any anticipation,
alienation, sale, transfer, assignment, pledge, encumbrance,
attachment or garnishment. Except as permitted under
Section 409A of the Code, any deferred compensation (within
the meaning of Section 409A of the Code) payable to a
participant or for a participants benefit under the
Amended Plan and grants of deferred compensation under the
Amended Plan may not be reduced by, or offset against, any
amount owing by a participant to Sherwin-Williams or any of its
affiliates.
If, at the time of a participants separation from service
(within the meaning of Section 409A of the Code),
(1) the participant is a specified employee (within the
meaning of Section 409A of the Code and using the
identification methodology selected by
Sherwin-Williams
from time to time) and (2) Sherwin-Williams makes a good
faith determination that an amount payable under the Amended
Plan constitutes deferred compensation (within the meaning of
Section 409A of the Code) the payment of which is required
to be delayed pursuant to the six-month delay rule set forth in
Section 409A of the Code in order to avoid taxes or
penalties under Section 409A of the Code, then
Sherwin-Williams will not pay such amount on the otherwise
scheduled payment date but will instead pay it, without
interest, on the first business day of the month after such
six-month period. Additionally, the Amended Plan provides for a
definition of a 409A Change in Control.
In light of the uncertainty with respect to the proper
application of Section 409A of the Code, Sherwin-Williams
reserves the right to make amendments to the Amended Plan and
grants made under the Amended Plan as Sherwin-Williams deems
necessary or desirable to avoid the imposition of taxes or
penalties under Section 409A of the Code. In any case, a
participant will be solely responsible and liable for the
satisfaction of all taxes and penalties that may be imposed on a
participant or for a participants account in connection
with the Amended Plan and grants under the Amended Plan
(including any taxes and penalties under Section 409A of
the Code), and neither
Sherwin-Williams
nor any of its affiliates will have any obligation to indemnify
or otherwise hold a participant harmless from any or all of such
taxes or penalties.
Effective Date. The Sherwin-Williams Company
2006 Equity and Performance Incentive Plan first became
effective April 20, 2006, the date immediately following
the date it was approved by shareholders. The Amended Plan will
be effective as of the first day immediately following the date
Sherwin-Williams shareholders approve it.
59
Amendments. The Board of Directors may amend
the Amended Plan from time to time without further approval by
Sherwin-Williams shareholders, except if an amendment
(1) would materially increase the benefits accruing to
participants; (2) would materially increase the number of
securities which may be issued under the Amended Plan;
(3) would materially modify the requirements for
participation in the Amended Plan; or (4) must otherwise be
approved by the shareholders in order to comply with applicable
law or the rules and regulations of the New York Stock Exchange.
In addition, except in connection with a corporate transaction
or event described in the Amended Plan, the terms of outstanding
awards may not be amended to reduce the option price of
outstanding option rights or the base price of outstanding SARs,
or cancel outstanding option rights or SARs in exchange for
cash, other awards or option rights or SARs with an option price
or base price, as applicable, that is less than the option price
of the original option rights or base price of the original
SARs, as applicable, without shareholder approval.
If permitted by Section 409A of the Code, but subject to
the next paragraph, in the case of a termination of employment
by reason of death, disability or normal or early retirement of
a participant who holds an option right or SAR not immediately
exercisable in full, or any shares of restricted stock as to
which the substantial risk of forfeiture or the prohibition or
restriction on transfer has not lapsed, or any restricted stock
units as to which the restriction period has not been completed,
or any performance shares or performance units which have not
been fully earned, or any other awards made pursuant to the
Amended Plan subject to any vesting schedule or transfer
restriction, or who holds shares of common stock subject to any
other transfer restriction imposed pursuant to the Amended Plan,
or in the case of a change of control, the Board of Directors
may, in its sole discretion, accelerate the time at which such
option right, SAR or other award may be exercised or the time at
which such substantial risk of forfeiture or prohibition or
restriction on transfer will lapse or the time when such
restriction period will end or the time at which such
performance shares or performance units will be deemed to have
been fully earned or the time when such other awards will be
deemed to have been fully earned or vested or that such transfer
restriction will terminate or may waive any other limitation or
requirement under any such award.
Subject to the prohibition on option repricing described above,
the Board of Directors may amend the terms of any award granted
under the Amended Plan prospectively or retroactively, except in
the case of an award intended to satisfy the requirements for
qualified performance-based compensation under
Section 162(m) of the Code (other than in connection with
the participants death or disability, or a change of
control) where such action would result in the loss of the
otherwise available exemption of the award under
Section 162(m) of the Code. In such case, the Board of
Directors will not make any modification of the management
objectives or the level or levels of achievement with respect to
such award. Subject to adjustments (as described above), no such
amendment will impair the rights of any participant without his
or her consent. The Board of Directors may, in its discretion,
terminate the Amended Plan at any time. Termination of the
Amended Plan will not affect the rights of participants or their
successors under any awards outstanding and not exercised in
full on the date of termination.
Qualified Performance-Based Compensation under
Section 162(m) of the Code. The Amended Plan
contains various provisions intended to help Sherwin-Williams
administer the Amended Plan in a manner that will permit awards
to be designed to satisfy the requirements for qualified
performance-based compensation under Section 162(m)
of the Code.
Term of the Amended Plan. No grant will be
made under the Amended Plan more than 10 years after the
date on which the Amended Plan is approved by
Sherwin-Williams shareholders, but all grants made on or
prior to such date will continue in effect thereafter subject to
the terms thereof and of the Amended Plan.
Federal
Income Tax Consequences
The following is a brief summary of some of the federal income
tax consequences of certain transactions under the Amended Plan
based on federal income tax laws in effect on January 1,
2010. This summary is not intended to be complete and does not
describe state or local tax consequences.
60
Tax
Consequences to Participants.
Non-qualified Option Rights. In general,
(1) no income will be recognized by an optionee at the time
a non-qualified option right is granted; (2) at the time of
exercise of a non-qualified option right, ordinary income will
be recognized by the optionee in an amount equal to the
difference between the option price paid for the shares and the
fair market value of the shares, if unrestricted, on the date of
exercise; and (3) at the time of sale of shares acquired
pursuant to the exercise of a non-qualified option right,
appreciation (or depreciation) in value of the shares after the
date of exercise will be treated as either short-term or
long-term capital gain (or loss) depending on how long the
shares have been held.
Incentive Option Rights. No income generally
will be recognized by an optionee upon the grant or exercise of
an incentive stock option. The exercise of an incentive stock
option, however, may result in alternative minimum tax
liability. If shares of common stock are issued to the optionee
pursuant to the exercise of an incentive stock option, and if no
disqualifying disposition of such shares is made by such
optionee within two years after the date of grant or within one
year after the transfer of such shares to the optionee, then
upon sale of such shares, any amount realized in excess of the
option price will be taxed to the optionee as a long-term
capital gain and any loss sustained will be a long-term capital
loss.
If shares of common stock acquired upon the exercise of an
incentive stock option are disposed of prior to the expiration
of either holding period described above, the optionee generally
will recognize ordinary income in the year of disposition in an
amount equal to the excess (if any) of the fair market value of
such shares at the time of exercise (or, if less, the amount
realized on the disposition of such shares if a sale or
exchange) over the option price paid for such shares. Any
further gain (or loss) realized by the participant generally
will be taxed as short-term or long-term capital gain (or loss)
depending on the holding period.
SARs. No income will be recognized by a
participant in connection with the grant of a tandem SAR or a
free-standing SAR. When the SAR is exercised, the participant
normally will be required to include as taxable ordinary income
in the year of exercise an amount equal to the amount of cash
received and the fair market value of any unrestricted shares of
common stock received on the exercise.
Restricted Stock. The recipient of restricted
stock generally will be subject to tax at ordinary income rates
on the fair market value of the restricted stock (reduced by any
amount paid by the participant for such restricted stock) at
such time as the shares are no longer subject to forfeiture or
restrictions on transfer for purposes of Section 83 of the
Code (Restrictions). However, a recipient who so
elects under Section 83(b) of the Code within 30 days
of the date of transfer of the shares will have taxable ordinary
income on the date of transfer of the shares equal to the excess
of the fair market value of such shares (determined without
regard to the Restrictions) over the purchase price, if any, of
such restricted stock. If a Section 83(b) election has not
been made, any dividends received with respect to restricted
stock that is subject to the Restrictions generally will be
treated as compensation that is taxable as ordinary income to
the participant.
Restricted Stock Units. No income generally
will be recognized upon the award of restricted stock units. Any
subsequent transfer of unrestricted shares of common stock or
cash in satisfaction of such award will generally result in the
recipient recognizing ordinary income at the time of transfer,
in an amount equal to the aggregate amount of cash and the fair
market value of the unrestricted shares of common stock received
over the amount paid, if any, by the participant.
Performance Shares and Performance Units. No
income generally will be recognized upon the grant of
performance shares or performance units. Upon payment in respect
of the earn-out of performance shares or performance units, the
recipient generally will be required to include as taxable
ordinary income in the year of receipt an amount equal to the
amount of cash received and the fair market value of any
unrestricted shares of common stock received.
Tax
Consequences to Sherwin-Williams
To the extent that a participant recognizes ordinary income in
the circumstances described above, Sherwin-Williams or the
subsidiary for
61
which the participant performs services will be entitled to a
corresponding deduction provided that, among other things, the
income meets the test of reasonableness, is an ordinary and
necessary business expense, is not an excess parachute
payment within the meaning of Section 280G of the
Code and is not disallowed by the $1 million limitation on
certain executive compensation under Section 162(m) of the
Code.
New
Plan Benefits
It is not possible to determine specific amounts and types of
awards that may be awarded in the future under the Amended Plan
because the grant and actual settlement of awards will be
discretionary.
The Board of Directors unanimously recommends that you
vote FOR Proposal 2 to approve the Amended
Plan.
RATIFICATION
OF APPOINTMENT
OF THE INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM
(PROPOSAL 3)
The Audit Committee has appointed Ernst & Young LLP as our
independent registered public accounting firm to audit our
consolidated financial statements for the fiscal year ending
December 31, 2010. Ernst & Young LLP acted as our
independent registered public accounting firm for the fiscal
year ended December 31, 2009. Additional information
regarding the services provided to us by Ernst & Young LLP
during 2009 is set forth under the caption entitled
Matters Relating to the Independent Registered Public
Accounting Firm.
Representatives of Ernst & Young LLP are expected to
be present at the Annual Meeting and will have an opportunity to
make a statement if they wish and to respond to appropriate
shareholder questions.
Although shareholder ratification is not required under the laws
of the State of Ohio, we are submitting the appointment of Ernst
& Young LLP to our shareholders for ratification at the
Annual Meeting as a matter of good corporate practice in order
to provide a means by which our shareholders may communicate
their opinion to the Audit Committee. If our shareholders do not
ratify the appointment of Ernst & Young LLP, the Audit
Committee will reconsider the appointment.
The Board of Directors unanimously recommends that you
vote FOR Proposal 3 relating to the
ratification of the appointment of Ernst & Young LLP
as our independent registered public accounting firm for the
fiscal year ending December 31, 2010.
MATTERS
RELATING TO THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
Fees Paid to Ernst & Young
LLP. The following table sets forth the fees
for services provided by Ernst & Young LLP during the
fiscal years ended December 31, 2008 and December 31,
2009.
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
2008
|
|
Audit Fees
|
|
$
|
1,945,000
|
|
|
$
|
1,851,100
|
|
Audit-Related Fees
|
|
|
125,000
|
|
|
|
125,000
|
|
Tax Fees
|
|
|
23,000
|
|
|
|
15,900
|
|
All Other Fees
|
|
|
-0-
|
|
|
|
-0-
|
|
Total
|
|
$
|
2,093,000
|
|
|
$
|
1,992,000
|
|
The following is a description of the nature of the services
comprising the fees disclosed in the table above for each of the
four categories of services. The Audit Committee has considered
whether providing non-audit services is compatible with
maintaining Ernst & Young LLPs independence.
Audit Fees. These are fees for professional
services rendered by Ernst & Young LLP for the integrated
audit of our annual consolidated financial statements
and the effectiveness of internal control over financial
reporting; the review of financial statements included in our
Quarterly Reports on
Form 10-Q;
certain audits of foreign subsidiary financial statements
required by local statutes; and services that are typically
rendered in connection with statutory and regulatory filings or
engagements.
Audit-Related Fees. These are fees for
assurance and related services rendered by Ernst & Young
LLP that are reasonably related to the performance of the audit
or the review of our financial statements that are not included
as audit fees. These services include employee benefit plan
audits, consultation on accounting
62
matters in foreign jurisdictions, and consultation on financial
accounting and reporting.
Tax Fees. These are fees for professional
services rendered by Ernst & Young LLP with respect to tax
compliance, tax advice and tax planning. These services include
the review of certain tax returns, tax audit assistance in
foreign jurisdictions, and consulting on tax planning matters.
All Other Fees. These are fees for other
services rendered by Ernst & Young LLP that do not meet the
above category descriptions and are permissible under applicable
laws and regulations.
Audit Committee Pre-approval
Policy. The Audit Committee is responsible
for pre-approving all audit services and permitted non-audit
services (including the fees and retention terms) to be
performed for us by Ernst & Young LLP prior to their
engagement for such services. The Audit Committee has adopted a
pre-approval policy pursuant to which the Audit Committee
establishes detailed pre-approved categories of non-audit
services that may be performed by Ernst & Young LLP
during the fiscal year, subject to dollar limitations set by the
Audit Committee. The Audit Committee has also delegated to the
Chairman of the Audit Committee the authority to pre-approve all
audit and non-audit services when the entire Audit Committee is
unable to pre-approve services. The Chairman must report to the
Audit Committee at its next meeting all such services
pre-approved since the last meeting.
None of the fees paid to Ernst & Young LLP under the
categories Audit-Related, Tax and All Other were approved by the
Audit Committee after the services were rendered pursuant to the
deminimis exception established by the Securities and Exchange
Commission.
SHAREHOLDER
PROPOSAL RELATING TO MAJORITY VOTING
(PROPOSAL 4)
The United Brotherhood of Carpenters Pension Fund, 101
Constitution Avenue, N.W., Washington, D.C. 20001,
beneficial owner of 1,495 shares of Sherwin-Williams common
stock, has submitted the following proposal. The Board of
Directors recommends a vote AGAINST this
proposal.
Director
Election Majority Vote Standard Proposal
Resolved: That the shareholders of The
Sherwin-Williams Company (Company) hereby request
that the Board of Directors initiate the appropriate process to
amend the Companys articles of incorporation to provide
that director nominees shall be elected by the affirmative vote
of the majority of votes cast at an annual meeting of
shareholders, with a plurality vote standard retained for
contested director elections, that is, when the number of
director nominees exceeds the number of board seats.
Supporting Statement: In order to
provide shareholders a meaningful role in director elections,
our Companys director election vote standard should be
changed to a majority vote standard. A majority vote standard
would require that a nominee receive a majority of the votes
cast in order to be elected. The standard is particularly
well-suited for the vast majority of director elections in which
only board nominated candidates are on the ballot. We believe
that a majority vote standard in board elections would establish
a challenging vote standard for board nominees and improve the
performance of individual directors and entire boards. Our
Company presently uses a plurality vote standard in all director
elections. Under the plurality vote standard, a nominee for the
board can be elected with as little as a single affirmative
vote, even if a substantial majority of the votes cast are
withheld from the nominee.
In response to strong shareholder support for a majority vote
standard in director elections, a strong majority of the
nations leading companies, including Intel, General
Electric, Motorola, Hewlett-Packard, Morgan Stanley, Wal-Mart,
Home Depot, Gannett, Marathon Oil, and Safeway have adopted a
majority vote standard in company bylaws or articles of
incorporation. Additionally, these companies have adopted
director resignation policies in their bylaws or corporate
governance policies to address post-election issues related to
the status of director nominees that fail to win election.
However, our Company has responded only partially to the call
for change, simply adopting a post-election director resignation
policy that sets procedures for addressing the status of
director nominees that receive more withhold
63
votes than for votes. The plurality vote standard
remains in place.
We believe that a post-election director resignation policy
without a majority vote standard in Company bylaws or articles
is an inadequate reform. The critical first step in establishing
a meaningful majority vote policy is the adoption of a majority
vote standard. With a majority vote standard in place, the Board
can then consider action on developing post-election procedures
to address the status of directors that fail to win election. A
majority vote standard combined with a post-election director
resignation policy would establish a meaningful right for
shareholders to elect directors, and reserve for the Board an
important post-election role in determining the continued status
of an unelected director. We feel that this combination of the
majority vote standard with a post-election policy represents a
true majority vote standard.
Sherwin-Williams
Response
The Board of Directors recommends a vote
AGAINST Proposal 4.
This proposal requests that we adopt a voting standard for
director elections that differs from the plurality voting
standard, the current default standard under Ohio law. The
plurality voting standard provides that the nominees who receive
the most affirmative votes are elected to serve as directors.
After careful consideration, the Board of Directors recommends a
vote against this proposal because:
|
|
|
|
|
our shareholders rejected this proposal at our 2008 and 2009
Annual Meetings;
|
|
|
|
we implemented a majority voting policy in 2006 that addresses
the proponents concerns;
|
|
|
|
our current corporate governance practices already ensure that
our directors are highly qualified;
|
|
|
|
the shareholder proposal creates uncertainty; and
|
|
|
|
the ramifications of majority voting are not completely
understood.
|
Our Shareholders Rejected This Proposal At Our 2008 and 2009
Annual Meetings.
This shareholder presented this proposal at last years
Annual Meeting and at our 2008 Annual Meeting, and our
shareholders rejected the proposal each time. Notwithstanding
the clear vote of our shareholders, this shareholder is
presenting the proposal again this year.
We Have Already Implemented A Majority Voting Policy
Like a number of other large public companies facing this issue,
in order to address concerns relating to director candidates who
do not receive a majority of the votes cast, we have adopted a
majority voting policy. Our policy was adopted on July 19,
2006 and is posted in the Corporate Governance
section on the Investor Relations page of our
website at www.sherwin.com.
Our policy provides that, in an uncontested election, any
director nominee who receives a greater number of
withheld votes than for votes is
required promptly to submit his resignation to the Board of
Directors. In addition:
|
|
|
|
|
The Nominating and Corporate Governance Committee will promptly
consider the tendered resignation and will recommend to the
Board of Directors whether to accept the tendered resignation or
take some other action.
|
|
|
|
The Board of Directors will act on the Nominating
Committees recommendation no later than the next scheduled
Nominating Committee meeting (within 120 days from the
shareholder vote).
|
|
|
|
The director who tendered his resignation will not participate
in the Nominating Committees recommendation or the Board
of Directors consideration of the tendered resignation.
|
|
|
|
We will promptly disclose publicly the Board of Directors
decision and process in a report filed with the SEC.
|
We believe our policy strikes an appropriate balance in ensuring
that our shareholders continue to have a meaningful role in
electing directors while preserving the ability of the Board of
Directors to exercise its independent judgment and to
64
consider all relevant factors in accepting the resignation of a
director opposed by shareholders.
Our Current Process Elects Highly Qualified Directors
Adoption of a strict majority voting standard seems especially
unwarranted in our case. We have a strong corporate governance
process designed to identify and propose director nominees who
will best serve the interests of Sherwin-Williams and our
shareholders. The Board of Directors maintains a Nominating
Committee that is composed entirely of independent directors,
and all of the members of the Board of Directors, other than the
Chairman and Chief Executive Officer, are independent.
The Nominating Committee applies a rigorous set of criteria in
identifying director nominees and has established procedures to
consider and evaluate persons recommended by shareholders. Our
strong corporate governance has been recognized by RiskMetrics
Group. According to its February 1, 2010 rankings,
RiskMetrics has ranked Sherwin-Williams ahead of 93.2% of the
companies in the Retailing group, as measured by
RiskMetrics Corporate Governance Quotient.
As a result of these practices, our shareholders have
consistently elected, by a plurality, highly qualified directors
from diverse business backgrounds, substantially all of whom
have been independent within standards adopted by
the New York Stock Exchange. Changing our current voting system
to majority voting would have had no effect on director
elections during the past ten years. The Board of Directors
believes that the votes over this period reflect our
shareholders confidence in the Board of Directors and in
the governance protections the Board of Directors has
implemented.
The
Proposal Causes Uncertainty
In contrast to our majority voting policy, the majority voting
standard requested by the proposal causes uncertainty. Under
Ohio law, an incumbent director who is not re-elected
holds over and continues to serve with the same
voting rights and powers until his or her successor is elected
and qualified. Therefore, even if the proposal were adopted, we
could not force a director who failed to receive a majority vote
to leave the Board of Directors until his or her successor is
elected at a subsequent shareholder meeting.
In contrast, under our existing majority voting policy, a
director who receives more withhold votes than
for votes is required promptly to tender his or her
resignation. The Board of Directors in turn will act on the
tendered resignation after considering all relevant facts and
circumstances in a process that will be completed and publicly
disclosed promptly.
The
Ramifications Are Not Completely Understood
Ohio law requires the plurality voting standard in director
elections unless the corporations articles of
incorporation provide otherwise. Our Board of Directors cannot
adopt majority voting in our Code of Regulations, an approach
that other companies have recently taken. We can adopt majority
voting only through shareholder approval of an amendment to our
Articles of Incorporation.
The legal community, shareholder advocates, governance experts,
public companies and other groups continue to evaluate the
consequences of majority voting. Plurality voting has long been
the accepted standard, and the rules governing plurality voting
are well established and widely understood. A majority voting
standard involves potential issues for which there is little
precedent. Any change in voting standards should not be
undertaken without a complete understanding of the full
ramifications of its adoption.
We have been monitoring, and we will continue to monitor,
developments on this topic. We do not believe that our
interests, or our shareholders interests, would be best
served by adopting majority voting at this time.
The Board of Directors unanimously recommends that you vote
AGAINST Proposal 4 relating to majority
voting.
65
SECURITY
OWNERSHIP OF MANAGEMENT
The following table sets forth, as to each director and nominee,
each named executive and all directors and executive officers as
a group, information regarding the amount and nature of shares
of our common stock beneficially owned at December 31,
2009. All of the directors, nominees and executive officers have
sole voting and investment power over the shares of common stock
listed or share voting and investment power with his or her
spouse, except as otherwise provided below. No director, nominee
or executive officer beneficially owns any shares of ESOP serial
preferred stock.
|
|
|
|
|
|
|
|
|
|
|
Amount and
|
|
|
|
|
Nature of
|
|
Percent of
|
|
|
Common Stock
|
|
Common Stock
|
Name of Beneficial Owner
|
|
Beneficially
Owned(1,2,3,4,5)
|
|
Beneficially Owned
|
|
A. F. Anton
|
|
|
8,053
|
|
|
|
*
|
|
J. C. Boland
|
|
|
11,767
|
|
|
|
*
|
|
C. M. Connor
|
|
|
1,529,995
|
|
|
|
1.39
|
%
|
S. P. Hennessy
|
|
|
259,008
|
|
|
|
*
|
|
D. F. Hodnik
|
|
|
9,153
|
|
|
|
*
|
|
T. G. Kadien
|
|
|
1,483
|
|
|
|
*
|
|
S. J. Kropf
|
|
|
15,903
|
|
|
|
*
|
|
G. E. McCullough
|
|
|
30,943
|
|
|
|
*
|
|
A. M. Mixon, III
|
|
|
42,835
|
|
|
|
*
|
|
C. E.
Moll(6)
|
|
|
35,166
|
|
|
|
*
|
|
J. G. Morikis
|
|
|
283,405
|
|
|
|
*
|
|
S. J. Oberfeld
|
|
|
214,070
|
|
|
|
*
|
|
T. W. Seitz
|
|
|
160,085
|
|
|
|
*
|
|
R. K. Smucker
|
|
|
26,695
|
|
|
|
*
|
|
J. M. Stropki, Jr.
|
|
|
2,483
|
|
|
|
*
|
|
All directors and executive officers as a group
|
|
|
3,270,515
|
|
|
|
2.94
|
%
|
|
|
* |
Represents less than 1% of the total number of shares of
common stock outstanding.
|
|
|
1
|
The amounts listed include shares of common stock held under
plans offered by Sherwin-Williams for which the directors and
executive officers have the right to direct the vote, including
the following approximate number of shares included in units
held under our Employee Stock Purchase and Savings Plan:
Mr. Connor (45,840), Mr. Hennessy (17,022),
Mr. Morikis (15,368), Mr. Oberfeld (25,574),
Mr. Seitz (12,485), and all executive officers as a group
(191,261). Shares of common stock held under our Employee Stock
Purchase and Savings Plan are not directly allocated to
individual participants of the plan, but instead are held in a
separate fund. Participants acquire units of this fund. The fund
also holds short-term investments, the amount of which
fluctuates on a daily basis. The number of shares of common
stock shown as being held by the executive officers in the plan
is the approximate number of shares in the fund allocable to
each of the executive officers. The number of shares allocable
to each of the executive officers fluctuates on a daily basis
based upon the amount of short-term investments held in the fund
and the market value of our common stock.
|
|
2
|
The amounts listed include the following number of shares of
common stock owned by immediate family members of the directors
and executive officers, for which each such person disclaims
beneficial ownership: Mr. Moll (340) and all directors and
executive officers as a group (340).
|
|
3
|
The amounts listed include shares of restricted stock owned.
|
|
|
4 |
The amounts listed include the following number of shares of
common stock for which the directors and executive officers have
the right to acquire beneficial ownership, within
sixty days from December 31, 2009, through the
exercise of stock options: Mr. Connor (1,004,401),
Mr. Hennessy (135,000), Mrs. Kropf (7,000),
Mr. McCullough (9,000), Mr. Mixon (11,000),
Mr. Moll (1,167),
|
66
|
|
|
|
|
Mr. Morikis (133,334), Mr. Oberfeld (110,847),
Mr. Seitz (84,707), Mr. Smucker (3,500), and all
directors and executive officers as a group (1,863,233).
|
|
|
5
|
The amounts listed do not include the following approximate
number of shares of shadow stock owned by directors under our
Director Deferred Fee Plan: Mr. Boland (22,303),
Mrs. Kropf (9,802), Mr. Mixon (31,914), and all
directors as a group (64,019). Under our Director Deferred Fee
Plan, nonemployee directors may defer payment of all or a
portion of their directors fees into a shadow stock
account. Shares of shadow stock are credited to a separate
account in which directors acquire units. Units are payable only
in cash. The number of shares of shadow stock allocable to the
directors fluctuates on a daily basis based upon the market
value of our common stock. Directors have no voting rights
associated with shadow stock, and ownership of shadow stock does
not result in any beneficial ownership of common stock.
|
|
6
|
Includes 2,000 shares owned by the MTD Holdings Inc pension
fund, of which Mr. Moll is a trustee.
|
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
The following table sets forth, as to each beneficial owner
known to us to own more than five percent of each class of
voting securities, information regarding shares owned by each as
of the most recent practicable date.
Common
Stock
|
|
|
|
|
|
|
|
|
|
|
Amount and
|
|
|
|
|
|
|
Nature of
|
|
|
Percent of
|
|
Name of Beneficial Owner
|
|
Beneficial Ownership
|
|
|
Class
|
|
The Sherwin-Williams Company
Employee Stock Purchase and Savings Plan
|
|
|
17,579,750(1)
|
|
|
|
16.0%
|
|
101 West Prospect Avenue
Cleveland, Ohio 44115
|
|
|
|
|
|
|
|
|
Massachusetts Financial Services Company
|
|
|
7,401,225(2)
|
|
|
|
6.5%
|
|
500 Boylston Street
Boston, Massachusetts 02116
|
|
|
|
|
|
|
|
|
ESOP
Serial Preferred Stock
|
|
|
|
|
|
|
|
|
|
|
Amount and
|
|
|
|
|
|
|
Nature of
|
|
|
Percent of
|
|
Name of Beneficial Owner
|
|
Beneficial Ownership
|
|
|
Class
|
|
The Sherwin-Williams Company
Employee Stock Purchase and Savings Plan
|
|
|
216,753(3)
|
|
|
|
100%
|
|
101 West Prospect Avenue
Cleveland, Ohio 44115
|
|
|
|
|
|
|
|
|
|
|
1
|
The shares of common stock reflected in the table are owned at
December 31, 2009. Shares of common stock owned pursuant to
our Employee Stock Purchase and Savings Plan are voted by the
trustee in accordance with written instructions of plan
participants. If no instructions are received by the trustee,
the trustee votes such shares (along with any unallocated shares
held in the plan) in the same proportion as it votes those
shares for which it receives proper instructions.
|
|
2
|
Based on a Schedule 13G filed on February 3, 2010,
Massachusetts Financial Services Company and/or certain other
entities (MFS) owned 7,401,225 shares of common
stock at December 31, 2009. Of the total shares, MFS had
sole dispositive power over all of the shares, sole voting power
over 6,343,109 shares, and shared voting power and shared
dispositive power over none of the shares.
|
|
3
|
The shares of ESOP serial preferred stock reflected in the table
are owned at December 31, 2009. Shares of ESOP serial
preferred stock are held in an unallocated account in our
Employee Stock Purchase and Savings Plan. Shares are voted by
the trustee in the same proportion as unallocated shares of
common stock are voted, as described in footnote 1 above.
|
67
SECTION
16(a)
BENEFICIAL OWNERSHIP
REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934 requires
our directors and executive officers to file reports of
ownership and changes in ownership of our equity securities with
the SEC. To our knowledge, based solely on information furnished
to us and written representations by such persons, all of our
directors and executive officers complied with their filing
requirements in 2009, except that (a) Mr. Anton inadvertently
filed a late Form 4 to report one transaction for a
purchase of common stock and (b) Mr. Seitz inadvertently filed a
late Form 4 to report one transaction for a sale of common
stock.
CERTAIN
RELATIONSHIPS
AND TRANSACTIONS
WITH RELATED PERSONS
As part of our Business Ethics Policy, directors and employees
are expected to make business decisions and take actions based
upon the best interests of Sherwin-Williams and not based upon
personal relationships or benefits.
The Board of Directors recognizes that some transactions,
arrangements and relationships present a heightened risk of an
actual or perceived conflict of interest and has adopted a
written policy governing these transactions. This policy governs
any transaction, arrangement or relationship (or any series of
similar transactions, arrangements or relationships) in which
Sherwin-Williams was, is or will be a participant and the amount
involved exceeds $120,000, and in which any of the following
persons had, has or will have a direct or indirect material
interest:
|
|
|
|
|
Our directors, nominees for director or executive officers;
|
|
|
|
any person who is known to be the beneficial owner of more than
5% of any class of our voting securities;
|
|
|
|
any immediate family member of any of the foregoing persons; and
|
|
|
|
any entity in which any of the foregoing persons is employed or
is a partner or principal or in a similar position or in which
such person has a 5% or greater beneficial ownership interest.
|
The Nominating and Corporate Governance Committee of the Board
of Directors is responsible to review and approve these
transactions.
In response to an annual questionnaire, directors, director
nominees and executive officers are required to submit to the
Nominating Committee a description of any current or proposed
transaction and provide updates during the year. In addition, we
will provide any similar available information with respect to
any known transactions with beneficial owners of 5% or more of
our voting securities. At each calendar years first
regularly scheduled Nominating Committee meeting, management
shall provide information regarding transactions to be entered
into by Sherwin-Williams for that calendar year.
If management becomes aware of any transactions subsequent to
that meeting, such transactions may be presented for approval at
the next meeting, or where it is not practicable or desirable to
wait until the next meeting, to the Chair of the Nominating
Committee (who will possess delegated authority to act between
meetings) subject to ratification by the Nominating Committee at
its next meeting. In the event management becomes aware of any
transaction that was not approved under the policy, management
will present the transaction to the Nominating Committee for its
action, which may include termination, amendment or ratification
of the transaction.
The Nominating Committee (or the Chair) will approve only those
transactions that are in, or are not inconsistent with, the best
interests of Sherwin-Williams and our shareholders, as is
determined in good faith in accordance with its business
judgment. In addition, the transaction must be on terms
comparable to those that could be obtained in arms length
dealings with an unrelated third party.
Sherwin-Williams will disclose all related person transactions
in its securities filings. No reportable transactions existed
during 2009, and there are currently no such proposed
transactions.
68
SHAREHOLDER
PROPOSALS FOR
THE 2011 ANNUAL MEETING
Proposals to Be Included in the Proxy
Statement. Under SEC rules, shareholder
proposals must be received at our principal executive offices,
101 West Prospect Avenue, 12th Floor, Midland
Building, Cleveland, Ohio
44115-1075,
Attention: Corporate Secretary, on or before November 9,
2010 in order to be considered for inclusion in the proxy
materials relating to the 2011 Annual Meeting of Shareholders.
Upon timely receipt of any such proposal, we will determine
whether or not to include such proposal in the proxy materials
in accordance with applicable regulations governing the
solicitation of proxies.
Proposals Not to Be Included in the Proxy
Statement. Under our Regulations,
shareholders must follow certain procedures to nominate a person
for election as a director or to introduce an item of business
at an Annual Meeting of Shareholders, which is not intended to
be included in our proxy materials. These procedures provide
that nominations for director nominees and/or an item of
business to be introduced at an Annual Meeting must be timely
submitted in writing to us at our principal executive offices at
101 West Prospect Avenue, 12th Floor, Midland Building,
Cleveland, Ohio
44115-1075,
Attention: Corporate Secretary.
To be timely, a shareholders notice must be delivered to
or mailed and received at our principal executive offices not
fewer than 60 nor more than 90 calendar days prior to the
Annual Meeting. In the event that public announcement of the
date of the Annual Meeting is not made at least 75 calendar
days prior to the date of the Annual Meeting and the Annual
Meeting is held on a date more than ten calendar days before or
after the first anniversary of the date on which the prior
years Annual Meeting was held, notice by the shareholder,
to be timely, must be received not later than the close of
business on the 10th calendar day following the day on which
public announcement is first made of the date of the Annual
Meeting.
These time limits also apply in determining whether notice is
timely for purposes of SEC rules relating to the exercise of
discretionary voting authority. If we do not receive timely
notice, or if we meet other SEC requirements, the persons named
as proxies in the proxy materials for that meeting will use
their discretion in voting at the meeting.
Our Regulations set forth specific requirements for the notice.
You can access a copy of our Regulations in the Corporate
Governance section on the Investor Relations
page of our website at www.sherwin.com. You may also receive a
copy of our Regulations by writing to us at: The
Sherwin-Williams Company, 101 West Prospect Avenue, 12th
Floor, Midland Building, Cleveland, Ohio
44115-1075,
Attention: Investor Relations.
HOUSEHOLDING
INFORMATION
Some banks, brokers and other nominees are participating in the
practice of householding proxy statements and annual
reports. This means that beneficial holders of our common stock
who share the same address or household may not receive separate
copies of this proxy statement and our 2009 Annual Report. We
will promptly deliver an additional copy of either document to
you if you write or call us at: The Sherwin-Williams Company,
101 West Prospect Avenue, 12th Floor, Midland Building,
Cleveland, Ohio
44115-1075,
Attention: Investor Relations,
(216) 566-2000.
ANNUAL
REPORT ON FORM 10-K
We will provide to each shareholder who is solicited to vote
at the 2010 Annual Meeting of Shareholders, upon the request of
such person and without charge, a copy of our 2009 Annual Report
on Form 10-K. Please write or call us at: The
Sherwin-
Williams Company, 101 West Prospect Avenue, 12th Floor, Midland
Building, Cleveland, Ohio
44115-1075,
Attention: Investor Relations,
(216) 566-2000.
69
APPENDIX
A
THE SHERWIN-WILLIAMS COMPANY
Board of Directors
Director Independence Standards
The Board of Directors of The Sherwin-Williams Company has
adopted the following Director Independence Standards to assist
the Board in determining the independence of a director. To be
considered independent, the Board must affirmatively
determine that the director has no material relationship with
Sherwin-Williams (either directly or as a partner, shareholder
or officer of an organization that has a relationship with
Sherwin-Williams). In each case, the Board shall broadly
consider all relevant facts and circumstances, including the
directors commercial, industrial, banking, consulting,
legal, accounting, charitable and familial relationships. The
Board shall also consider such other criteria as the Board may
determine from time to time.
|
|
|
|
1.
|
In no event will a director be considered
independent if such director fails to qualify as an
independent director under Rule 303A.02(b) of
the New York Stock Exchange Listed Company Manual. In addition,
a director will not be independent if: (i) the director is,
or has been within the last three years, an employee of
Sherwin-Williams; (ii) an immediate family member of the
director is, or has been within the last three years, an
executive officer of Sherwin-Williams; (iii) the director
has received, or an immediate family member of the director has
received, during any twelve-month period within the last three
years, more than $120,000 in direct compensation from
Sherwin-Williams, other than director and committee fees and
pension or other forms of deferred compensation for prior
service (provided such compensation is not contingent in any way
on continued service); (iv) the director is a current
partner or employee of Sherwin-Williams independent
auditor, or an immediate family member of the director is a
current partner of Sherwin-Williams independent auditor;
(v) an immediate family member of the director is a current
employee of Sherwin-Williams independent auditor and
personally works on Sherwin-Williams audit, or the
director or an immediate family member of the director was
within the last three years a partner or employee of
Sherwin-Williams independent auditor and personally worked
on Sherwin-Williams audit within that time; or
(vi) the director or an immediate family member of the
director is, or has been within the last three years, employed
as an executive officer of another company where any of
Sherwin-Williams present executive officers at the same
time serves or served on that companys compensation
committee.
|
|
|
2.
|
In addition to the relationships described in paragraph 1,
audit committee members may not (i) directly or indirectly
accept any consulting, advisory or other compensatory fee from
Sherwin-Williams or any of its subsidiaries or (ii) be an
affiliated person of Sherwin-Williams or any of its
subsidiaries. Audit committee members may receive
directors fees, in the form of cash, stock, stock units,
stock options or other consideration ordinarily available to
directors, as well as regular benefits that other directors
receive.
|
|
|
3.
|
The following relationships will not be considered to be
material relationships that would impair a directors
independence: (i) if the director is a current employee, or
an immediate family member of the director is a current
executive officer, of another company that, has made payments
to, or received payments from, Sherwin-Williams for property or
services in an amount which, in any of the last three fiscal
years, is less than $1 million or two percent, whichever is
greater, of such other companys annual consolidated gross
revenues; (ii) if the director, or an immediate family
member of the director, is an executive officer of another
company which is indebted to Sherwin-Williams, or to which
Sherwin-Williams is indebted, in an amount which is less than
five percent of such other companys total consolidated
assets; (iii) if the director, or an immediate family
member of the director, serves as an officer, director or
trustee of a foundation, university, charitable or other
not-for-profit organization,
|
A-1
|
|
|
|
|
and Sherwin-Williams or Sherwin-Williams
Foundations discretionary charitable contributions
(Sherwin-Williams Foundation matching of employee
charitable contributions will not be included in the amount of
the Foundations contributions for this purpose) to the
organization, in the aggregate, are less than $500,000 or five
percent, whichever is greater, of that organizations
latest publicly available annual consolidated gross revenues;
(iv) if the director serves as a director or executive
officer of another company that also uses Sherwin-Williams
independent auditor; (v) if the director is a member of, or
associated with, the same professional association, or social,
educational, civic, charitable, fraternal or religious
organization or club as another Sherwin-Williams director or
executive officer; or (vi) if the director serves on the
board of directors of another company at which another
Sherwin-Williams director or executive officer also serves on
the board of directors (except as set forth in paragraph 1 above
regarding compensation committee interlocks).
|
|
|
|
|
4.
|
For relationships not covered by the categorical standards in
paragraphs 1 and 3, the determination of whether the
relationship is material or not, and therefore whether the
director would be independent or not, shall be made by the
directors who satisfy the standards set forth in
paragraphs 1 and 3. Sherwin-Williams will explain in its
next proxy statement the basis for any Board determination that
a relationship is immaterial despite the fact that it does not
meet the categorical standards set forth in paragraphs 1
and/or 3
above.
|
|
|
5.
|
The Board shall undertake an annual review of the independence
of all directors. In advance of the meeting at which this review
occurs, each director shall be asked to provide the Board with
full information regarding the directors (including
immediate family members) business, charitable and other
relationships with Sherwin-Williams to enable the Board to
evaluate the directors independence.
|
|
|
6.
|
Directors have an affirmative obligation to inform the Board of
any material changes in their circumstances or relationships
that may impact their designation by the Board as
independent. This obligation includes all business,
charitable and other relationships between directors (including
immediate family members) and Sherwin-Williams and its
affiliates.
|
For purposes of these Director Independence Standards,
immediate family member includes a persons
spouse, parents, children, siblings, mothers and
fathers-in-law,
sons and
daughters-in-law,
brothers and
sisters-in-law,
and anyone (other than domestic employees) who shares such
persons home.
A-2
APPENDIX B
THE
SHERWIN-WILLIAMS COMPANY
2006 Equity and Performance Incentive Plan
(Amended and Restated as of April 21, 2010)
|
|
|
|
1.
|
Purpose. The purpose of this 2006
Equity and Performance Incentive Plan (Amended and Restated as
of April 21, 2010) is to attract and retain officers
and other employees of The Sherwin-Williams Company and its
Subsidiaries and to provide to such persons incentives and
rewards for performance.
|
|
|
2.
|
Definitions. As used in this Plan,
|
|
|
|
|
(a)
|
Appreciation Right means a right granted
pursuant to Section 5 of this Plan, and will include both
Free-Standing Appreciation Rights and Tandem Appreciation Rights.
|
|
|
(b)
|
Assumed has the meaning provided in
Section 12 of this Plan.
|
|
|
(c)
|
Base Price means the price to be used as the
basis for determining the Spread upon the exercise of a
Free-Standing Appreciation Right or a Tandem Appreciation Right.
|
|
|
(d)
|
Board means the Board of Directors of the
Company and, to the extent of any delegation by the Board to a
committee (or subcommittee thereof) pursuant to Section 10
of this Plan, such committee (or subcommittee).
|
|
|
(e)
|
Cause has the meaning provided in
Section 12 of this Plan.
|
|
|
(f)
|
Change of Control means, except as may be
otherwise prescribed by the Board in any Evidence of Award, the
occurrence of any of the following events:
|
|
|
|
|
(i)
|
any individual, entity or group (within the meaning of Section
13(d)(3) or 14(d)(2) of the Exchange Act) (a Person)
is or becomes the beneficial owner (within the meaning of
Rule 13d-3
promulgated under the Exchange Act) of 30% or more of the
combined voting power of the then-outstanding Voting Stock of
Company; provided, however, that:
|
|
|
|
|
(A)
|
for purposes of this Section 2(f)(i), the following
acquisitions will not constitute a Change in Control:
(1) any acquisition of Voting Stock directly from Company
that is approved by a majority of the Incumbent Directors,
(2) any acquisition of Voting Stock by Company or any
Subsidiary, (3) any acquisition of Voting Stock by the
trustee or other fiduciary holding securities under any employee
benefit plan (or related trust) sponsored or maintained by
Company or any Subsidiary, and (4) any acquisition of
Voting Stock by any Person pursuant to a Business Transaction
that complies with clauses (A), (B) and (C) of
Section 2(f)(iii) below;
|
|
|
(B)
|
if any Person is or becomes the beneficial owner of 30% or more
of combined voting power of the then-outstanding Voting Stock as
a result of a transaction described in clause (1) of
Section 2(f)(i)(A) above and such Person thereafter becomes
the beneficial owner of any additional shares of Voting Stock
representing 1% or more of the then-outstanding Voting Stock,
other than in an acquisition directly from Company that is
approved by a majority of the Incumbent Directors or other than
as a result of a stock dividend, stock split or similar
transaction effected by Company in which all holders of Voting
Stock are treated equally, such subsequent acquisition shall be
treated as a Change in Control; or
|
B-1
|
|
|
|
(C)
|
a Change in Control will not be deemed to have occurred if a
Person is or becomes the beneficial owner of 30% or more of the
Voting Stock as a result of a reduction in the number of shares
of Voting Stock outstanding pursuant to a transaction or series
of transactions that is approved by a majority of the Incumbent
Directors unless and until such Person thereafter becomes the
beneficial owner of any additional shares of Voting Stock
representing 1% or more of the then-outstanding Voting Stock,
other than as a result of a stock dividend, stock split or
similar transaction effected by Company in which all holders of
Voting Stock are treated equally; and
|
|
|
(D)
|
if at least a majority of the Incumbent Directors determine in
good faith that a Person has acquired beneficial ownership of
30% or more of the Voting Stock inadvertently, and such Person
divests as promptly as practicable but no later than the date,
if any, set by the Incumbent Board a sufficient number of shares
so that such Person beneficially owns less than 30% of the
Voting Stock, then no Change in Control shall have occurred as a
result of such Persons acquisition; or
|
|
|
|
|
(ii)
|
a majority of the Board ceases to be comprised of Incumbent
Directors; or
|
|
|
(iii)
|
the consummation of a reorganization, merger or consolidation,
or sale or other disposition of all or substantially all of the
assets of Company or the acquisition of the stock or assets of
another corporation, or other transaction (each, a
Business Transaction), unless, in each case,
immediately following such Business Transaction (A) the
Voting Stock outstanding immediately prior to such Business
Transaction continues to represent (either by remaining
outstanding or by being converted into voting stock of the
surviving entity or any parent thereof), more than 50% of the
combined voting power of the then outstanding shares of voting
stock of the entity resulting from such Business Transaction
(including, without limitation, an entity which as a result of
such transaction owns Company or all or substantially all of
Companys assets either directly or through one or more
subsidiaries), (B) no Person (other than Company, such
entity resulting from such Business Transaction, or any employee
benefit plan (or related trust) sponsored or maintained by
Company, any Subsidiary or such entity resulting from such
Business Transaction) beneficially owns, directly or indirectly,
30% or more of the combined voting power of the then outstanding
shares of voting stock of the entity resulting from such
Business Transaction, and (C) at least a majority of the
members of the board of directors of the entity resulting from
such Business Transaction were Incumbent Directors at the time
of the execution of the initial agreement or of the action of
the Board providing for such Business Transaction; or
|
|
|
(iv)
|
approval by the shareholders of Company of a complete
liquidation or dissolution of Company, except pursuant to a
Business Transaction that complies with clauses (A),
(B) and (C) of Section 2(f)(iii).
|
|
|
(v)
|
For purposes of this Section 2(f), the term Incumbent
Directors shall mean, during any period of two consecutive
years, individuals who at the beginning of such period
constituted the Board and any new director (other than a
director initially elected or nominated as a director as a
result of an actual or threatened election contest with respect
to directors or any other actual or threatened solicitation of
proxies by or on behalf of such director) whose election by the
Board or nomination for election by the Companys
shareholders was approved by a vote of at least two-thirds (2/3)
of the directors then
|
B-2
|
|
|
|
|
still in office who either were directors at the beginning of
the period or whose election or nomination for election was
previously so approved.
|
|
|
|
|
(g)
|
Code means the Internal Revenue Code of 1986,
as amended from time to time.
|
|
|
(h)
|
Common Stock means Common Stock, par value
$1.00 each, of the Company or any security into which such
shares of Common Stock may be changed by reason of any
transaction or event of the type referred to in Section 11
of this Plan.
|
|
|
(i)
|
Company means The Sherwin-Williams Company,
an Ohio corporation, and its successors.
|
|
|
(j)
|
Covered Employee means a Participant who is,
or is determined by the Board to be likely to become, a
covered employee within the meaning of
Section 162(m) of the Code (or any successor provision).
|
|
|
|
|
(k)
|
Date of Grant means the date specified by the
Board on which a grant of Option Rights, Appreciation Rights,
Performance Shares, Performance Units or Other Awards, or a
grant or sale of Restricted Stock, Restricted Stock Units or
Other Awards, will become effective (which date will not be
earlier than the date on which the Board takes action with
respect thereto).
|
|
|
|
|
(l)
|
Director means a member of the Board of
Directors of the Company.
|
|
|
(m)
|
Effective Date means the date immediately
following the date that this Plan is approved by the
shareholders of the Company.
|
|
|
(n)
|
Evidence of Award means an agreement,
certificate, resolution or other type or form of writing or
other evidence approved by the Board that sets forth the terms
and conditions of Option Rights, Appreciation Rights,
Performance Shares, Performance Units or Other Awards granted,
or a grant or sale of Restricted Stock, Restricted Stock Units
or Other Awards. An Evidence of Award may be in an electronic
medium, may be limited to notation on the books and records of
the Company and, unless otherwise determined by the Board, need
not be signed by a representative of the Company or a
Participant.
|
|
|
(o)
|
Exchange Act means the Securities Exchange
Act of 1934, as amended, and the rules and regulations
thereunder, as such law, rules and regulations may be amended
from time to time.
|
|
|
(p)
|
Free-Standing Appreciation Right means an
Appreciation Right granted pursuant to Section 5 of this
Plan that is not granted in tandem with an Option Right.
|
|
|
(q)
|
Good Reason has the meaning provided in
Section 12 of this Plan.
|
|
|
(r)
|
Incentive Stock Options means Option Rights
that are intended to qualify as incentive stock
options under Section 422 of the Code or any
successor provision.
|
|
|
(s)
|
Management Objectives means the measurable
performance objective or objectives established pursuant to this
Plan for Participants who have received grants of Performance
Shares or Performance Units or, when so determined by the Board,
Option Rights, Appreciation Rights, Restricted Stock, Restricted
Stock Units, Other Awards or dividend credits pursuant to this
Plan. Management Objectives may be described in terms of
Company-wide objectives or objectives that are related to the
performance of the individual Participant or of the Subsidiary,
division, department, region or function within the Company or
Subsidiary in which the Participant is employed. The Management
Objectives may be made relative to the performance of one or
more other companies or subsidiaries, divisions, departments,
regions or functions within such other companies, and may be
made relative to an index or one or more of the
|
B-3
|
|
|
|
|
performance criteria themselves. The Board may grant awards
subject to Management Objectives that are either Qualified
Performance-Based Awards or are not Qualified Performance-Based
Awards. The Management Objectives applicable to any Qualified
Performance-Based Award to a Covered Employee will be based on
one or more, or a combination, of the following criteria:
|
|
|
|
|
(i)
|
Appreciation in value of shares;
|
|
|
(ii)
|
Total shareholder return;
|
|
|
(iii)
|
Earnings per share;
|
|
|
(iv)
|
Operating income;
|
|
|
(v)
|
Net income;
|
|
|
(vi)
|
Pretax earnings;
|
|
|
(vii)
|
Earnings before interest, taxes, depreciation and amortization;
|
|
|
(viii)
|
Pro forma net income;
|
|
|
(ix)
|
Return on equity;
|
|
|
(x)
|
Return on designated assets;
|
|
|
(xi)
|
Return on capital;
|
|
|
(xii)
|
Economic value added;
|
|
|
(xiii)
|
Revenues;
|
|
|
(xiv)
|
Expenses;
|
|
|
(xv)
|
Operating profit margin;
|
|
|
(xvi)
|
Operating cash flow;
|
|
|
(xvii)
|
Free cash flow;
|
|
|
(xviii)
|
Cash flow return on investment;
|
|
|
(xix)
|
Operating margin or net profit margin; or
|
|
|
(xx)
|
Any of the above criteria as compared to the performance of a
published or a special index deemed applicable by the Board,
including, but not limited to, the Standard &
Poors 500 Stock Index.
|
If the Board determines that a change in the business,
operations, corporate structure or capital structure of the
Company, or the manner in which it conducts its business, or
other events or circumstances render the Management Objectives
unsuitable, the Board may in its discretion modify such
Management Objectives or the related level or levels of
achievement, in whole or in part, as the Board deems appropriate
and equitable, except in the case of a Qualified
Performance-Based Award (other than in connection with a Change
of Control) where such action would result in the loss of the
otherwise available exemption of the award under
Section 162(m) of the Code. In such case, the Board will
not make any modification of the Management Objectives or the
level or levels of achievement with respect to such Covered
Employee.
|
|
|
|
(t)
|
Market Value Per Share means, as of any
particular date, the average of the highest and lowest reported
sales prices of the Common Stock during normal trading hours on
the New York Stock Exchange Composite Tape or, if not
listed on such exchange, on any other national securities
exchange on which the Common Stock is listed. If there is no
regular public trading market for such Common Stock, the Market
Value Per
|
B-4
|
|
|
|
|
Share of the Common Stock shall be determined by the Board. The
Board is authorized to adopt another fair market value pricing
method, provided such method is stated in the Evidence of Award,
and is in compliance with the fair market value pricing rules
set forth in Section 409A of the Code.
|
|
|
|
|
(u)
|
Optionee means the optionee named in an
Evidence of Award evidencing an outstanding Option Right.
|
|
|
(v)
|
Option Price means the purchase price payable
on exercise of an Option Right.
|
|
|
(w)
|
Option Right means the right to purchase
shares of Common Stock upon exercise of an option granted
pursuant to Section 4 of this Plan.
|
|
|
(x)
|
Other Award means an award granted pursuant
to Section 9 of this Plan.
|
|
|
(y)
|
Participant means a person who is selected by
the Board to receive benefits under this Plan and who is at the
time an officer or other employee of the Company or any one or
more of its Subsidiaries, or who has agreed to commence serving
in any of such capacities within 90 days of the Date of
Grant. The term Participant shall also include any
person who provides services to the Company or a Subsidiary that
are substantially equivalent to those typically provided by an
employee.
|
|
|
(z)
|
Performance Period means, in respect of a
Performance Share or Performance Unit, a period of time
established pursuant to Section 8 of this Plan within which
the Management Objectives relating to such Performance Share or
Performance Unit are to be achieved.
|
|
|
(aa)
|
Performance Share means a bookkeeping entry
that records the equivalent of one share of Common Stock awarded
pursuant to Section 8 of this Plan.
|
|
|
(bb)
|
Performance Unit means a bookkeeping entry
awarded pursuant to Section 8 of this Plan that records a
unit equivalent to $1.00 or such other value as is determined by
the Board.
|
|
|
(cc)
|
Plan means The Sherwin-Williams Company 2006
Equity and Performance Incentive Plan (Amended and Restated as
of April 21, 2010), as may be further amended from time to
time.
|
|
|
(dd)
|
Post-CIC Period has the meaning provided in
Section 12 of this Plan.
|
|
|
(ee)
|
Qualified Performance-Based Award means any
award of Performance Shares, Performance Units, Restricted
Stock, Restricted Stock Units or Other Awards, or portion of
such award, to a Covered Employee that is intended to satisfy
the requirements for qualified performance-based
compensation under Section 162(m) of the Code.
|
|
|
(ff)
|
Restricted Stock means shares of Common Stock
granted or sold pursuant to Section 6 of this Plan as to
which neither the substantial risk of forfeiture nor the
prohibition on transfer has expired.
|
|
|
(gg)
|
Restriction Period means the period of time
during which Restricted Stock Units are subject to restrictions,
as provided in Section 7 of this Plan.
|
|
|
(hh)
|
Restricted Stock Unit means an award made
pursuant to Section 7 of this Plan of the right to receive
shares of Common Stock or cash at the end of a specified period.
|
|
|
(ii)
|
Spread means the excess of the Market Value
Per Share on the date when an Appreciation Right is exercised
over the Option Price or Base Price provided for in the related
Option Right or Free-Standing Appreciation Right, respectively.
|
B-5
|
|
|
|
(jj)
|
Subsidiary means a corporation, company or
other entity (i) at least 50 percent of whose
outstanding shares or securities (representing the right to vote
for the election of directors or other managing authority) are,
or (ii) which does not have outstanding shares or
securities (as may be the case in a partnership, joint venture
or unincorporated association), but at least 50 percent of
whose ownership interest representing the right generally to
make decisions for such other entity is, now or hereafter, owned
or controlled, directly or indirectly, by the Company except
that for purposes of determining whether any person may be a
Participant for purposes of any grant of Incentive Stock
Options, Subsidiary means any corporation in which
at the time the Company owns or controls, directly or
indirectly, at least 50 percent of the total combined
voting power represented by all classes of stock issued by such
corporation.
|
|
|
(kk)
|
Tandem Appreciation Right means an
Appreciation Right granted pursuant to Section 5 of this
Plan that is granted in tandem with an Option Right.
|
3. Shares Subject to this Plan.
|
|
|
|
(a)
|
Maximum Shares Available Under Plan.
|
|
|
|
|
(i)
|
Subject to adjustment as provided in Section 11 of this
Plan, the number of shares of Common Stock that may be issued or
transferred (A) upon the exercise of Option Rights or
Appreciation Rights; (B) as Restricted Stock and released
from substantial risks of forfeiture thereof; (C) in
payment of Restricted Stock Units; (D) in payment of
Performance Shares or Performance Units that have been earned;
(E) as Other Awards or in payment of Other Awards, or
(F) in payment of dividend equivalents paid with respect to
awards made under this Plan will not exceed in the aggregate
19,200,000 shares of Common Stock (10,000,000 of which were
approved by shareholders in 2006 and 9,200,000 of which will be
added upon approval by shareholders in 2010), plus any shares of
Common Stock relating to awards that expire or are forfeited or
are cancelled under this Plan. Such shares may be shares of
original issuance or treasury shares or a combination of the
foregoing.
|
|
|
(ii)
|
Each share of Common Stock issued or transferred pursuant to an
award of Option Rights or Appreciation Rights will reduce the
aggregate plan limit described above in Section 3(a)(i) by
one share of Common Stock. Each share of Common Stock issued or
transferred (and in the case of Restricted Shares, released from
all substantial risk of forfeiture) pursuant to an award other
than Option Rights or Appreciation Rights shall reduce the
aggregate plan limit described above in Section 3(a)(i) by
(A) one share of Common Stock if issued or transferred
pursuant to an award granted prior to the Effective Date and
(B) 2 shares of Common Stock if issued or transferred
pursuant to an award granted on or after the Effective Date. Any
shares of Common Stock that again become available for issuance
pursuant to this Section 3 shall be added back to the
aggregate plan limit in the same manner such shares were
originally deducted from the aggregate plan limit pursuant to
this Section 3(a)(ii).
|
|
|
(iii)
|
Shares of Common Stock covered by an award granted under this
Plan shall not be counted as used unless and until they are
actually issued and delivered to a Participant and, therefore,
the total number of shares available under this Plan as of a
given date shall not be reduced by any shares relating to prior
awards that have expired or have been forfeited or cancelled.
Upon payment in cash of the benefit provided by any award
granted under this Plan, any shares of Common Stock that were
covered by that award will be available for issue or transfer
hereunder. Notwithstanding anything to the contrary contained
herein: (A) if shares of Common Stock are tendered or
otherwise used in
|
B-6
|
|
|
|
|
payment of the Option Price of a Option Right, the total number
of shares covered by the Option Right being exercised shall
count against the aggregate plan limit described above;
(B) shares of Common Stock withheld by the Company to
satisfy the tax withholding obligation shall count against the
aggregate plan limit described above; (C) the number of
shares of Common Stock that are repurchased by the Company with
Option Right proceeds shall not increase the aggregate plan
limit described above; and (D) the number of shares of
Common Stock covered by an Appreciation Right, to the extent
that it is exercised and settled in shares of Common Stock,
whether or not all shares of Common Stock covered by the award
are actually issued to the Participant upon exercise of the
Appreciation Right, shall be considered issued or transferred
pursuant to this Plan. If, under this Plan, a Participant has
elected to give up the right to receive compensation in exchange
for shares of Common Stock based on fair market value, such
shares of Common Stock shall not count against the aggregate
plan limit described above.
|
|
|
|
|
(b)
|
Incentive Stock Option
Limit. Notwithstanding anything in this
Section 3, or elsewhere in this Plan, to the contrary and
subject to adjustment pursuant to Section 11 of this Plan,
the aggregate number of shares of Common Stock actually issued
or transferred by the Company upon the exercise of Incentive
Stock Options shall not exceed 19,200,000.
|
|
|
(c)
|
Individual Participant
Limits. Notwithstanding anything in this
Section 3, or elsewhere in this Plan, to the contrary and
subject to adjustment pursuant to Section 11 of this Plan:
|
|
|
|
|
(i)
|
No Participant shall be granted Option Rights or Appreciation
Rights, in the aggregate, for more than 500,000 shares of
Common Stock during any calendar year.
|
|
|
(ii)
|
No Participant will be granted Qualified Performance-Based
Awards of Restricted Stock, Restricted Stock Units or
Performance Shares or in the form of Other Awards payable in
Common Stock, in the aggregate, for more than
200,000 shares of Common Stock during any calendar year.
|
|
|
(iii)
|
No Participant will receive in any calendar year a Qualified
Performance-Based Award of Performance Units having an aggregate
maximum value as of their respective Dates of Grant in excess of
$5,000,000.
|
|
|
(iv)
|
No Participant will receive in any calendar year a Qualified
Performance-Based Award in the form of Other Awards payable in
cash under Section 9(b) having an aggregate maximum value
in excess of $5,000,000.
|
|
|
|
|
(d)
|
Exclusion from Certain
Restrictions. Notwithstanding anything in
this Plan to the contrary, up to 5% of the maximum number of
shares of Common Stock provided for in Section 3(a)(i)
above may be used for awards granted under Sections 6
through 9 of this Plan that do not comply with the three-year
requirements set forth in Sections 6(c), 7(c) and 9(d) of
this Plan and the one-year requirements of Sections 6(e),
7(a), 8(b) and 9(d) of this Plan.
|
4. Option Rights. The Board may,
from time to time and upon such terms and conditions as it may
determine, authorize the granting to Participants of options to
purchase shares of Common Stock. Each such grant will be subject
to all of the requirements contained in the following provisions:
|
|
|
|
(a)
|
Each grant will specify the number of shares of Common Stock to
which it pertains subject to the limitations set forth in
Section 3 of this Plan.
|
B-7
|
|
|
|
(b)
|
Each grant will specify an Option Price per share, which may not
be less than the Market Value Per Share on the Date of Grant.
|
|
|
(c)
|
Each grant will specify whether the Option Price will be payable
(i) in cash or by check acceptable to the Company or by
wire transfer of immediately available funds, (ii) by the
actual or constructive transfer to the Company of shares of
Common Stock owned by the Optionee having a value at the time of
exercise equal to the total Option Price, (iii) by a
combination of such methods of payment, or (iv) by such
other methods as may be approved by the Board.
|
|
|
(d)
|
To the extent permitted by law, any grant may provide for
deferred payment of the Option Price from the proceeds of sale
through a bank or broker on a date satisfactory to the Company
of some or all of the shares to which such exercise relates.
|
|
|
(e)
|
Successive grants may be made to the same Participant whether or
not any Option Rights previously granted to such Participant
remain unexercised.
|
|
|
(f)
|
Each grant will specify the period or periods of continuous
service by the Optionee with the Company or any Subsidiary that
is necessary before the Option Rights or installments thereof
will become exercisable. A grant of Option Rights may provide
for the earlier exercise of such Option Rights in the event of
the retirement, death or disability of the Participant or a
Change of Control.
|
|
|
(g)
|
Any grant of Option Rights may specify Management Objectives
that must be achieved as a condition to the exercise of such
rights. The grant of such Option Rights will specify that,
before the exercise of such rights, the Board must determine
that the Management Objectives have been satisfied.
|
|
|
(h)
|
Option Rights granted under this Plan may be (i) options,
including, without limitation, Incentive Stock Options, that are
intended to qualify under particular provisions of the Code,
(ii) options that are not intended so to qualify, or
(iii) combinations of the foregoing. Incentive Stock
Options may only be granted to Participants who meet the
definition of employees under Section 3401(c)
of the Code.
|
|
|
(i)
|
The exercise of an Option Right will result in the cancellation
on a share- for-share basis of any Tandem Appreciation Right
authorized under Section 5 of this Plan.
|
|
|
(j)
|
No Option Right will be exercisable more than 10 years from
the Date of Grant.
|
|
|
(k)
|
Each grant of Option Rights will be evidenced by an Evidence of
Award. Each Evidence of Award shall be subject to this Plan and
shall contain such terms and provisions, consistent with this
Plan, as the Board may approve.
|
5. Appreciation Rights.
|
|
|
|
(a)
|
The Board may also, from time to time and upon such terms and
conditions as it may determine, authorize the granting
(i) to any Optionee, of Tandem Appreciation Rights in
respect of Option Rights granted hereunder, and (ii) to any
Participant, of Free-Standing Appreciation Rights. A Tandem
Appreciation Right will be a right of the Optionee, exercisable
by surrender of the related Option Right, to receive from the
Company an amount determined by the Board, which will be
expressed as a percentage of the Spread (not exceeding
100 percent) at the time of exercise. Tandem Appreciation
Rights may be granted at any time prior to the exercise or
termination of the related Option Rights; provided, however,
that a Tandem Appreciation Right awarded in relation to an
Incentive Stock Option must be granted concurrently with such
Incentive Stock Option. A Free-Standing Appreciation Right will
be a right of the Participant to receive from the Company an
amount determined by the Board, which
|
B-8
|
|
|
|
|
will be expressed as a percentage of the Spread (not exceeding
100 percent) at the time of exercise.
|
|
|
|
|
(b)
|
Each grant of Appreciation Rights may utilize any or all of the
authorizations, and will be subject to all of the requirements,
contained in the following provisions:
|
|
|
|
|
(i)
|
Any grant may specify that the amount payable on exercise of an
Appreciation Right may be paid by the Company in cash, in shares
of Common Stock or in any combination thereof and may either
grant to the Participant or retain in the Board the right to
elect among those alternatives.
|
|
|
(ii)
|
Any grant may specify that the amount payable on exercise of an
Appreciation Right may not exceed a maximum specified by the
Board at the Date of Grant.
|
|
|
(iii)
|
Any grant may specify waiting periods before exercise and
permissible exercise dates or periods.
|
|
|
(iv)
|
Any grant may specify that such Appreciation Right may be
exercised only in the event of, or earlier in the event of, the
retirement, death or disability of the Participant or a Change
of Control.
|
|
|
(v)
|
Any grant of Appreciation Rights may specify Management
Objectives that must be achieved as a condition of the exercise
of such Appreciation Rights. The grant of such Appreciation
Rights will specify that, before the exercise of such
Appreciation Rights, the Board must determine that the
Management Objectives have been satisfied.
|
|
|
(vi)
|
Each grant of Appreciation Rights will be evidenced by an
Evidence of Award, which Evidence of Award will describe such
Appreciation Rights, identify the related Option Rights (if
applicable), and contain such other terms and provisions,
consistent with this Plan, as the Board may approve.
|
|
|
|
|
(c)
|
Any grant of Tandem Appreciation Rights will provide that such
Tandem Appreciation Rights may be exercised only at a time when
the related Option Right is also exercisable and at a time when
the Spread is positive, and by surrender of the related Option
Right for cancellation. Successive grants of Tandem Appreciation
Rights may be made to the same Participant regardless of whether
any Tandem Appreciation Rights previously granted to the
Participant remain unexercised.
|
|
|
(d)
|
Regarding Free-Standing Appreciation Rights only:
|
|
|
|
|
(i)
|
Each grant will specify in respect of each Free-Standing
Appreciation Right a Base Price, which may not be less than the
Market Value Per Share on the Date of Grant;
|
|
|
(ii)
|
Successive grants may be made to the same Participant regardless
of whether any Free-Standing Appreciation Rights previously
granted to the Participant remain unexercised; and
|
|
|
(iii)
|
No Free-Standing Appreciation Right granted under this Plan may
be exercised more than 10 years from the Date of Grant.
|
6. Restricted Stock. The Board may
also, from time to time and upon such terms and conditions as it
may determine, authorize the grant or sale of Restricted Stock
to Participants. Each such grant or sale may utilize any or all
of the authorizations, and will be subject to all of the
requirements, contained in the following provisions:
|
|
|
|
(a)
|
Each such grant or sale will constitute an immediate transfer of
the ownership of shares of Common Stock to the Participant in
consideration of the performance of services, entitling such
Participant to voting, dividend and other ownership rights, but
|
B-9
|
|
|
|
|
subject to the substantial risk of forfeiture and restrictions
on transfer hereinafter referred to.
|
|
|
|
|
(b)
|
Each such grant or sale may be made without additional
consideration or in consideration of a payment by such
Participant that is less than the Market Value Per Share at the
Date of Grant.
|
|
|
(c)
|
Each such grant or sale will provide that the Restricted Stock
covered by such grant or sale that vests upon the passage of
time will be subject to a substantial risk of
forfeiture within the meaning of Section 83 of the
Code for a period to be determined by the Board at the Date of
Grant or upon achievement of Management Objectives referred to
in Section 6(e) below. If the elimination of restrictions
is based only on the passage of time rather than the achievement
of Management Objectives, the period of time will be no shorter
than three years, except that the restrictions may be removed no
sooner than ratably on an annual basis during the three-year
period as determined by the Board at the Date of Grant.
|
|
|
(d)
|
Each such grant or sale will provide that during or after the
period for which such substantial risk of forfeiture is to
continue, the transferability of the Restricted Stock will be
prohibited or restricted in the manner and to the extent
prescribed by the Board at the Date of Grant (which restrictions
may include, without limitation, rights of repurchase or first
refusal in the Company or provisions subjecting the Restricted
Stock to a continuing substantial risk of forfeiture in the
hands of any transferee).
|
|
|
(e)
|
Any grant of Restricted Stock may specify Management Objectives
that, if achieved, will result in termination or early
termination of the restrictions applicable to such Restricted
Stock; provided, however, that restrictions relating to
Restricted Stock that vests upon the achievement of Management
Objectives may not terminate sooner than one year from the Date
of Grant. Each grant may specify in respect of such Management
Objectives a minimum acceptable level of achievement and may set
forth a formula for determining the number of shares of
Restricted Stock on which restrictions will terminate if
performance is at or above the minimum level, but falls short of
full achievement of the specified Management Objectives. The
grant of Restricted Stock will specify that, before the
termination or early termination of the restrictions applicable
to such Restricted Stock, the Board must determine that the
Management Objectives have been satisfied.
|
|
|
(f)
|
Notwithstanding anything to the contrary contained in this Plan,
any grant or sale of Restricted Stock may provide for the
earlier lapse of the substantial risk of forfeiture for such
Restricted Stock in the event of the retirement, death or
disability of the Participant or a Change of Control.
|
|
|
(g)
|
Any such grant or sale of Restricted Stock may require that any
or all dividends or other distributions paid thereon during the
period of such restrictions be automatically deferred and
reinvested in additional shares of Restricted Stock, which may
be subject to the same restrictions as the underlying award;
provided, however, that dividends or other distributions on
Restricted Stock subject to restrictions that lapse as a result
of the achievement of Management Objectives shall be deferred
until and paid contingent upon the achievement of the applicable
Management Objectives.
|
|
|
(h)
|
Each grant or sale of Restricted Stock will be evidenced by an
Evidence of Award and will contain such terms and provisions,
consistent with this Plan, as the Board may approve. Unless
otherwise directed by the Board, (i) all certificates
representing shares of Restricted Stock will be held in custody
by the Company until all restrictions thereon will have lapsed,
together with a stock power or powers executed by the
Participant in whose name such certificates are registered,
endorsed in blank and covering such Shares, or (ii) all
shares of Restricted Stock shall be held at the
|
B-10
|
|
|
|
|
Companys transfer agent in book entry form with
appropriate restrictions relating to the transfer of such shares
of Restricted Stock.
|
7. Restricted Stock Units. The
Board may also, from time to time and upon such terms and
conditions as it may determine, authorize the granting or sale
of Restricted Stock Units to Participants. Each such grant or
sale may utilize any or all of the authorizations, and will be
subject to all of the requirements, contained in the following
provisions:
|
|
|
|
(a)
|
Each such grant or sale will constitute the agreement by the
Company to deliver shares of Common Stock or cash to the
Participant in the future in consideration of the performance of
services, but subject to the fulfillment of such conditions
(which may include the achievement of Management Objectives)
during the Restriction Period as the Board may specify. If a
grant of Restricted Stock Units specifies that the Restriction
Period will terminate upon the achievement of Management
Objectives, such Restriction Period may not terminate sooner
than one year from the Date of Grant. Each grant may specify in
respect of such Management Objectives a minimum acceptable level
of achievement and may set forth a formula for determining the
number of shares of Restricted Stock Units on which restrictions
will terminate if performance is at or above the minimum level,
but falls short of full achievement of the specified Management
Objectives. The grant of such Restricted Stock Units will
specify that, before the termination or early termination of the
restrictions applicable to such Restricted Stock Units, the
Board must determine that the Management Objectives have been
satisfied.
|
|
|
(b)
|
Each such grant or sale may be made without additional
consideration or in consideration of a payment by such
Participant that is less than the Market Value Per Share at the
Date of Grant.
|
|
|
(c)
|
If the Restriction Period lapses only by the passage of time
rather than the achievement of Management Objectives, each such
grant or sale will be subject to a Restriction Period of not
less than three years, except that a grant or sale may provide
that the Restriction Period shall expire not sooner than ratably
on an annual basis during the three-year period as determined by
the Board at the Date of Grant.
|
|
|
(d)
|
Notwithstanding anything to the contrary contained in this Plan,
any grant or sale of Restricted Stock Units may provide for the
earlier lapse or other modification of the Restriction Period in
the event of the retirement, death or disability of the
Participant or a Change of Control.
|
|
|
(e)
|
During the Restriction Period, the Participant will have no
right to transfer any rights under his or her award and will
have no rights of ownership in the shares of Common Stock
deliverable upon payment of the Restricted Stock Units and shall
have no right to vote them, but the Board may at the Date of
Grant, authorize the payment of dividend equivalents on such
Restricted Stock Units on either a current, deferred or
contingent basis, either in cash or in additional shares of
Common Stock; provided, however, that dividend equivalents on
Restricted Stock Units subject to a Restriction Period that
lapses as a result of the achievement of Management Objectives
shall be deferred until and paid contingent upon the achievement
of the applicable Management Objectives.
|
|
|
(f)
|
Each grant or sale will specify the time and manner of payment
of Restricted Stock Units that have been earned. Any grant or
sale may specify that the amount payable with respect thereto
may be paid by the Company in cash, in shares of Common Stock or
in any combination thereof and may either grant to the
Participant or retain in the Board the right to elect among
those alternatives.
|
|
|
(g)
|
Each grant or sale of Restricted Stock Units will be evidenced
by an Evidence of Award and will contain such terms and
provisions, consistent with this Plan, as the Board may approve.
|
B-11
8. Performance Shares and Performance
Units. The Board may also, from time to time
and upon such terms and conditions as it may determine,
authorize the granting of Performance Shares and Performance
Units that will become payable to a Participant upon achievement
of specified Management Objectives during the Performance
Period. Each such grant may utilize any or all of the
authorizations, and will be subject to all of the requirements,
contained in the following provisions:
|
|
|
|
(a)
|
Each grant will specify the number of Performance Shares or
Performance Units to which it pertains, which number may be
subject to adjustment to reflect changes in compensation or
other factors; provided, however, that no such adjustment will
be made in the case of a Qualified Performance-Based Award
(other than in connection with the death or disability of the
Participant or a Change of Control) where such action would
result in the loss of the otherwise available exemption of the
award under Section 162(m) of the Code.
|
|
|
(b)
|
The Performance Period with respect to each Performance Share or
Performance Unit will be such period of time (not less than one
year), commencing with the Date of Grant as will be determined
by the Board at the time of grant which may be subject to
earlier lapse or other modification in the event of the
retirement, death or disability of the Participant or a Change
of Control.
|
|
|
(c)
|
Any grant of Performance Shares or Performance Units will
specify Management Objectives which, if achieved, will result in
payment or early payment of the award, and each grant may
specify in respect of such specified Management Objectives a
minimum acceptable level or levels of achievement and will set
forth a formula for determining the number of Performance Shares
or Performance Units that will be earned if performance is at or
above the level(s), but falls short of full achievement of the
specified Management Objectives. The grant of Performance Shares
or Performance Units will specify that, before the Performance
Shares or Performance Units will be earned and paid, the
Board must determine that the Management Objectives have been
satisfied.
|
|
|
(d)
|
Each grant will specify the time and manner of payment of
Performance Shares or Performance Units that have been earned.
Any grant may specify that the amount payable with respect
thereto may be paid by the Company in cash, in shares of Common
Stock or in any combination thereof and may either grant to the
Participant or retain in the Board the right to elect among
those alternatives.
|
|
|
(e)
|
Any grant of Performance Shares may specify that the amount
payable with respect thereto may not exceed a maximum specified
by the Board at the Date of Grant. Any grant of Performance
Units may specify that the amount payable or the number of
shares of Common Stock issued with respect thereto may not
exceed maximums specified by the Board at the Date of Grant.
|
|
|
(f)
|
The Board may at the Date of Grant of Performance Shares,
provide for the payment of dividend equivalents to the holder
thereof, either in cash or in additional shares of Common Stock,
on a deferred basis contingent upon the achievement of the
applicable Management Objectives.
|
|
|
(g)
|
Each grant of Performance Shares or Performance Units will be
evidenced by an Evidence of Award and will contain such other
terms and provisions, consistent with this Plan, as the Board
may approve.
|
9. Other Awards.
|
|
|
|
(a)
|
The Board may, subject to limitations under applicable law,
grant to any Participant such other awards that may be
denominated or payable in, valued in whole or in part by
reference to, or otherwise based on, or related to, shares of
Common Stock or factors that may influence the value of such
shares, including, without limitation, convertible or
exchangeable debt securities, other rights convertible or
exchangeable into shares of
|
B-12
|
|
|
|
|
Common Stock, purchase rights for shares of Common Stock, awards
with value and payment contingent upon performance of the
Company or specified Subsidiaries, affiliates or other business
units thereof or any other factors designated by the Board, and
awards valued by reference to the book value of shares of Common
Stock or the value of securities of, or the performance of
specified Subsidiaries or affiliates or other business units of
the Company. The Board shall determine the terms and conditions
of such awards. Shares of Common Stock delivered pursuant to an
award in the nature of a purchase right granted under this
Section 9 shall be purchased for such consideration, paid
for at such time, by such methods, and in such forms, including,
without limitation, cash, shares of Common Stock, other awards,
notes or other property, as the Board shall determine.
|
|
|
|
|
(b)
|
Cash awards, as an element of or supplement to any other award
granted under this Plan, may also be granted pursuant to this
Section 9 of this Plan.
|
|
|
(c)
|
The Board may grant shares of Common Stock as a bonus, or may
grant other awards in lieu of obligations of the Company or a
Subsidiary to pay cash or deliver other property under this Plan
or under other plans or compensatory arrangements, subject to
such terms as shall be determined by the Board in a manner that
complies with Section 409A of the Code.
|
|
|
(d)
|
If the earning or vesting of, or elimination of restrictions
applicable to, Other Awards is based only on the passage of time
rather than the achievement of Management Objectives, the period
of time shall be no shorter than three years, except that the
restrictions may be removed no sooner than ratably on an annual
basis during the three-year period as determined by the Board at
the Date of Grant. If the earning or vesting of, or elimination
of restrictions applicable to, Other Awards is based on the
achievement of Management Objectives, the earning, vesting or
restriction period may not terminate sooner than one year from
the Date of Grant.
|
10. Administration of this Plan.
|
|
|
|
(a)
|
This Plan will be administered by the Board, which may from time
to time delegate all or any part of its authority under this
Plan to the Compensation and Management Development Committee or
any other committee of the Board (or a subcommittee thereof), as
constituted from time to time. To the extent of any such
delegation, references in this Plan to the Board will be deemed
to be references to such committee or subcommittee.
|
|
|
(b)
|
The interpretation and construction by the Board of any
provision of this Plan or of any agreement, notification or
document evidencing the grant of Option Rights, Appreciation
Rights, Restricted Stock, Restricted Stock Units, Performance
Shares, Performance Units or Other Awards and any determination
by the Board pursuant to any provision of this Plan or of any
such agreement, notification or document will be final and
conclusive.
|
|
|
(c)
|
To the extent permitted by Ohio law, the Board may, from time to
time, delegate to one or more officers of the Company the
authority of the Board to grant and determine the terms and
conditions of awards granted under this Plan. In no event shall
any such delegation of authority be permitted with respect to
awards to any executive officer or any person subject to
Section 162(m) of the Code or who is an officer, director
or more than 10% beneficial owner of any class of the
Companys equity securities that is registered pursuant to
Section 12 of the Exchange Act, as determined by the Board
in accordance with Section 16 of the Exchange Act.
|
11. Adjustments. The Board shall
make or provide for such adjustments in the numbers of shares of
Common Stock covered by outstanding Option Rights, Appreciation
Rights, Restricted Stock Units, Performance Shares, Performance
Units and, if applicable, in the number of shares of Common
Stock covered by outstanding Other Awards granted hereunder, in
the Option Price and Base Price
B-13
provided in outstanding Appreciation Rights, and in the kind of
shares covered thereby, as the Board, in its sole discretion,
may determine is equitably required to prevent dilution or
enlargement of the rights of Participants or Optionees that
otherwise would result from (a) any stock dividend, stock
split, combination of shares, recapitalization or other change
in the capital structure of the Company, or (b) any merger,
consolidation, spin-off, split- off, spin-out,
split-up,
reorganization, partial or complete liquidation or other
distribution of assets, issuance of rights or warrants to
purchase securities, or (c) any other corporate transaction
or event having an effect similar to any of the foregoing.
Moreover, in the event of any such transaction or event, the
Board, in its discretion, may provide in substitution for any or
all outstanding awards under this Plan such alternative
consideration (including cash), if any, as it may determine to
be equitable in the circumstances and may require in connection
therewith the surrender of all awards so replaced in a manner
that complies with Section 409A of the Code. In addition,
for each Option Right or Appreciation Right with an Option Price
or Base Price greater than the consideration offered in
connection with any such transaction or event or change of
control, the Board may in its sole discretion elect to cancel
such Option Right or Appreciation Right without any payment to
the person holding such Option Right or Appreciation Right. The
Board shall also make or provide for such adjustments in the
numbers of shares specified in Section 3 of this Plan as
the Board in its sole discretion may determine is appropriate to
reflect any transaction or event described in this
Section 11; provided, however, that any such adjustment to
the number specified in Section 3(b)(i) will be made only
if and to the extent that such adjustment would not cause any
option intended to qualify as an Incentive Stock Option to fail
to so qualify.
12. Change of Control. Notwithstanding anything to
the contrary in this Plan, the following provisions shall apply
in connection with a Change of Control:
|
|
|
|
(a)
|
Awards Assumed by Successor
|
|
|
|
|
(i)
|
Upon the occurrence of a Change of Control, any awards made
under this Plan that are Assumed (as defined in
Section 12(a)(v) below) by the entity effecting the Change
of Control shall continue to vest and become exercisable in
accordance with the terms of the original grant unless, during
the three-year period commencing on the date of the Change of
Control (Post-CIC Period):
|
|
|
|
|
(A)
|
the Participant is involuntarily terminated for reasons other
than for Cause (as defined in Section 12(a)(iii)
below); or
|
|
|
(B)
|
the Participant terminates his or her employment for Good Reason
(as defined in Section 12(a)(iv) below).
|
|
|
|
|
(ii)
|
If a Participants employment is terminated as described in
Section 12(a)(i) above, any outstanding Option Rights and
Appreciation Rights shall become fully vested and exercisable,
any restrictions that apply to awards made pursuant to this Plan
shall lapse, and awards made pursuant to this Plan that are
subject to Management Objectives shall immediately be earned or
vest and shall become immediately payable in accordance with
their terms as if 100% of the Management Objectives have been
achieved, on the date of termination; provided, that any
Participant who terminates his or her employment for Good Reason
must:
|
|
|
|
|
(A)
|
provide the Company with a written notice of his her or her
intent to terminate employment for Good Reason within
60 days after the Participant becomes aware of the
circumstances giving rise to Good Reason; and
|
|
|
(B)
|
allow the Company thirty days to remedy such circumstances to
the extent curable.
|
B-14
|
|
|
|
(iii)
|
Solely for purposes of this Section 12(a),
Cause shall mean that the Participant shall have:
|
|
|
|
|
(A)
|
been convicted of a criminal violation involving, in each case,
fraud, embezzlement or theft in connection with
Participants duties or in the course of Participants
employment with Company or any subsidiary;
|
|
|
(B)
|
committed intentional wrongful damage to property of Company or
any Subsidiary; or
|
|
|
(C)
|
committed intentional wrongful disclosure of secret processes or
confidential information of Company or any Subsidiary;
|
and any such act shall have been demonstrably and materially
harmful to Company. For purposes of this Plan, no act or failure
to act on the part of Participant will be deemed
intentional if it was due primarily to an error in
judgment or negligence, but will be deemed
intentional only if done or omitted to be done by
Participant not in good faith and without reasonable belief that
Participants action or omission was in the best interest
of Company.
|
|
|
|
(iv)
|
Solely for purposes of this Section 12(a), Good
Reason shall mean the occurrence, during the Post-CIC
Period, of any of the following events without the
Participants written consent:
|
|
|
|
|
(A)
|
failure to elect or reelect or otherwise to maintain Participant
in the office or the position, or a substantially equivalent or
better office or position, of or with Company
and/or a
Subsidiary (or any successor thereto by operation of law or
otherwise), as the case may be, which Participant held
immediately prior to a Change in Control, or the removal of
Participant as a Director of Company
and/or a
Subsidiary (or any successor thereto) if Participant shall have
been a Director of Company
and/or a
Subsidiary immediately prior to the Change in Control;
|
|
|
(B)
|
failure of Company to remedy any of the following within 10
calendar days after receipt by Company of written notice thereof
from Participant: 1) a significant adverse change in the
nature or scope of the authorities, powers, functions,
responsibilities or duties attached to the position with Company
and any Subsidiary which Participant held immediately prior to
the Change in Control, 2) a reduction in Participants
Base Pay received from Company and any Subsidiary; 3) a
reduction in Participants Incentive Pay opportunity as
compared with the Incentive Pay opportunity most recently paid
prior to the Change in Control, or 4) the termination or
denial of Participants rights to Employee Benefits or a
reduction in the scope or value thereof;
|
|
|
(C)
|
the liquidation, dissolution, merger, consolidation or
reorganization of Company or the transfer of all or
substantially all of its business
and/or
assets, unless the successor (by liquidation, merger,
consolidation, reorganization, transfer or otherwise) to which
all or substantially all of its business
and/or
assets have been transferred (by operation of law or otherwise)
assumed all duties and obligation of Company under; or
|
|
|
|
|
(D)
|
Company requires Participant to have Participants
principal location of work changed to any location that is in
excess of 30 miles from the location thereof immediately
prior to the Change in Control, or requires Participant to
travel away from Participants office in the course of
discharging Participants responsibilities or duties
hereunder at least
|
B-15
|
|
|
|
|
20% more (in terms of aggregate days in any calendar year or in
any calendar quarter when annualized for purposes of comparison
to any prior year) than was required of Participant in any of
the three full years immediately prior to the Change in Control.
|
|
|
|
|
(E)
|
Definitions. As used in this Section 12(a),
|
|
|
|
|
1)
|
Base Pay means Participants annual base
salary rate as in effect from time to time.
|
|
|
2)
|
Incentive Pay means an annual bonus,
incentive or other payment of compensation, in addition to Base
Pay, made or to be made in regard to services rendered in any
year pursuant to any bonus, incentive, profit-sharing,
performance, discretionary pay or similar agreement, policy,
plan, program or arrangement (whether or not funded) of Company
or a Subsidiary, or any successor thereto. Incentive
Pay does not include any stock option, stock appreciation,
stock purchase, restricted stock, private equity, long-term
incentive or similar plan, program, arrangement or grant,
whether or not provided under a plan, program or arrangement
described in the preceding sentence.
|
|
|
3)
|
Employee Benefits means the perquisites,
benefits and service credit for benefits as provided under any
and all employee retirement income and welfare benefit policies,
plans, programs or arrangements in which Participant is entitled
to participate, including without limitation any stock option,
performance share, performance unit, stock purchase, stock
appreciation, savings, pension, supplemental executive
retirement, or other retirement income or welfare benefit,
deferred compensation, incentive compensation, group or other
life, health, medical/hospital or other insurance (whether
funded by actual insurance or self-insured by Company or a
Subsidiary), disability, salary continuation, expense
reimbursement and other employee benefit policies, plans,
programs or arrangements that may now exist or any equivalent
successor policies, plans, programs or arrangements that may be
adopted hereafter by Company or a Subsidiary, providing benefits
and service credit for benefits at least as great in the
aggregate as are payable thereunder immediately prior to a
Change in Control.
|
|
|
|
|
(v)
|
For purposes of this Section 12(a), an award shall be
considered assumed (Assumed) if each of the
following conditions are met:
|
|
|
|
|
(A)
|
Option Rights, Appreciation Rights and Other Awards (to the
extent such Other Awards are payable in cash and not subject to
Management Objectives) are converted into replacement awards in
a manner that complies with Section 409A of the Code;
|
|
|
(B)
|
Restricted Stock Unit and Restricted Stock awards that are not
subject to Management Objectives are converted into replacement
awards covering a number of shares of the entity effecting the
Change of Control (or a successor or parent corporation), as
determined in a manner substantially similar to the treatment of
an equal number of shares of Common Stock covered by the awards;
provided, that to the extent that any portion of the
consideration received by holders of shares of Common Stock in
the Change Control transaction is not in the
|
B-16
|
|
|
|
|
form of the common stock of such entity (or a successor or
parent corporation), the number of shares covered by the
replacement awards shall be based on the average of the high and
low selling prices of the common stock of such entity (or a
successor or parent corporation) on the established stock
exchange on the trading day immediately preceding the date of
the Change of Control;
|
|
|
|
|
(C)
|
Performance Shares, Performance Units and all other awards
subject to Management Objectives are converted into replacement
awards that preserve the value of such awards at the time of the
Change of Control;
|
|
|
|
|
(D)
|
the replacement awards contain provisions for scheduled vesting
and treatment on termination of employment (including the
definition of Cause and Good Reason) that are no less favorable
to the Participant than the underlying awards being replaced,
and all other terms of the replacement awards (other than the
security and number of shares represented by the replacement
awards) are substantially similar to, or more favorable to the
Participant than, the terms of the underlying awards; and
|
|
|
|
|
(E)
|
the security represented by the replacement awards, if any, is
of a class that is publicly held and widely traded on an
established stock exchange.
|
|
|
|
|
(b)
|
Awards Not Assumed by Successor
|
|
|
|
|
(i)
|
Upon the occurrence of a Change of Control, any awards made
under this Plan that are not Assumed by the entity effecting the
Change of Control shall become fully vested and exercisable on
the date of the Change of Control or shall immediately vest and
become immediately payable in accordance with their terms as if
100% of the applicable Management Objectives have been achieved,
and any restrictions that apply to such awards shall lapse.
|
|
|
(ii)
|
For each Option Right and Appreciation Right, the Participant
shall receive a payment equal to the difference between the
consideration (consisting of cash or other property (including
securities of a successor or parent corporation)) received by
holders of Common Stock in the Change of Control transaction and
the exercise price of the applicable Option Right or
Appreciation Right, if such difference is positive. Such payment
shall be made in the same form as the consideration received by
holders of Common Stock. Any Option Rights or Appreciation
Rights with an exercise price that is higher than the per share
consideration received by holders of Common Stock in connection
with the Change of Control shall be cancelled for no additional
consideration.
|
|
|
(iii)
|
The Participant shall receive the consideration (consisting of
cash or other property (including securities of a successor or
parent corporation)) that such Participant would have received
in the Change of Control transaction had he or she been,
immediately prior to such transaction, a holder of the number of
shares of Common Stock equal to the number of Restricted Stock
Units and/or
shares of Restricted Stock covered by the award and the number
of shares of Common Stock payable under Section 12(b)(i)
for awards subject to Management Objectives.
|
|
|
(iv)
|
The payments contemplated by Sections 12(b)(ii) and
12(b)(iii) shall be made at the same time as consideration is
paid to the holders of the Common Stock in connection with the
Change of Control.
|
B-17
|
|
|
|
(v)
|
Notwithstanding anything to the contrary in this Plan, if the
Change of Control does not constitute a 409A Change of Control
and the payment or benefit constitutes a deferral of
compensation under Section 409A of the Code, then to the
extent necessary to comply with Section 409A of the Code
payment or delivery shall be made on the date of payment or
delivery originally provided for such payment or benefit.
|
13. Recapture Provisions. Any
Evidence of Award may provide for the cancellation or forfeiture
of an award or the forfeiture and repayment to the Company of
any gain related to an award, or other provisions intended to
have a similar effect, upon such terms and conditions as may be
determined by the Board in accordance with the Companys
Executive Adjustment and Recapture Policy, as may be amended
from time to time, any successor policy or otherwise.
14. Non U.S. Participants. In
order to facilitate the making of any grant or combination of
grants under this Plan, the Board may provide for such special
terms for awards to Participants who are foreign nationals or
who are employed by the Company or any Subsidiary outside of the
United States of America or who provide services to the
Company under an agreement with a foreign nation or agency, as
the Board may consider necessary or appropriate to accommodate
differences in local law, tax policy or custom. Moreover, the
Board may approve such supplements to or amendments,
restatements or alternative versions of this Plan (including,
without limitation,
sub-plans)
as it may consider necessary or appropriate for such purposes,
without thereby affecting the terms of this Plan as in effect
for any other purpose, and the Secretary or other appropriate
officer of the Company may certify any such document as having
been approved and adopted in the same manner as this Plan. No
such special terms, supplements, amendments or restatements,
however, will include any provisions that are inconsistent with
the terms of this Plan as then in effect unless this Plan could
have been amended to eliminate such inconsistency without
further approval by the shareholders of the Company.
15. Transferability.
|
|
|
|
(a)
|
No Option Right or Appreciation Right granted under this Plan
shall be transferable by the Participant except by will or the
laws of descent and distribution, and in no event shall any
award granted under this Plan be transferred for value. Except
as otherwise determined by the Board, Option Rights and
Appreciation Rights will be exercisable during the
Participants lifetime only by him or her or, in the event
of the Participants legal incapacity to do so, by his or
her guardian or legal representative acting on behalf of the
Participant in a fiduciary capacity under state law
and/or court supervision.
|
|
|
(b)
|
The Board may specify at the Date of Grant that part or all of
the shares of Common Stock that are (i) to be issued or
transferred by the Company upon the exercise of Option Rights or
Appreciation Rights, upon the termination of the Restriction
Period applicable to Restricted Stock Units or upon payment
under any grant of Performance Shares, Performance Units or
Other Awards or (ii) no longer subject to the substantial
risk of forfeiture and restrictions on transfer referred to in
Section 6 of this Plan, will be subject to further
restrictions on transfer.
|
16. Withholding Taxes. To the
extent that the Company is required to withhold federal, state,
local or foreign taxes in connection with any payment made or
benefit realized by a Participant or other person under this
Plan, and the amounts available to the Company for such
withholding are insufficient, it will be a condition to the
receipt of such payment or the realization of such benefit that
the Participant or such other person make arrangements
satisfactory to the Company for payment of the balance of such
taxes required to be withheld, which arrangements (in the
discretion of the Board) may include relinquishment of a portion
of such benefit. If a Participants benefit is to be
received in the form of Common Stock, and such Participant fails
to make arrangements for the payment of tax, the Company shall
withhold such shares of Common Stock having a value equal to the
amount required to be withheld. Notwithstanding the foregoing,
unless otherwise provided by the
B-18
Board, when a Participant is required to pay the Company an
amount required to be withheld under applicable income and
employment tax laws, the Participant may elect to satisfy the
obligation, in whole or in part, by electing to have withheld,
from the shares required to be delivered to the Participant,
shares of Common Stock having a value equal to the amount
required to be withheld (except in the case of Restricted Stock
where an election under Section 83(b) of the Code has been
made), or by delivering to the Company other shares of Common
Stock held by such Participant. The shares used for tax
withholding will be valued at an amount equal to the Market
Value Per Share of such Common Stock on the date the benefit is
to be included in Participants income. In no event shall
the Market Value Per Share of the shares of Common Stock to be
withheld
and/or
delivered pursuant to this Section to satisfy applicable
withholding taxes in connection with the benefit exceed the
minimum amount of taxes required to be withheld. Participants
shall also make such arrangements as the Company may require for
the payment of any withholding tax obligation that may arise in
connection with the disposition of shares of Common Stock
acquired upon the exercise of Option Rights.
17. Compliance with Section 409A of the
Code.
|
|
|
|
(a)
|
To the extent applicable, it is intended that this Plan and any
grants made hereunder comply with the provisions of
Section 409A of the Code, so that the income inclusion
provisions of Section 409A(a)(1) of the Code do not apply
to the Participants. This Plan and any grants made hereunder
shall be administered in a manner consistent with this intent.
Any reference in this Plan to Section 409A of the Code will
also include any regulations or any other formal guidance
promulgated with respect to such Section by the
U.S. Department of the Treasury or the Internal Revenue
Service.
|
|
|
(b)
|
Neither a Participant nor any of a Participants creditors
or beneficiaries shall have the right to subject any deferred
compensation (within the meaning of Section 409A of the
Code) payable under this Plan and grants of deferred
compensation hereunder to any anticipation, alienation, sale,
transfer, assignment, pledge, encumbrance, attachment or
garnishment. Except as permitted under Section 409A of the
Code, any deferred compensation (within the meaning of
Section 409A of the Code) payable to a Participant or for a
Participants benefit under this Plan and grants of
deferred compensation hereunder may not be reduced by, or offset
against, any amount owing by a Participant to the Company or any
of its affiliates.
|
|
|
(c)
|
If, at the time of a Participants separation from service
(within the meaning of Section 409A of the Code),
(i) the Participant shall be a specified employee (within
the meaning of Section 409A of the Code and using the
identification methodology selected by the Company from time to
time) and (ii) the Company shall make a good faith
determination that an amount payable hereunder constitutes
deferred compensation (within the meaning of Section 409A
of the Code) the payment of which is required to be delayed
pursuant to the six-month delay rule set forth in
Section 409A of the Code in order to avoid taxes or
penalties under Section 409A of the Code, then the Company
shall not pay such amount on the otherwise scheduled payment
date but shall instead pay it, without interest, on the first
business day of the month after such six-month period.
|
|
|
(d)
|
For purposes of the Plan and its underlying agreements, a
409A Change in Control means the date on which any
one of the following occurs: (i) any one person, or more
than one person acting as a group (as determined under Code
Section 409A and the regulations promulgated thereunder),
acquires (or has acquired during the twelve (12) month
period ending on the date of the most recent acquisition by such
person or persons) ownership of stock of the Company possessing
30% or more of the total voting power of the stock of the
Company; or (ii) a majority of the members of the Board is
replaced during any
12-month
period by directors whose appointment or election is not
|
B-19
|
|
|
|
|
endorsed by a majority of the members of the Board before the
date of such appointment or election; or (iii) any one
person, or more than one person acting as a group (as determined
under Code Section 409A and the regulations promulgate
thereunder), acquires ownership of stock of the Company that,
together with stock held by such person or group, constitutes
more than 50% of the total fair market value or total voting
power of the stock of the Company; or (iv) any one person,
or more than one person acting as a group (as determined under
Code Section 409A and the regulation thereunder), acquires
(or has acquired during the twelve (12) month period ending
on the date of the most recent acquisition by such person or
persons) assets from the Company that have a total gross fair
market value equal to or more than 40% of the total gross fair
market value of all of the assets of the Company before such
acquisition or acquisitions. For this purpose, gross fair
market value means the value of the assets of the Company,
or the value of the assets being disposed of, determined without
regard to any liabilities associated with such assets.
|
|
|
|
|
(e)
|
Notwithstanding any provision of this Plan and grants hereunder
to the contrary, in light of the uncertainty with respect to the
proper application of Section 409A of the Code, the Company
reserves the right to make amendments to this Plan and grants
hereunder as the Company deems necessary or desirable to avoid
the imposition of taxes or penalties under Section 409A of
the Code. In any case, a Participant shall be solely responsible
and liable for the satisfaction of all taxes and penalties that
may be imposed on a Participant or for a Participants
account in connection with this Plan and grants hereunder
(including any taxes and penalties under Section 409A of
the Code), and neither the Company nor any of its affiliates
shall have any obligation to indemnify or otherwise hold a
Participant harmless from any or all of such taxes or penalties.
|
18. Additional Restrictions with Respect to Qualified
Performance-Based Awards.
|
|
|
|
(a)
|
Qualified Performance-Based Awards shall be granted by a
committee, which may be the Compensation and Management
Development Committee or any other committee of the Board (or a
subcommittee thereof), provided that such committee consists
solely of two or more outside directors within the
meaning of Section 162(m) of the Code.
|
|
|
(b)
|
To the extent that a Qualified Performance-Based Award shall be
based on achievement of Management Objectives, the committee
shall establish and approve the Management Objectives in writing
prior to the latest possible date, but in no event more than
90 days after the commencement of services to which the
Management Objectives relates, that will not jeopardize the
award as qualifying as qualified performance-based
compensation under Section 162(m) of the Code.
|
|
|
(c)
|
Other than in connection with the Participants death or
disability, or a Change in Control, the terms of a Qualified
Performance-Based Award may not be amended where such action
would result in the loss of the otherwise available exemption of
the award under Section 162(m) of the Code.
|
|
|
(d)
|
In no event shall a Participants Qualified
Performance-Based Awards exceed the Individual Participant
Limits described in Section 3(c).
|
|
|
(e)
|
Qualified Performance-Based Awards are intended to satisfy the
requirements for qualified performance-based
compensation under Section 162(m) of the Code and the
terms relating to such awards are to be interpreted and operated
accordingly.
|
19. Effective Date. The
Sherwin-Williams Company 2006 Equity and Performance Incentive
Plan first became effective on April 20, 2006, the date
immediately following the date it was approved by shareholders.
No grants have been or are permitted under The Sherwin-Williams
Company 2003 Stock Plan on or after April 20, 2006. This
Plan shall be effective as of the Effective Date.
B-20
20. Amendments.
|
|
|
|
(a)
|
The Board may at any time and from time to time amend this Plan
in whole or in part; provided, however, that if an amendment to
this Plan (i) would materially increase the benefits
accruing to Participants under this Plan, (ii) would
materially increase the number of securities which may be issued
under this Plan, (iii) would materially modify the
requirements for participation in this Plan or (iv) must
otherwise be approved by the shareholders of the Company in
order to comply with applicable law or the rules of the New York
Stock Exchange or, if the shares of Common Stock are not traded
on the New York Stock Exchange, the principal national
securities exchange upon which the shares of Common Stock are
traded or quoted, then, such amendment will be subject to
shareholder approval and will not be effective unless and until
such approval has been obtained.
|
|
|
(b)
|
Except in connection with a corporate transaction or event
described in Section 11 of this Plan, the terms of
outstanding awards may not be amended to reduce the Option Price
of outstanding Option Rights or the Base Price of outstanding
Appreciation Rights, or cancel outstanding Option Rights or
Appreciation Rights in exchange for cash, other awards or Option
Rights or Appreciation Rights with an Option Price or Base
Price, as applicable, that is less than the Option Price of the
original Option Rights or Base Price of the original
Appreciation Rights, as applicable, without shareholder
approval. This Section 20(b) is intended to prohibit the
repricing of underwater Option Rights and
Appreciation Rights and will not be construed to prohibit the
adjustments provided for in Section 11 of this Plan.
Notwithstanding any provision of this Plan to the contrary, this
Section 20(b) may not be amended without shareholder
approval.
|
|
|
(c)
|
If permitted by Section 409A of the Code, but subject to
the paragraph that follows, in case of termination of employment
by reason of death, disability or normal or early retirement of
a Participant who holds an Option Right or Appreciation Right
not immediately exercisable in full, or any shares of Restricted
Stock as to which the substantial risk of forfeiture or the
prohibition or restriction on transfer has not lapsed, or any
Restricted Stock Units as to which the Restriction Period has
not been completed, or any Performance Shares or Performance
Units which have not been fully earned, or any Other Awards that
have not been fully earned or that are subject to any vesting
schedule or transfer restriction, or who holds shares of Common
Stock subject to any transfer restriction imposed pursuant to
Section 15 of this Plan, or in the case of a Change of
Control, the Board may, in its sole discretion, accelerate the
time at which such Option Right, Appreciation Right or other
award may be exercised or the time at which such substantial
risk of forfeiture or prohibition or restriction on transfer
will lapse or the time when such Restriction Period will end or
the time at which such Performance Shares or Performance Units
will be deemed to have been fully earned or the time when such
Other Awards shall be deemed to have been fully earned or vested
or that such transfer restriction will terminate or may waive
any other limitation or requirement under any such award.
|
|
|
|
|
|
Subject to Section 17(b) hereof, the Board may amend the
terms of any award theretofore granted under this Plan
prospectively or retroactively, except in the case of a
Qualified Performance-Based Award (other than in connection with
the Participants death or disability, or a Change of
Control) where such action would result in the loss of the
otherwise available exemption of the award under
Section 162(m) of the Code. In such case, the Board will
not make any modification of the Management Objectives or the
level or levels of achievement with respect to such Qualified
Performance-Based Award. Subject to Section 11 above, no
such amendment shall impair the rights of any Participant
without his or her consent. The Board may, in its discretion,
terminate this
|
B-21
|
|
|
|
|
Plan at any time. Termination of this Plan will not affect the
rights of Participants or their successors under any awards
outstanding hereunder and not exercised in full on the date of
termination.
|
21. Termination. No grant will be
made under this Plan after April 20, 2020 (more than
10 years after the date on which this Plan is approved by
the shareholders of the Company), but all grants made on or
prior to such date will continue in effect thereafter subject to
the terms thereof and of this Plan.
22. Governing Law. This Plan and
all grants and awards and actions taken thereunder shall be
governed by and construed in accordance with the internal
substantive laws of the State of Ohio.
23. Miscellaneous Provisions.
|
|
|
|
(a)
|
The Company will not be required to issue any fractional shares
of Common Stock pursuant to this Plan. The Board may provide for
the elimination of fractions or for the settlement of fractions
in cash.
|
|
|
(b)
|
This Plan will not confer upon any Participant any right with
respect to continuance of employment or other service with the
Company or any Subsidiary, nor will it interfere in any way with
any right the Company or any Subsidiary would otherwise have to
terminate such Participants employment or other service at
any time.
|
|
|
(c)
|
To the extent that any provision of this Plan would prevent any
Option Right that was intended to qualify as an Incentive Stock
Option from qualifying as such, that provision will be null and
void with respect to such Option Right. Such provision, however,
will remain in effect for other Option Rights and there will be
no further effect on any provision of this Plan.
|
|
|
(d)
|
No award under this Plan may be exercised by the holder thereof
if such exercise, and the receipt of cash or stock thereunder,
would be, in the opinion of counsel selected by the Board,
contrary to law or the regulations of any duly constituted
authority having jurisdiction over this Plan.
|
|
|
(e)
|
Absence on leave approved by a duly constituted officer of the
Company or any of its Subsidiaries shall not be considered
interruption or termination of service of any employee for any
purposes of this Plan or awards granted hereunder.
|
|
|
(f)
|
No Participant shall have any rights as a stockholder with
respect to any shares subject to awards granted to him or her
under this Plan prior to the date as of which he or she is
actually recorded as the holder of such shares upon the stock
records of the Company.
|
|
|
(g)
|
The Board may condition the grant of any award or combination of
awards authorized under this Plan on the surrender or deferral
by the Participant of his or her right to receive a cash bonus
or other compensation otherwise payable by the Company or a
Subsidiary to the Participant.
|
|
|
(h)
|
Participants shall provide the Company with a written election
form setting forth the name and contact information of the
person who will have beneficial ownership rights upon the death
of the Participant.
|
|
|
(i)
|
If any provision of this Plan is or becomes invalid, illegal or
unenforceable in any jurisdiction, or would disqualify this Plan
or any award under any law deemed applicable by the Board, such
provision shall be construed or deemed amended or limited in
scope to conform to applicable laws or, in the discretion of the
Board, it shall be stricken and the remainder of this Plan shall
remain in full force and effect.
|
B-22
YOUR VOTE IS IMPORTANT. PLEASE VOTE TODAY.
We encourage you to take advantage of Internet or telephone voting.
Both are available 24 hours a day, 7 days a week.
Internet and telephone voting is available through 11:59 PM Eastern Time the day prior to Annual
Meeting day.
INTERNET http:
//www.proxyvoting.com/shw
Use the Internet to vote your proxy. Have your proxy card in hand when you access the web site.
OR
TELEPHONE
1-866-540-5760
Use any touch-tone telephone to vote your proxy. Have your proxy card in hand when you call.
If you vote your proxy by Internet
or by telephone, you do NOT need to mail
back your proxy card.
To vote by mail,
mark, sign and date your proxy card and
return it in the enclosed postage-paid
envelope.
Your Internet or telephone vote authorizes
the named proxies to vote your shares in
the same manner as if you marked, signed
and returned your proxy card.
WO#
68937
6 FOLD AND DETACH HERE 6
THIS PROXY WILL BE VOTED AS DIRECTED, OR IF NO DIRECTION IS INDICATED,
WILL BE VOTED FOR THE ELECTION OF DIRECTORS, FOR ITEMS 2 AND 3 AND AGAINST ITEM 4.
|
|
|
|
|
|
|
Please mark your votes as
indicated in this example
|
|
x |
The Board of Directors recommends a vote FOR all nominees for director:
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR ALL |
|
WITHHOLD FOR ALL |
|
*EXCEPTIONS |
|
|
|
|
|
|
|
|
|
1.
|
|
ELECTION OF DIRECTORS |
|
|
|
|
|
|
|
|
Nominees: |
|
|
|
|
|
|
|
|
01 A.F. ANTON
02 J.C. BOLAND
|
|
o
|
|
o
|
|
o |
|
|
03 C.M. CONNOR |
|
|
|
|
|
04 D.F. HODNIK |
|
|
|
|
|
|
|
|
05 T.G. KADIEN |
|
|
|
|
|
|
|
|
06 S.J. KROPF |
|
|
|
|
|
|
|
|
07 G.E. MCCULLOUGH |
|
|
|
|
|
|
|
|
08 A.M. MIXON, III |
|
|
|
|
|
|
|
|
09 C.E. MOLL |
|
|
|
|
|
|
|
|
10 R.K. SMUCKER |
|
|
|
|
|
|
|
|
11 J.M. STROPKI, JR. |
|
|
|
|
|
|
|
|
|
(INSTRUCTIONS: To withhold authority to vote for any individual nominee, mark the |
|
|
Exceptions box above and write that nominees name in the space provided below.) |
The Board of Directors recommends a vote FOR proposals 2 and 3:
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR |
|
AGAINST |
|
ABSTAIN |
|
|
|
|
|
|
|
|
|
2.
|
|
Amend and Restate the 2006 Equity and Performance Incentive Plan.
|
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
3.
|
|
Ratify Ernst & Young LLP as our independent registered public accounting firm for 2010.
|
|
o
|
|
o
|
|
o |
The Board of Directors recommends a vote AGAINST proposal 4:
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR |
|
AGAINST |
|
ABSTAIN |
|
|
|
|
|
|
|
|
|
4.
|
|
Shareholder proposal relating to majority voting.
|
|
o
|
|
o
|
|
o |
* Exceptions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mark Here for
Address Change
or Comments
SEE REVERSE
|
|
o |
Please sign exactly as your name appears hereon. Joint owners should each sign. When signing as
attorney, executor, administrator, trustee, guardian or in other representative capacity, please
give your full title.
ADMISSION TICKET - 2010 ANNUAL MEETING
2010 ANNUAL MEETING OF SHAREHOLDERS
THE SHERWIN-WILLIAMS COMPANY
Tuesday, April 20, 2010
9:00 A.M.
Landmark
Conference Center
927 Midland Building
101 West Prospect Avenue
Cleveland, Ohio
At the
Annual Meeting, shareholders will act upon the proposals outlined in the Notice of Annual
Meeting of Shareholders, including the election of directors, the
amendment and restatement of
the 2006 Equity and Performance Incentive Plan, the ratification of the appointment of
Sherwin-Williams independent registered public accounting firm, the consideration of a
shareholder proposal relating to majority voting if presented at the Annual Meeting, and the
consideration of such other business as may properly come before the Annual Meeting.
This Admission Ticket only admits the shareholder identified on the reverse side and is
non-transferable. We may also ask you to present valid photo identification to enter the Annual
Meeting.
Choose MLinkSM for fast, easy and secure 24/7 online access to
your future proxy materials, investment plan statements, tax documents and
more. Simply log on to Investor ServiceDirect® at www.bnymellon.com/shareowner/isd where step-by-step instructions will prompt you
through enrollment.
Important
notice regarding the availability of proxy materials for
the
Annual Meeting of Shareholders to be held on April 20, 2010.
The Proxy Statement and the 2009 Annual Report to Shareholders are
available at:
http://proxymaterials.sherwin.com
FOLD AND DETACH HERE
PROXY/VOTING INSTRUCTION CARD
THE SHERWIN-WILLIAMS COMPANY
ANNUAL MEETING OF SHAREHOLDERS APRIL 20, 2010
The undersigned hereby appoints C.M. CONNOR, S.P. HENNESSY and L.E. STELLATO, and each of
them, with power to act without the other and with power of substitution, as proxies and
attorneys-in-fact and hereby authorizes them to represent and vote,
as provided on the other side,
all the shares of common stock and ESOP serial preferred stock of The Sherwin-Williams Company
which the undersigned is entitled to vote, and, in their discretion,
to vote upon such other
business as may properly come before the Annual Meeting of Shareholders to be held April 20, 2010
or at any adjournment or postponement thereof, with all powers which
the undersigned would possess
if present at the Meeting. This card also provides voting instructions for shares of common stock,
if any, held for the account of the undersigned by The Bank of New
York Mellon, as agent of the
Stock Ownership and Automatic Dividend Reinvestment Plan, and by Fidelity Management Trust Company,
as trustee of the Employee Stock Purchase and Savings Plan.
This card is solicited jointly by the Board of Directors, The Bank of New York Mellon (with
respect to shares held under the Dividend Reinvestment Plan) and Fidelity (with respect to
shares held under the Stock Purchase and Savings Plan). If you do not timely sign and return this
card, the proxy holders cannot vote your shares (or, in the case of the Employee Stock Purchase
and Savings Plan, if you do not sign and return this card by the close of business on April 15,
2010, your shares will be voted in the same proportion as Fidelity votes those shares for which it
receives proper instructions).
Address Change/Comments
(Mark the corresponding box on the reverse side)
BNY
MELLON SHAREOWNER SERVICES
P.O. BOX 3550
SOUTH HACKENSACK, NJ 07606-9250
(Continued and to be marked, dated and signed, on the other side)
WO#
68937